index	sentence	label
0	@COMPOUND$) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/FE65 nuclear translocation and @PROTEIN$ activation.	1
1	@COMPOUND$) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-@PROTEIN$/FE65 nuclear translocation and GSK3 beta activation.	1
2	@COMPOUND$) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/@PROTEIN$ nuclear translocation and GSK3 beta activation.	1
3	Here, we used a human neuronal cell line MC65 conditional expression of an amyloid precursor protein fragment (@PROTEIN$) to investigate the protection mechanism of epigallocatechin gallate (EGCG), the main constituent of @COMPOUND$.	0
4	Here, we used a human neuronal cell line MC65 conditional expression of an amyloid precursor protein fragment (@PROTEIN$) to investigate the protection mechanism of @COMPOUND$), the main constituent of green tea.	0
5	The @PROTEIN$ was purified to homogeneity using ammonium @COMPOUND$ precipitation, and ion exchange chromatography with a fold purification of 1.8 and a recovery of 49%.	0
6	The @PROTEIN$ was purified to homogeneity using @COMPOUND$ sulfate precipitation, and ion exchange chromatography with a fold purification of 1.8 and a recovery of 49%.	0
7	In addition, we demonstrated that Hsp20, @PROTEIN$ and HspB8 induced interleukin-6 production in cultured pericytes and astrocytes, which could be antagonized by @COMPOUND$, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	0
8	In addition, we demonstrated that Hsp20, HspB2 and HspB8 induced @PROTEIN$ production in cultured pericytes and astrocytes, which could be antagonized by @COMPOUND$, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	1
9	In addition, we demonstrated that Hsp20, HspB2 and @PROTEIN$ induced interleukin-6 production in cultured pericytes and astrocytes, which could be antagonized by @COMPOUND$, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	0
10	Although @PROTEIN$4 has been repeatedly associated with altered sphingomyelin and @COMPOUND$ levels in tissue culture and rodent models, there has not been a direct quantification of sphingomyelin or sterol levels in the brains of patients with different forms of ApoE.	1
11	Here we show that during growth in media containing @COMPOUND$ and in complex medium without glucose RamB activates expression of the @PROTEIN$ gene, encoding the E1p subunit of the pyruvate dehydrogenase complex.	0
12	In addition, treatment with @COMPOUND$ increased interleukin-4 (@PROTEIN$) mRNA and reversed the age-related decrease in hippocampal IL-4 concentration.	1
13	@PROTEIN$ (Cox-2) is a key enzyme in the conversion of @COMPOUND$ to prostaglandins that has been shown to have a particular importance in the progression of several malignancies including nasopharyngeal carcinoma (NPC).	1
14	Cyclooxygenase-2 (@PROTEIN$) is a key enzyme in the conversion of @COMPOUND$ to prostaglandins that has been shown to have a particular importance in the progression of several malignancies including nasopharyngeal carcinoma (NPC).	1
15	Other potential treatments discussed for possible use with long-acting @PROTEIN$ overdoses include incision and drainage of the injection site, glucagon, and @COMPOUND$.	0
16	To assess whether follicle-stimulating hormone (FSH) and basic fibroblast growth factor (bFGF) modulate @COMPOUND$ production in Sertoli cells by regulating the expression of GCLC, @PROTEIN$ and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	0
17	To assess whether follicle-stimulating hormone (FSH) and @PROTEIN$ (bFGF) modulate @COMPOUND$ production in Sertoli cells by regulating the expression of GCLC, GCLM and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	0
18	To assess whether follicle-stimulating hormone (FSH) and basic fibroblast growth factor (bFGF) modulate @COMPOUND$ production in Sertoli cells by regulating the expression of @PROTEIN$, GCLM and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	0
19	In conclusion, our results show that FSH and bFGF increase @COMPOUND$ levels in Sertoli cells through stimulation of the de novo synthesis and recycling by upregulating @PROTEIN$ and GR expression respectively.	0
20	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and @PROTEIN$ (POD) activities, and LPO.	0
21	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (SOD) and @PROTEIN$ (POD) activities, and LPO.	0
22	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (@PROTEIN$) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and LPO.	0
23	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, @PROTEIN$ (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and LPO.	0
24	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (@PROTEIN$) and peroxidase (POD) activities, and LPO.	0
25	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and peroxidase (@PROTEIN$) activities, and LPO.	0
26	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (@PROTEIN$) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and LPO.	0
27	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (@PROTEIN$) and peroxidase (POD) activities, and LPO.	0
28	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and @PROTEIN$.	0
29	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, @PROTEIN$ (SOD) and peroxidase (POD) activities, and LPO.	0
30	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (SOD) and peroxidase (@PROTEIN$) activities, and LPO.	0
31	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, ascorbic acid, @PROTEIN$ (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and @COMPOUND$ contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and LPO.	0
32	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, superoxide dismutase (SOD) and peroxidase (POD) activities, and @PROTEIN$.	0
33	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, @COMPOUND$, catalase (CAT) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and proline contents, @PROTEIN$ (SOD) and peroxidase (POD) activities, and LPO.	0
34	Selenium and @COMPOUND$ levels were not associated to @PROTEIN$ Abeta42.	0
35	In vitro, the degradation of synthetic Abeta substrate added to @PROTEIN$ was markedly accelerated by low levels (2microM) of exogenous zinc and @COMPOUND$.	1
36	Structure-function studies of nitrated @PROTEIN$ in aging heart and skeletal muscle demonstrate stoichiometric nitration of vicinal tyrosines, Tyr (294) and Tyr (295), on the lumenal side of the membrane-spanning helix, @COMPOUND$, which correlates with partial inhibition of Ca(2+)-ATPase activity suggesting a possible regulatory function in down-regulating mitochondrial energy production and the associated generation of reactive oxygen/nitrogen species.	0
37	Structure-function studies of nitrated @PROTEIN$ in aging heart and skeletal muscle demonstrate stoichiometric nitration of vicinal tyrosines, Tyr (294) and Tyr (295), on the lumenal side of the membrane-spanning helix, M4, which correlates with partial inhibition of Ca(2+)-ATPase activity suggesting a possible regulatory function in down-regulating mitochondrial energy production and the associated generation of reactive @COMPOUND$/nitrogen species.	0
38	Structure-function studies of nitrated @PROTEIN$ in aging heart and skeletal muscle demonstrate stoichiometric nitration of vicinal tyrosines, Tyr (294) and Tyr (295), on the lumenal side of the membrane-spanning helix, M4, which correlates with partial inhibition of Ca(2+)-ATPase activity suggesting a possible regulatory function in down-regulating mitochondrial energy production and the associated generation of reactive oxygen/@COMPOUND$ species.	0
39	The @PROTEIN$ gene product forms part of a complex with the glucocorticoid receptor and can modulate @COMPOUND$-binding affinity.	1
40	The FKBP5 gene product forms part of a complex with the @PROTEIN$ and can modulate @COMPOUND$-binding affinity.	1
41	Toxicity and characterization of @PROTEIN$-inhibition induced by @COMPOUND$ in Artemia salina larvae.	1
42	@COMPOUND$-induced depressive-like behavior is mediated by @PROTEIN$ activation in mice.	1
43	We report that peripheral administration of @COMPOUND$ (LPS) activates @PROTEIN$ and culminates in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in both the forced-swim and tail suspension tests.	1
44	Administration of L-@COMPOUND$, a metabolite of tryptophan that is generated by @PROTEIN$, to naive mice dose dependently induces depressive-like behavior.	1
45	Administration of L-kynurenine, a metabolite of @COMPOUND$ that is generated by @PROTEIN$, to naive mice dose dependently induces depressive-like behavior.	1
46	Expression of senescence-associated beta-galactosidase (SA-beta-@PROTEIN$) by human skin fibroblasts, effect of advanced glycation end-products and @COMPOUND$ or rhamnose-rich polysaccharides.	0
47	Expression of senescence-associated @PROTEIN$ (SA-beta-Gal) by human skin fibroblasts, effect of advanced glycation end-products and @COMPOUND$ or rhamnose-rich polysaccharides.	0
48	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), @COMPOUND$ (Apo) and phencyclidine (PCP).	0
49	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (@COMPOUND$), apomorphine (Apo) and phencyclidine (PCP).	0
50	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), @COMPOUND$ (Apo) and phencyclidine (PCP).	0
51	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of @COMPOUND$ (Amp), apomorphine (Apo) and phencyclidine (PCP).	0
52	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of @COMPOUND$ (Amp), apomorphine (Apo) and phencyclidine (PCP).	0
53	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), apomorphine (Apo) and @COMPOUND$ (PCP).	0
54	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), apomorphine (Apo) and @COMPOUND$ (PCP).	0
55	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (@COMPOUND$), apomorphine (Apo) and phencyclidine (PCP).	0
56	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, Bcl2, P53 and @PROTEIN$ D1.	1
57	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, Bcl2, @PROTEIN$ and Cyclin D1.	1
58	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: @PROTEIN$, Bcl2, P53 and Cyclin D1.	1
59	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, @PROTEIN$, P53 and Cyclin D1.	1
60	The array and western blotting showed that Bcl2 and @PROTEIN$ D1 expression were down regulated; P53 expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	1
61	The array and western blotting showed that Bcl2 and Cyclin D1 expression were down regulated; P53 expression was not affected while @PROTEIN$ was over expressed by combination of @COMPOUND$ with Dox.	1
62	The array and western blotting showed that Bcl2 and Cyclin D1 expression were down regulated; @PROTEIN$ expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	0
63	The array and western blotting showed that @PROTEIN$ and Cyclin D1 expression were down regulated; P53 expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	1
64	In conclusion, @COMPOUND$ chemosensitizes resistant breast cancer cells to Dox cytotoxicity by down regulating expression of Bcl2 and @PROTEIN$ D1, augmenting caspase 3 activity as well as inducing cell cycle block in G(1) and S phases.	1
65	In conclusion, @COMPOUND$ chemosensitizes resistant breast cancer cells to Dox cytotoxicity by down regulating expression of @PROTEIN$ and Cyclin D1, augmenting caspase 3 activity as well as inducing cell cycle block in G(1) and S phases.	1
66	Randomised trials have demonstrated that the efficacy of anti-tumour necrosis factor (@PROTEIN$) agents is significantly increased by concomitant @COMPOUND$ (MTX) in rheumatoid arthritis (RA).	1
67	Neither @PROTEIN$ nor ATP altered production of reactive oxygen intermediates (ROI) or reactive @COMPOUND$ intermediates (RNI) by bovine monocytes.	0
68	Neither @PROTEIN$ nor ATP altered production of reactive @COMPOUND$ intermediates (ROI) or reactive nitrogen intermediates (RNI) by bovine monocytes.	0
69	Neither @PROTEIN$ nor @COMPOUND$ altered production of reactive oxygen intermediates (ROI) or reactive nitrogen intermediates (RNI) by bovine monocytes.	0
70	Surprisingly, a deletion of the @PROTEIN$ gene affected not only insoluble @COMPOUND$) reduction, which requires pili, but also soluble Fe(III) reduction, which, in contrast, does not require pili.	1
71	Systemic administration of @PROTEIN$ vesicle elevates tumor tissue @COMPOUND$ tension and modifies tumor response to irradiation.	1
72	Inhibition of LTP by beta-amyloid is prevented by activation of @PROTEIN$ and stimulation of the @COMPOUND$/PKA signalling pathway.	0
73	Furthermore, it has also been reported that @COMPOUND$-treated pigs significantly increase mean arterial blood pressure compared with controls and that the decrease in @PROTEIN$ synthesis and release contributes to the elevated blood pressure.	1
74	Mitochondrial dysfunction was associated with higher levels of reactive @COMPOUND$ species, an altered Bcl-xL/Bax ratio and reduction of @PROTEIN$ IV activity.	0
75	Mitochondrial dysfunction was associated with higher levels of reactive @COMPOUND$ species, an altered Bcl-xL/@PROTEIN$ ratio and reduction of COX IV activity.	0
76	The dose of @PROTEIN$ (2.5 microg/kg) was chosen to mimic the @COMPOUND$ concentrations seen during mixing of unfamiliar sows.	0
77	Our data suggest HumDN1 genotypes are related to total @COMPOUND$ levels in Han Chinese MI patients, but @PROTEIN$ gene polymorphisms are not associated with susceptibility to MI in Han Chinese.	0
78	Specifically, @COMPOUND$ was shown to alter S. mutans gene expression levels of gtfB, a known virulence factor, and yfiV, a putative @PROTEIN$ of cell-surface fatty acid genes.	1
79	Specifically, @COMPOUND$ was shown to alter S. mutans gene expression levels of @PROTEIN$, a known virulence factor, and yfiV, a putative transcriptional regulator of cell-surface fatty acid genes.	1
80	"To determine if response to endocrine therapy of breast cancer can be predicted by either a metabolic ""flare reaction"" detected by positron emission tomography (PET) with 2-((18)F)-fluoro-@COMPOUND$ (FDG), induced by an estradiol challenge, or by @PROTEIN$ (ER) status, determined by PET with the estrogen analog 16alpha-((18)F)fluoroestradiol-17beta (FES)."	0
81	"To determine if response to endocrine therapy of breast cancer can be predicted by either a metabolic ""flare reaction"" detected by positron emission tomography (PET) with 2-((18)F)-fluoro-2-deoxyglucose (FDG), induced by an @COMPOUND$ challenge, or by @PROTEIN$ (ER) status, determined by PET with the estrogen analog 16alpha-((18)F)fluoroestradiol-17beta (FES)."	0
82	Depletion of @COMPOUND$ levels was accompanied by the induction of @PROTEIN$ (GR) after 24h exposure with each of the four carbamates to CHO-K1 cells.	1
83	@COMPOUND$ and wortmannin inhibited the upregulation induced by @PROTEIN$ stimulation and amino acid deprivation but not that induced by osmotic shock.	1
84	Chloroquine and @COMPOUND$ inhibited the upregulation induced by @PROTEIN$ stimulation and amino acid deprivation but not that induced by osmotic shock.	1
85	Moreover, PD98059 and SP600125 inhibited only amino acid deprivation-induced upregulation and @COMPOUND$ inhibited only @PROTEIN$-induced upregulation.	1
86	Moreover, PD98059 and @COMPOUND$ inhibited only amino acid deprivation-induced upregulation and SB202190 inhibited only @PROTEIN$-induced upregulation.	0
87	Moreover, @COMPOUND$ and SP600125 inhibited only amino acid deprivation-induced upregulation and SB202190 inhibited only @PROTEIN$-induced upregulation.	0
88	The role of phosphorylated @PROTEIN$ (p-Akt) in oral carcinogenesis induced by @COMPOUND$ and alkaline environments was investigated.	0
89	Myeloperoxidase (@PROTEIN$) is an endogenous oxidant enzyme that generates reactive @COMPOUND$ species (ROS).	1
90	Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), luteinizing hormone receptor (@PROTEIN$) and estrogen receptor-beta (ER-beta).	0
91	Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), luteinizing hormone receptor (LHR) and @PROTEIN$ (ER-beta).	0
92	Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), @PROTEIN$ (LHR) and estrogen receptor-beta (ER-beta).	0
93	Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), luteinizing hormone receptor (LHR) and estrogen receptor-beta (@PROTEIN$).	0
94	Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (@PROTEIN$), luteinizing hormone receptor (LHR) and estrogen receptor-beta (ER-beta).	0
95	Results showed that a moderate dose of @PROTEIN$ (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma @COMPOUND$ (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), luteinizing hormone receptor (LHR) and estrogen receptor-beta (ER-beta).	1
96	No correlation was detected between serum @PROTEIN$ level and @COMPOUND$-25(OH)D3, which was under normal range in 60% of the patients.	0
97	The higher @PROTEIN$ levels in women was accompanied by higher serum levels of glucose, albumin, Ca, @COMPOUND$, Na and FT4.	1
98	The higher @PROTEIN$ levels in women was accompanied by higher serum levels of glucose, albumin, Ca, cholesterol, @COMPOUND$ and FT4.	1
99	The higher @PROTEIN$ levels in women was accompanied by higher serum levels of @COMPOUND$, albumin, Ca, cholesterol, Na and FT4.	1
100	Comparison of 50 patients with the lowest @PROTEIN$ levels (mean of 3.4ng/ml) to 50 patients with highest leptin levels (mean of 34ng/ml), did not indicate differences in both @COMPOUND$ and ICTP between these two populations in spite of the highly significant difference in leptin levels.	0
101	The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus glycoprotein (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter @PROTEIN$ (EAAC1) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of Rab1.	0
102	The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus @PROTEIN$ (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter excitatory amino-acid carrier 1 (EAAC1) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of Rab1.	0
103	The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus glycoprotein (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter excitatory amino-acid carrier 1 (EAAC1) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of @PROTEIN$.	0
104	The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus glycoprotein (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter excitatory amino-acid carrier 1 (@PROTEIN$) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of Rab1.	0
105	Resveratrol did not attenuate GA-induced generation of @COMPOUND$, but it did block GA-induced phosphorylation of connexin 43 (@PROTEIN$), a key modulator of GJIC.	0
106	@COMPOUND$ did not attenuate GA-induced generation of hydrogen peroxide, but it did block GA-induced phosphorylation of connexin 43 (@PROTEIN$), a key modulator of GJIC.	1
107	Resveratrol did not attenuate GA-induced generation of @COMPOUND$, but it did block GA-induced phosphorylation of @PROTEIN$ (Cx43), a key modulator of GJIC.	0
108	@COMPOUND$ did not attenuate GA-induced generation of hydrogen peroxide, but it did block GA-induced phosphorylation of @PROTEIN$ (Cx43), a key modulator of GJIC.	1
109	Furthermore, @COMPOUND$ down-regulated GA-induced phosphorylation of extracellular signal-regulated kinase (@PROTEIN$)1/2, one of the critical regulators of Cx43.	1
110	Furthermore, @COMPOUND$ down-regulated GA-induced phosphorylation of extracellular signal-regulated kinase (ERK)1/2, one of the critical regulators of @PROTEIN$.	1
111	@COMPOUND$ accumulated cells in S phase of the cell cycle and reduced @PROTEIN$ expression.	1
112	Indeed, treatment of cells with 1 muM @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary @PROTEIN$ (GFAP) and down regulation of telomerase activity.	1
113	Indeed, treatment of cells with 1 muM all-trans @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (@PROTEIN$) and down regulation of telomerase activity.	1
114	Indeed, treatment of cells with 1 muM @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (@PROTEIN$) and down regulation of telomerase activity.	1
115	Indeed, treatment of cells with 1 muM all-trans retinoic acid (@COMPOUND$) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary @PROTEIN$ (GFAP) and down regulation of telomerase activity.	1
116	Indeed, treatment of cells with 1 muM all-trans @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary @PROTEIN$ (GFAP) and down regulation of telomerase activity.	1
117	Indeed, treatment of cells with 1 muM all-trans retinoic acid (@COMPOUND$) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (@PROTEIN$) and down regulation of telomerase activity.	1
118	Wright staining and ApopTag assay showed, respectively, morphological and biochemical features of apoptosis in glioblastoma cells following exposure to 200 units/ml @PROTEIN$ for 48 h. Induction of differentiation was associated with decreases in levels of nuclear factor kappa B (NFkappaB), inducible @COMPOUND$ synthase (iNOS), and production of nitric oxide (NO) so as to increase sensitivity to IFN-gamma for apoptosis.	0
119	Wright staining and ApopTag assay showed, respectively, morphological and biochemical features of apoptosis in glioblastoma cells following exposure to 200 units/ml IFN-gamma for 48 h. Induction of differentiation was associated with decreases in levels of nuclear factor kappa B (NFkappaB), inducible @COMPOUND$ synthase (@PROTEIN$), and production of nitric oxide (NO) so as to increase sensitivity to IFN-gamma for apoptosis.	0
120	@COMPOUND$) promotes cytoprotection by activating @PROTEIN$-mediated up-regulation of antioxidant defence.	1
121	Here, we addressed this issue and found that @COMPOUND$) triggered nuclear accumulation of @PROTEIN$ (Nrf2), a transcription factor that up-regulates antioxidant-/electrophile-responsive element (ARE-EpRE)-related genes, in PC12 cells.	1
122	Here, we addressed this issue and found that @COMPOUND$) triggered nuclear accumulation of NF-E2-related factor-2 (@PROTEIN$), a transcription factor that up-regulates antioxidant-/electrophile-responsive element (ARE-EpRE)-related genes, in PC12 cells.	1
123	Using a cell culture model of synaptic NMDA receptor-dependent synaptic potentiation, we find that this is mediated exclusively by NR2B-containing @PROTEIN$, as implicated by NR2B-specific antagonists and the use of selective vs. non-selective doses of the NR2A-preferring antagonist @COMPOUND$-AAM077.	1
124	The net exercise-induced increase in 6-keto-PGF (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma @COMPOUND$, IL-6 or @PROTEIN$ concentrations).	0
125	The net exercise-induced increase in 6-keto-PGF (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma @COMPOUND$, @PROTEIN$ or TNF-alpha concentrations).	0
126	The net exercise-induced increase in 6-keto-@PROTEIN$ (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma @COMPOUND$, IL-6 or TNF-alpha concentrations).	0
127	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), stem cell factor (SCF), @PROTEIN$ (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
128	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of @PROTEIN$ interleukin-3 (IL-3), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
129	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (@PROTEIN$) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
130	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and @PROTEIN$ (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
131	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (@PROTEIN$), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
132	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), stem cell factor (@PROTEIN$), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
133	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), @PROTEIN$ (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
134	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (@COMPOUND$) has been tested from the point of view of potentiating the effects of hematopoietic growth factors interleukin-3 (IL-3), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (@PROTEIN$), and granulocyte colony-stimulating factor (G-CSF) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	0
135	Significant elevation of numbers of GM-CFC evoked by the combinations of @COMPOUND$ with IL-3, @PROTEIN$, or GM-CSF as compared with these growth factors alone has been noted.	0
136	Significant elevation of numbers of GM-CFC evoked by the combinations of @COMPOUND$ with @PROTEIN$, SCF, or GM-CSF as compared with these growth factors alone has been noted.	0
137	Combination of @COMPOUND$ with @PROTEIN$ did not induce significantly higher numbers of GM-CFC in comparison with G-CSF alone.	0
138	Joint action of three drugs, namely of @COMPOUND$+ IL-3+ @PROTEIN$, produced significantly higher numbers of GM-CFC in comparison with the combinations of IB-MECA+ IL-3, IB-MECA+ GM-CSF, or IL-3+ GM-CSF.	0
139	Joint action of three drugs, namely of @COMPOUND$+ @PROTEIN$+ GM-CSF, produced significantly higher numbers of GM-CFC in comparison with the combinations of IB-MECA+ IL-3, IB-MECA+ GM-CSF, or IL-3+ GM-CSF.	0
140	Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with insulin-like growth factor-1 (IGF-1), transforming growth factor-beta1 (@PROTEIN$), or a combination of both growth factors were mixed with OPF, a poly(ethylene glycol)-diacrylate crosslinker and the radical initiators ammonium persulfate and @COMPOUND$, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0
141	Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with insulin-like growth factor-1 (@PROTEIN$), transforming growth factor-beta1 (TGF-beta1), or a combination of both growth factors were mixed with OPF, a poly(ethylene glycol)-diacrylate crosslinker and the radical initiators ammonium persulfate and @COMPOUND$, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0
142	Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with insulin-like growth factor-1 (IGF-1), transforming growth factor-beta1 (@PROTEIN$), or a combination of both growth factors were mixed with OPF, a @COMPOUND$ crosslinker and the radical initiators ammonium persulfate and N,N,N',N'-tetramethylethylenediamine, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0
143	Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with @PROTEIN$-like growth factor-1 (IGF-1), transforming growth factor-beta1 (TGF-beta1), or a combination of both growth factors were mixed with OPF, a poly(ethylene glycol)-diacrylate crosslinker and the radical initiators ammonium persulfate and @COMPOUND$, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0
144	Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with insulin-like growth factor-1 (@PROTEIN$), transforming growth factor-beta1 (TGF-beta1), or a combination of both growth factors were mixed with OPF, a @COMPOUND$ crosslinker and the radical initiators ammonium persulfate and N,N,N',N'-tetramethylethylenediamine, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0
145	Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with @PROTEIN$-like growth factor-1 (IGF-1), transforming growth factor-beta1 (TGF-beta1), or a combination of both growth factors were mixed with OPF, a @COMPOUND$ crosslinker and the radical initiators ammonium persulfate and N,N,N',N'-tetramethylethylenediamine, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	0
146	Treatment of H9c2 cell with low concentrations of Dox causes alterations in fibrous @PROTEIN$ including the nuclear lamina and sarcomeric cardiac myosin, as well as mitochondrial depolarization and fragmentation, membrane blebbing with cell shape changes, and @COMPOUND$ externalization.	0
147	Nicotine, @COMPOUND$, and chlorpyrifos induced the phosphorylation of @PROTEIN$ and 2.	1
148	Nicotine, muscarine, and @COMPOUND$ induced the phosphorylation of @PROTEIN$ and 2.	1
149	@COMPOUND$, muscarine, and chlorpyrifos induced the phosphorylation of @PROTEIN$ and 2.	1
150	Adult bone marrow (BM)-derived @PROTEIN$-producing cells (IPCs) are capable of regulating blood @COMPOUND$ levels in chemically induced hyperglycemic mice.	1
151	Treatment with @COMPOUND$ activated glucose metabolism in INS-1 cells in high-glucose culture conditions, and appeared to maximize the BM-derived IPCs ability to synthesize @PROTEIN$.	1
152	Treatment with benfotiamine activated @COMPOUND$ metabolism in INS-1 cells in high-glucose culture conditions, and appeared to maximize the BM-derived IPCs ability to synthesize @PROTEIN$.	0
153	Benfotiamine was not shown to induce the glucose receptor Glut-2, however it was shown to activate @PROTEIN$, the enzyme responsible for conversion of glucose to @COMPOUND$.	1
154	Benfotiamine was not shown to induce the glucose receptor @PROTEIN$, however it was shown to activate glucokinase, the enzyme responsible for conversion of glucose to @COMPOUND$.	0
155	@COMPOUND$ was not shown to induce the glucose receptor Glut-2, however it was shown to activate @PROTEIN$, the enzyme responsible for conversion of glucose to glucose-6-phosphate.	1
156	@COMPOUND$ was not shown to induce the glucose receptor @PROTEIN$, however it was shown to activate glucokinase, the enzyme responsible for conversion of glucose to glucose-6-phosphate.	0
157	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of Glut-2, glucokinase, insulin, and @PROTEIN$.	1
158	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of Glut-2, @PROTEIN$, insulin, and GAPDH.	1
159	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of Glut-2, glucokinase, @PROTEIN$, and GAPDH.	1
160	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of @PROTEIN$, glucokinase, insulin, and GAPDH.	1
161	) and two @COMPOUND$ tensions (5 and 20%) were compared for their ability to sustain blastocyst survival and @PROTEIN$ production from days 8 to 11 post-insemination.	0
162	In conclusion, culturing blastocysts of cattle in a 5% @COMPOUND$ environment with M199 containing serum sustains embryo viability and permits constitutive and inducible @PROTEIN$ production.	1
163	Incubation in 20% @COMPOUND$ increases @PROTEIN$ production.	1
164	A series of novel bis-pyridinium oximes connected by bis-@COMPOUND$, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited @PROTEIN$ (AChE) and compared with the established antidote 2-PAM and obidoxime.	0
165	A series of novel bis-pyridinium oximes connected by bis-@COMPOUND$, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited acetylcholinesterase (@PROTEIN$) and compared with the established antidote 2-PAM and obidoxime.	0
166	A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against @COMPOUND$ (DFP) inhibited acetylcholinesterase (@PROTEIN$) and compared with the established antidote 2-PAM and obidoxime.	0
167	A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited @PROTEIN$ (AChE) and compared with the established antidote 2-PAM and @COMPOUND$.	0
168	A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited acetylcholinesterase (@PROTEIN$) and compared with the established antidote 2-PAM and @COMPOUND$.	0
169	A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against @COMPOUND$ (DFP) inhibited @PROTEIN$ (AChE) and compared with the established antidote 2-PAM and obidoxime.	0
170	Recent studies have focused on possible functional disorders of the enteric nervous system within the abomasal wall, since cattle with abomasal displacement have an increased activity of neuronal @PROTEIN$, as well as decreased @COMPOUND$ sensitivity.	0
171	Then the review evaluates the involvement of @PROTEIN$ activated by the endogenous agonist @COMPOUND$ in the generation and propagation of epileptiform activity.	1
172	Glutamate @COMPOUND$ ligase (@PROTEIN$), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1
173	Glutamate cysteine ligase (@PROTEIN$), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in glutathione (@COMPOUND$) biosynthesis.	1
174	@PROTEIN$ (GCL), synthesizing gamma-glutamylcysteine from @COMPOUND$ and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1
175	Glutamate cysteine ligase (@PROTEIN$), synthesizing @COMPOUND$ from glutamate and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1
176	@PROTEIN$ (GCL), synthesizing @COMPOUND$ from glutamate and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1
177	Glutamate cysteine ligase (@PROTEIN$), synthesizing gamma-glutamylcysteine from @COMPOUND$ and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1
178	@PROTEIN$ (GCL), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in @COMPOUND$ (GSH) biosynthesis.	1
179	Glutamate cysteine ligase (@PROTEIN$), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in @COMPOUND$ (GSH) biosynthesis.	1
180	@PROTEIN$ (GCL), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in glutathione (@COMPOUND$) biosynthesis.	1
181	We observed that @COMPOUND$ inhibited the proteasome activities and increased the level and insolubility of different @PROTEIN$ species, including phosphorylated tau.	1
182	Moreover, @PROTEIN$ hydrolysis of baicalin sequentially yielded glucuronic acid and @COMPOUND$ as confirmed by co-TLC with authentic samples.	1
183	Moreover, @PROTEIN$ hydrolysis of @COMPOUND$ sequentially yielded glucuronic acid and baicalein as confirmed by co-TLC with authentic samples.	1
184	The effect of this diet alone or after 2 weeks of treatment with @COMPOUND$ or glimepiride on glucose homeostasis, lipid profile, and levels of resistin and @PROTEIN$ was studied.	0
185	The effect of this diet alone or after 2 weeks of treatment with rosiglitazone or @COMPOUND$ on glucose homeostasis, lipid profile, and levels of resistin and @PROTEIN$ was studied.	0
186	Rosiglitazone corrected the altered parameters measured, except for liver TGs ; similarly, @COMPOUND$ reinstated the inverted parameters but raised @PROTEIN$ level and, consequently, the HOMA index.	1
187	@COMPOUND$ corrected the altered parameters measured, except for liver TGs ; similarly, glimepiride reinstated the inverted parameters but raised @PROTEIN$ level and, consequently, the HOMA index.	0
188	Rosiglitazone corrected the altered parameters measured, except for liver @COMPOUND$ ; similarly, glimepiride reinstated the inverted parameters but raised @PROTEIN$ level and, consequently, the HOMA index.	0
189	Activation of ErbB3, @PROTEIN$ and Erk is essential for growth of human breast cancer cell lines with acquired resistance to @COMPOUND$.	0
190	Treatment with the EGFR inhibitor @COMPOUND$ preferentially inhibited growth and reduced the S phase fraction in the resistant cell lines concomitant with inhibition of Erk and unaltered @PROTEIN$ activation.	0
191	Since biliverdin and @COMPOUND$ are downstream products of heme degradation by @PROTEIN$ (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	1
192	Since biliverdin and bilirubin are downstream products of @COMPOUND$ degradation by @PROTEIN$ (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	0
193	Since @COMPOUND$ and bilirubin are downstream products of heme degradation by @PROTEIN$ (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	1
194	Here, we examine the effect of resistin on @COMPOUND$ uptake in human trophoblast cells and we demonstrate that transplacental glucose transport is mediated by @PROTEIN$ (GLUT)-1.	1
195	ERK1 and 2 activation stimulated @PROTEIN$ synthesis and resulted in increase of placental @COMPOUND$ uptake.	1
196	@PROTEIN$ and 2 activation stimulated GLUT-1 synthesis and resulted in increase of placental @COMPOUND$ uptake.	1
197	High resistin levels (50-100 ng/ml) seem able to affect @COMPOUND$-uptake, presumably by decreasing the cell surface @PROTEIN$.	1
198	@COMPOUND$-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by guanidinium/uronium type condensing reagent and used as fluorogenic substrates to localize @PROTEIN$ and tripeptidyl peptidase I activities in mammalian tissue sections.	1
199	Gly-Pro-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by @COMPOUND$/uronium type condensing reagent and used as fluorogenic substrates to localize @PROTEIN$ and tripeptidyl peptidase I activities in mammalian tissue sections.	1
200	@COMPOUND$-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by guanidinium/uronium type condensing reagent and used as fluorogenic substrates to localize dipeptidyl peptidase IV and @PROTEIN$ activities in mammalian tissue sections.	1
201	Gly-Pro-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by @COMPOUND$/uronium type condensing reagent and used as fluorogenic substrates to localize dipeptidyl peptidase IV and @PROTEIN$ activities in mammalian tissue sections.	0
202	The expressions of @PROTEIN$ mRNA in renal tissues were markedly up-regulated in untreated diabetic rats, and these could be notably reduced by @COMPOUND$ treatment.	1
203	In conclusion, @COMPOUND$ may have a potential therapeutic target in DN, which may be partly attributed to lowering of the expression of @PROTEIN$ in the local kidney and the urinary excretion of MCP-1.	1
204	The homomeric @PROTEIN$ (7) receptor is extraordinary in that in addition to distinctive localization and biological functions it exhibits several hallmark properties, for example, the receptor is potently inhibited by divalent cations such as calcium, magnesium, zinc and @COMPOUND$.	1
205	The homomeric @PROTEIN$ (7) receptor is extraordinary in that in addition to distinctive localization and biological functions it exhibits several hallmark properties, for example, the receptor is potently inhibited by divalent cations such as calcium, @COMPOUND$, zinc and copper.	1
206	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
207	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
208	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
209	Cadmium exposure diminished the activities of enzymatic antioxidants, @PROTEIN$ (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
210	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
211	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
212	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
213	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
214	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
215	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
216	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
217	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (@PROTEIN$) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
218	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
219	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
220	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), @PROTEIN$ (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
221	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (@PROTEIN$) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
222	Cadmium exposure diminished the activities of enzymatic antioxidants, @PROTEIN$ (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
223	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, @PROTEIN$ (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
224	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), @PROTEIN$ (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
225	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
226	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), @PROTEIN$ (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
227	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
228	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
229	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
230	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
231	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
232	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (@PROTEIN$) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
233	On the other hand, the levels of oxidized glutathione (@COMPOUND$), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to cadmium intoxication.	0
234	On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to @COMPOUND$ intoxication.	1
235	On the other hand, the levels of oxidized glutathione (@COMPOUND$), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to cadmium intoxication.	0
236	On the other hand, the levels of @COMPOUND$ (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to cadmium intoxication.	0
237	On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to @COMPOUND$ intoxication.	1
238	On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of @COMPOUND$ radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to cadmium intoxication.	0
239	On the other hand, the levels of @COMPOUND$ (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to cadmium intoxication.	0
240	On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of @COMPOUND$ radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to cadmium intoxication.	0
241	Although previous studies indicated reduced levels of @COMPOUND$ residues during apoptosis, elevated Sambucus nigra agglutinin (SNA) reactivity might be due to the degradation of high molecular weight @PROTEIN$ (probably including cadherin) that masked the SNA-binding residues of the plasma membrane prior to apoptosis.	0
242	Although previous studies indicated reduced levels of @COMPOUND$ residues during apoptosis, elevated Sambucus nigra @PROTEIN$ (SNA) reactivity might be due to the degradation of high molecular weight glycoproteins (probably including cadherin) that masked the SNA-binding residues of the plasma membrane prior to apoptosis.	1
243	Analysis of the protein domain features indicated typical conserved @COMPOUND$ residues containing a single whey acidic protein (@PROTEIN$) domain at the C-terminus.	0
244	Analysis of the protein domain features indicated typical conserved @COMPOUND$ residues containing a single @PROTEIN$ (WAP) domain at the C-terminus.	0
245	Cross-linked @PROTEIN$ (1/2) heteromers showed strongly reduced or absent function that was selectively recovered upon treatment with @COMPOUND$.	1
246	Permeabilization of K. marxianus cells in relation to @PROTEIN$ activity was carried out using cetyltrimethyl ammonium bromide (@COMPOUND$) to avoid the problem of enzyme extraction.	1
247	Permeabilization of K. marxianus cells in relation to @PROTEIN$ activity was carried out using cetyltrimethyl @COMPOUND$ (CTAB) to avoid the problem of enzyme extraction.	1
248	Although the levels of IL-4, IL-13, IL-10, and @PROTEIN$/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0
249	Although the levels of @PROTEIN$, IL-13, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0
250	Although the levels of IL-4, @PROTEIN$, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0
251	Although the levels of IL-4, IL-13, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and @PROTEIN$ were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0
252	Although the levels of IL-4, IL-13, @PROTEIN$, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, IL-6 and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	0
253	Although the levels of IL-4, IL-13, IL-10, and GRO/KC were affected by polymer implantation, but not dependent on a specific polymer, @PROTEIN$ and TNFalpha were significantly greater in those animals implanted with @COMPOUND$ and SR, materials that do not promote fusion.	1
254	We hypothesized that variants in @PROTEIN$ that lower LDL @COMPOUND$ levels are associated with reduced prevalence and incidence of peripheral artery disease (PAD).	1
255	@PROTEIN$ (DXS) catalyses the first committed step of the 2C-methyl-D-erythritol-4-phosphate (@COMPOUND$) pathway, which is an alternative isoprenoids biosynthetic route that has been recently discovered.	1
256	@PROTEIN$ (DXS) catalyses the first committed step of the 2C-methyl-@COMPOUND$ (MEP) pathway, which is an alternative isoprenoids biosynthetic route that has been recently discovered.	1
257	Our results suggest that @COMPOUND$)-induced changes in cytokine secretion by monocytes are diverse and may be influenced by Nrf2 but are not likely influenced by changes in whole-cell @PROTEIN$ levels.	1
258	Our results suggest that @COMPOUND$)-induced changes in cytokine secretion by monocytes are diverse and may be influenced by @PROTEIN$ but are not likely influenced by changes in whole-cell Trx1 levels.	1
259	To test the hypothesis that increasing @COMPOUND$ levels is associated with improved @PROTEIN$ resistance in patients with polycystic ovary syndrome (PCOS).	1
260	The present study was designed to understand the effects of sublethal concentrations of @COMPOUND$ (DIC) on hematological constituent (red blood corpuscles, white blood corpuscles (WBC), mean cell volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, platelet counts, hemoglobin and hematocrite levels) and serum damage marker enzymes (@PROTEIN$, alanin aminotransferase, alkaline phosphatase, and lactate dehydrogenase) in rats at subacute period under laboratory conditions.	0
261	The present study was designed to understand the effects of sublethal concentrations of @COMPOUND$ (DIC) on hematological constituent (red blood corpuscles, white blood corpuscles (WBC), mean cell volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, platelet counts, hemoglobin and hematocrite levels) and serum damage marker enzymes (aspartate aminotransferase, alanin aminotransferase, @PROTEIN$, and lactate dehydrogenase) in rats at subacute period under laboratory conditions.	0
262	The present study was designed to understand the effects of sublethal concentrations of @COMPOUND$ (DIC) on hematological constituent (red blood corpuscles, white blood corpuscles (WBC), mean cell volume, mean corpuscular @PROTEIN$, mean corpuscular hemoglobin concentration, platelet counts, hemoglobin and hematocrite levels) and serum damage marker enzymes (aspartate aminotransferase, alanin aminotransferase, alkaline phosphatase, and lactate dehydrogenase) in rats at subacute period under laboratory conditions.	0
263	@COMPOUND$ is known to bind @PROTEIN$, beta1 integrin and focal adhesion kinase, members of focal contacts, multi-protein complexes that mediate cell adhesion to the extracellular matrix.	1
264	Imatinib is transported by P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (@PROTEIN$), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of @COMPOUND$ is not fully understood due to incomplete data.	1
265	Imatinib is transported by P-glycoprotein (P-gp) and @PROTEIN$ (BCRP), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of @COMPOUND$ is not fully understood due to incomplete data.	1
266	@COMPOUND$ is transported by P-@PROTEIN$ (P-gp) and Breast Cancer Resistance Protein (BCRP), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of imatinib is not fully understood due to incomplete data.	1
267	@COMPOUND$ is transported by P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (@PROTEIN$), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of imatinib is not fully understood due to incomplete data.	1
268	@COMPOUND$ is transported by P-glycoprotein (P-gp) and @PROTEIN$ (BCRP), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of imatinib is not fully understood due to incomplete data.	1
269	Imatinib is transported by P-@PROTEIN$ (P-gp) and Breast Cancer Resistance Protein (BCRP), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of @COMPOUND$ is not fully understood due to incomplete data.	1
270	In conclusion, P-gp and @PROTEIN$ have only a modest effect on the ADME of @COMPOUND$ in comparison to metabolic elimination.	1
271	The considerable drug-drug interaction observed with elacridar or @COMPOUND$ is only partly mediated by inhibition of P-gp and @PROTEIN$ and far more by the inhibition of other elimination pathways.	1
272	The considerable drug-drug interaction observed with @COMPOUND$ or pantoprazole is only partly mediated by inhibition of P-gp and @PROTEIN$ and far more by the inhibition of other elimination pathways.	1
273	@COMPOUND$-induced growth inhibition was associated with induction of Cdk inhibitor p21, inhibition of @PROTEIN$ D1 and activation of caspase-3.	1
274	Only the @PROTEIN$ of pI 5.4 and superior to 7.6 hydrolyze the @COMPOUND$.	1
275	There was a significant increase in @PROTEIN$ oxidase activity at 2.5 mg/L, which might indicate @COMPOUND$'s disruption of the mitochondrial membrane and subsequently ATP synthesis.	1
276	There was a significant increase in @PROTEIN$ oxidase activity at 2.5 mg/L, which might indicate irgarol's disruption of the mitochondrial membrane and subsequently @COMPOUND$ synthesis.	1
277	Treatment of A549, which express wild-type @PROTEIN$, and H1299, which are p53-deficient, human lung cancer cells with @COMPOUND$ resulted in inhibition of cell proliferation and an increase in apoptotic cell death ; however, A549 cells were more sensitive to the berberine-induced cytotoxic effects than H1299 cells.	1
278	Furthermore @COMPOUND$ treatment markedly decreased the levels of TNF-alpha, IL-6 and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine @PROTEIN$.	1
279	Furthermore @COMPOUND$ treatment markedly decreased the levels of TNF-alpha, IL-6 and @PROTEIN$, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.	1
280	Furthermore @COMPOUND$ treatment markedly decreased the levels of TNF-alpha, @PROTEIN$ and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.	1
281	Furthermore @COMPOUND$ treatment markedly decreased the levels of @PROTEIN$, IL-6 and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.	1
282	Our study suggests that the modulation of the balance between pro- and anti-inflammatory cytokines towards the anti-inflammatory cytokine @PROTEIN$ is one salutary mechanism underlying how @COMPOUND$ influences post-MI remodelling and thus improves LV function.	1
283	However, @COMPOUND$ exhibited more potency in reducing @PROTEIN$ activity than methiocarb.	1
284	However, methomyl exhibited more potency in reducing @PROTEIN$ activity than @COMPOUND$.	1
285	Significant @PROTEIN$ activity changes, sensitivity of isozyme patterns (Mr of 60, 64, and 85kDa) and increased variation in ALP plasticity during acute exposure to @COMPOUND$ point to its possible aplication as an exposure biomarker.	1
286	@PROTEIN$ (EC 3.2.1.52) are lysosomal enzymes that remove terminal beta-glycosidically bound N-acetylglucosamine and @COMPOUND$ residues from a number of glycoconjugates.	1
287	@PROTEIN$ (EC 3.2.1.52) are lysosomal enzymes that remove terminal beta-glycosidically bound @COMPOUND$ and N-acetylgalactosamine residues from a number of glycoconjugates.	1
288	The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-alpha1 and TGF-beta1, protein expression of @PROTEIN$ and TXS, and production of @COMPOUND$ in liver perfusates were significantly decreased in UDCA-treated BDL rats.	0
289	The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-@PROTEIN$ and TGF-beta1, protein expression of iNOS and TXS, and production of @COMPOUND$ in liver perfusates were significantly decreased in UDCA-treated BDL rats.	0
290	The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-alpha1 and @PROTEIN$, protein expression of iNOS and TXS, and production of @COMPOUND$ in liver perfusates were significantly decreased in UDCA-treated BDL rats.	0
291	The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-alpha1 and TGF-beta1, protein expression of iNOS and @PROTEIN$, and production of @COMPOUND$ in liver perfusates were significantly decreased in UDCA-treated BDL rats.	0
292	The increased levels of hepatic @COMPOUND$ and @PROTEIN$ activity and decreased levels of TBARS and nitrite were also observed in UDCA-treated BDL rats.	0
293	The production of rhG-@PROTEIN$ was induced by switching from growth on @COMPOUND$ to growth on methanol.	0
294	The production of rhG-@PROTEIN$ was induced by switching from growth on glycerol to growth on @COMPOUND$.	1
295	In the induction phase, the @COMPOUND$ feed rate had a significant effect on the specific expression rate of rhG-@PROTEIN$.	1
296	Under this condition, a maximum concentration of 300 mg/l of rhG-@PROTEIN$ and the expression yield of 0.6 mg of rhG-CSF/g of @COMPOUND$ were attained.	1
297	Among seven additives tested, @COMPOUND$, Tween 80 and betaine exhibited the best results in respect of preventing the formation of rhG-@PROTEIN$ protein aggregates.	1
298	Among seven additives tested, Tween 20, Tween 80 and @COMPOUND$ exhibited the best results in respect of preventing the formation of rhG-@PROTEIN$ protein aggregates.	1
299	@COMPOUND$ potently reduces vascular inflammation and arteriosclerosis in @PROTEIN$-deficient ApoE ko mice.	1
300	Hypercholesterolemia is associated with decreased vascular @COMPOUND$ bioavailability and deletion of endothelial nitric oxide synthase (@PROTEIN$) markedly accelerates atherosclerosis development in apolipoprotein E knockout (apoE ko) mice.	0
301	Hypercholesterolemia is associated with decreased vascular @COMPOUND$ bioavailability and deletion of endothelial @PROTEIN$ (eNOS) markedly accelerates atherosclerosis development in apolipoprotein E knockout (apoE ko) mice.	0
302	Feeding long-chain n-3 polyunsaturated fatty acids during gestation increases intestinal @COMPOUND$ absorption potentially via the acute activation of @PROTEIN$.	0
303	Feeding long-chain n-3 @COMPOUND$ during gestation increases intestinal glucose absorption potentially via the acute activation of @PROTEIN$.	1
304	Furthermore, adding @COMPOUND$ (DHA) or an AMP-activated protein kinase (@PROTEIN$.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	0
305	Furthermore, adding @COMPOUND$ (DHA) or an AMP-activated @PROTEIN$ (AMPK.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	0
306	Furthermore, adding @COMPOUND$ (DHA) or an @PROTEIN$-activated protein kinase (AMPK.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	0
307	The model was used to investigate how on-treatment @PROTEIN$ related to baseline CRP and estimated treatment effects with @COMPOUND$.	1
308	Hepatocyte growth factor, keratinocyte growth factor or @PROTEIN$ prevented the effect of @COMPOUND$ on cell permeability, but not on PGE (2) release.	1
309	Hepatocyte growth factor, keratinocyte growth factor or insulin prevented the effect of @COMPOUND$ on cell permeability, but not on @PROTEIN$ (2) release.	0
310	@PROTEIN$ stimulated PGE (2) release mediated the reversible effect of @COMPOUND$ on tight junctions and, meanwhile, contributed to cell survival.	1
311	Cyclooxygenase-2 stimulated @PROTEIN$ (2) release mediated the reversible effect of @COMPOUND$ on tight junctions and, meanwhile, contributed to cell survival.	1
312	Interestingly, @COMPOUND$ inhibited the expression of ICAM and @PROTEIN$, followed by the suppression of macrophage recruitment into the aortic wall at 1 week after operation.	1
313	In addition, synthesis of collagen and @PROTEIN$ in the vascular wall were significantly increased by @COMPOUND$.	1
314	Organic cations (@COMPOUND$) are primarily excreted via vectorial transport by various renal organic cation transporters (@PROTEIN$).	1
315	In a rat ARF model, induction of ARF by @COMPOUND$ (UN) treatment significantly decreased the levels of @PROTEIN$ (slc22a2) mRNA and protein in the kidney medulla.	1
316	In all final products, @COMPOUND$ used to prepare the @PROTEIN$/lipid mixture was below 20 ppm.	1
317	Platelet reactivity and @COMPOUND$ resistance are associated with the H2 haplotype of the P2Y12-@PROTEIN$ receptor gene.	1
318	Platelet reactivity and @COMPOUND$ resistance are associated with the H2 haplotype of the @PROTEIN$-ADP receptor gene.	1
319	Our results showed 2a, 2d and 2g as the most active compounds that inhibited the HIV-1 reverse @PROTEIN$ catalytic activity with cytotoxicity lower than @COMPOUND$ and SI higher than DDC and DDI.	1
320	In its active form, @COMPOUND$ (TPP), it is a co-enzyme for several enzymes, including @PROTEIN$.	1
321	Coexpression pattern with @PROTEIN$ provides an indication that @COMPOUND$ could be the modulator of these adaptive responses to involution and dietary P restriction.	1
322	Dietary chia seed (Salvia hispanica L.) rich in @COMPOUND$ improves adiposity and normalises hypertriacylglycerolaemia and @PROTEIN$ resistance in dyslipaemic rats.	1
323	The present study investigates the benefits of the dietary intake of chia seed (Salvia hispanica L.) rich in @COMPOUND$ and fibre upon dyslipidaemia and @PROTEIN$ resistance (IR), induced by intake of a sucrose-rich (62.5 %) diet (SRD).	0
324	The present study investigates the benefits of the dietary intake of chia seed (Salvia hispanica L.) rich in alpha-linolenic acid and fibre upon dyslipidaemia and @PROTEIN$ resistance (IR), induced by intake of a @COMPOUND$-rich (62.5 %) diet (SRD).	0
325	@COMPOUND$ inhibits vasa vasorum neovascularization in aortas of @PROTEIN$ (-/-)/LDL(-/-) double knockout mice.	0
326	@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as protein kinase C (PKC)-alpha (30 min to 18 h), in concert with unaltered c-@PROTEIN$ N-amino terminal kinase levels and early inactivation of key death-related signals like PKC-delta (5 min to 18 h).	1
327	@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as protein kinase C (@PROTEIN$)-alpha (30 min to 18 h), in concert with unaltered c-jun N-amino terminal kinase levels and early inactivation of key death-related signals like PKC-delta (5 min to 18 h).	1
328	@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as protein kinase C (PKC)-alpha (30 min to 18 h), in concert with unaltered c-jun N-amino terminal kinase levels and early inactivation of key death-related signals like @PROTEIN$ (5 min to 18 h).	1
329	@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as @PROTEIN$ (PKC)-alpha (30 min to 18 h), in concert with unaltered c-jun N-amino terminal kinase levels and early inactivation of key death-related signals like PKC-delta (5 min to 18 h).	1
330	Phospholipidosis and down-regulation of the @PROTEIN$-K/PDK-1/Akt signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1
331	Phospholipidosis and down-regulation of the PI3-K/PDK-1/@PROTEIN$ signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1
332	Phospholipidosis and down-regulation of the PI3-K/@PROTEIN$-1/Akt signalling pathway are @COMPOUND$ inhibitable events associated with 7-ketocholesterol-induced apoptosis.	1
333	"Lack of @COMPOUND$ significantly changed mucin (MUC) dynamics, as reflected by the enlarged goblet-cell ""cup"" area relative to controls; decreased @PROTEIN$ mRNA expression in the jejunum, ileum and colon of VAD rats and increased MUC3 mRNA expression in the ileum and colon of these rats."	1
334	"Lack of @COMPOUND$ significantly changed mucin (MUC) dynamics, as reflected by the enlarged goblet-cell ""cup"" area relative to controls; decreased MUC2 mRNA expression in the jejunum, ileum and colon of VAD rats and increased @PROTEIN$ mRNA expression in the ileum and colon of these rats."	1
335	In addition, @COMPOUND$ deficiency down-regulated @PROTEIN$ 6 mRNA expression while up-regulating toll-like receptors 2 and 5 mRNA expressions.	1
336	@PROTEIN$ antagonism augments @COMPOUND$-induced downregulation of the 5-HT transporter.	1
337	In contrast, chronic @COMPOUND$ markedly decreased 5-@PROTEIN$ levels in all regions.	1
338	This downregulation of 5-@PROTEIN$ by @COMPOUND$ and its enhancement by Org 34850 can explain our recent observation that GR antagonists augment the SSRI-induced increase in extracellular 5-HT.	1
339	Treatment with @PROTEIN$ indicates that the dimensions of the small fibrils may be dependent upon the presence of @COMPOUND$ within the matrix.	1
340	@COMPOUND$ coatings reduce @PROTEIN$ and von Willebrand factor adsorption and platelet adhesion under both static and flow conditions.	1
341	@COMPOUND$ coatings reduce fibrinogen and @PROTEIN$ adsorption and platelet adhesion under both static and flow conditions.	1
342	Previous studies have showed that radio-frequency plasma deposited @COMPOUND$ coatings greatly reduced @PROTEIN$ adsorption (Gamma(Fg)) from highly diluted plasmas (0.1 and 1%) and subsequent platelet adhesion under static conditions.	1
343	Effects of inhibition of @PROTEIN$, iNOS, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and @COMPOUND$, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
344	Effects of inhibition of NOS, @PROTEIN$, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), @COMPOUND$, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
345	Effects of inhibition of @PROTEIN$, iNOS, and nNOS by N-nitro-@COMPOUND$ (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
346	Effects of inhibition of NOS, iNOS, and @PROTEIN$ by N-nitro-@COMPOUND$ (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
347	Effects of inhibition of NOS, iNOS, and @PROTEIN$ by N-nitro-L-arginine methyl ester (L-NAME), @COMPOUND$, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
348	Effects of inhibition of @PROTEIN$, iNOS, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), @COMPOUND$, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
349	Effects of inhibition of NOS, @PROTEIN$, and nNOS by N-nitro-@COMPOUND$ (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
350	Effects of inhibition of NOS, iNOS, and @PROTEIN$ by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and @COMPOUND$, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
351	Effects of inhibition of NOS, @PROTEIN$, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and @COMPOUND$, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
352	To achieve enzymatic production of calcium-stearate at unfavorable conditions, i.e., pH 10 and 60 degrees C, suitable @PROTEIN$ was selected and reaction conditions were optimized using calcium @COMPOUND$ and hydrogenated beef tallow as substrates.	1
353	To achieve enzymatic production of @COMPOUND$ at unfavorable conditions, i.e., pH 10 and 60 degrees C, suitable @PROTEIN$ was selected and reaction conditions were optimized using calcium hydroxide and hydrogenated beef tallow as substrates.	1
354	Under optimum conditions, 95% of beef tallow, in 2.5 h, was converted into @COMPOUND$ by using commercial @PROTEIN$ SDL 451.	1
355	@COMPOUND$ could selectively inhibited @PROTEIN$ expression and PGE2 production.	1
356	Celecoxib could selectively inhibited @PROTEIN$ expression and @COMPOUND$ production.	0
357	@COMPOUND$ also inhibited p(473Ser) Akt, raf and p53 expression, and induced apoptosis by release of @PROTEIN$ and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1
358	@COMPOUND$ also inhibited p(473Ser) @PROTEIN$, raf and p53 expression, and induced apoptosis by release of cytochrome c and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1
359	@COMPOUND$ also inhibited p(473Ser) Akt, @PROTEIN$ and p53 expression, and induced apoptosis by release of cytochrome c and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1
360	@COMPOUND$ also inhibited p(473Ser) Akt, raf and @PROTEIN$ expression, and induced apoptosis by release of cytochrome c and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	1
361	It was found that @COMPOUND$ administration produced lower levels of @PROTEIN$ and alkaline aminotransferase than that of the untreated group.	1
362	In addition, the levels of hepatic total protein, glutathione and @PROTEIN$ were higher in the @COMPOUND$ treated groups than those in the untreated control or the taurine depleted groups, while hepatic malondialdehyde content exhibited the negative effect.	1
363	In addition, the levels of hepatic total protein, glutathione and @PROTEIN$ were higher in the taurine treated groups than those in the untreated control or the taurine depleted groups, while hepatic @COMPOUND$ content exhibited the negative effect.	1
364	In addition, the levels of hepatic total protein, @COMPOUND$ and @PROTEIN$ were higher in the taurine treated groups than those in the untreated control or the taurine depleted groups, while hepatic malondialdehyde content exhibited the negative effect.	0
365	Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and @COMPOUND$ were all decreased in the taurine treated groups.	0
366	Moreover, the concentrations of hepatic hydroxyproline, serum @COMPOUND$, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and laminin were all decreased in the taurine treated groups.	0
367	Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, interleukin-6, @PROTEIN$-alpha and laminin were all decreased in the @COMPOUND$ treated groups.	1
368	Moreover, the concentrations of hepatic @COMPOUND$, serum hyaluronic acid, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and laminin were all decreased in the taurine treated groups.	0
369	Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and laminin were all decreased in the @COMPOUND$ treated groups.	1
370	Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, interleukin-6, @PROTEIN$-alpha and @COMPOUND$ were all decreased in the taurine treated groups.	0
371	Moreover, the concentrations of hepatic @COMPOUND$, serum hyaluronic acid, interleukin-2, interleukin-6, @PROTEIN$-alpha and laminin were all decreased in the taurine treated groups.	0
372	Moreover, the concentrations of hepatic hydroxyproline, serum @COMPOUND$, interleukin-2, interleukin-6, @PROTEIN$-alpha and laminin were all decreased in the taurine treated groups.	0
373	Pharmacological (@COMPOUND$) and molecular (shRNA) transcription inhibitor were used to impede formation of @PROTEIN$ transcripts.	1
374	A 5.5 kilobase-pair (kbp) @PROTEIN$-Kpn1 fragment containing gene(s) encoding for @COMPOUND$ degradation was cloned.	1
375	@COMPOUND$ also enhanced @PROTEIN$ release from VSMC.	1
376	@PROTEIN$ release by @COMPOUND$, although significant, was not as remarkable as that induced by TNF-alpha.	1
377	IL-6 release by @COMPOUND$, although significant, was not as remarkable as that induced by @PROTEIN$.	0
378	These data suggest that @COMPOUND$ upregulates @PROTEIN$ via mechanisms distinct from TNF-alpha and contributes to the intra- and extracellular IL-6 deposits within the vasculature.	1
379	These data suggest that @COMPOUND$ upregulates IL-6 via mechanisms distinct from @PROTEIN$ and contributes to the intra- and extracellular IL-6 deposits within the vasculature.	0
380	@COMPOUND$ upregulates @PROTEIN$ via mechanisms that are distinct from those of tumor necrosis factor-alpha, in vascular smooth muscle cells.	1
381	@COMPOUND$ upregulates interleukin-6 via mechanisms that are distinct from those of @PROTEIN$-alpha, in vascular smooth muscle cells.	0
382	Among the 7 IL examined, only @PROTEIN$ transcript was increased by @COMPOUND$ treatment in human aorta smooth muscle cells.	1
383	@PROTEIN$ transcripts increased up to 24 h after treatment with @COMPOUND$, and this effect was profoundly repressed by treatment with p38 MAPK inhibitors and to a lesser extent JNK inhibitors.	1
384	@COMPOUND$, 27-hydroxycholesterol or cholesterol, however, did not induce @PROTEIN$ expression.	0
385	7alpha-Hydroxy@COMPOUND$, 27-hydroxycholesterol or cholesterol, however, did not induce @PROTEIN$ expression.	0
386	7alpha-Hydroxycholesterol, @COMPOUND$ or cholesterol, however, did not induce @PROTEIN$ expression.	0
387	Mechanisms of @PROTEIN$ induction by @COMPOUND$ were investigated in comparison with tumor necrosis factor (TNF)-alpha.	1
388	Mechanisms of IL-6 induction by @COMPOUND$ were investigated in comparison with tumor necrosis factor (@PROTEIN$)-alpha.	0
389	Mechanisms of IL-6 induction by @COMPOUND$ were investigated in comparison with @PROTEIN$ (TNF)-alpha.	0
390	Whereas @PROTEIN$ activated IL-6 promoter, which was impaired by p38 MAPK inhibitors or by mutation in the NF-kappaB-binding site within the promoter region, @COMPOUND$ did not affect IL-6 promoter activity.	0
391	Whereas TNF-alpha activated @PROTEIN$ promoter, which was impaired by p38 MAPK inhibitors or by mutation in the NF-kappaB-binding site within the promoter region, @COMPOUND$ did not affect IL-6 promoter activity.	0
392	@COMPOUND$ significantly increased the amount of intracellular @PROTEIN$ protein in the presence of brefeldin A.	1
393	7-ketocholesterol significantly increased the amount of intracellular @PROTEIN$ protein in the presence of @COMPOUND$.	1
394	@COMPOUND$ inhibits human cervical cancer cell growth in vitro in association with @PROTEIN$ demethylation and re-expression.	1
395	Clinically, it has been approved that DNA methylation inhibitors, such as @COMPOUND$ (5-Aza-dC), can reverse @PROTEIN$ promoter methylation, but widespread clinical use of these inhibitors is limited by their toxicity and instability in aqueous solution.	1
396	Clinically, it has been approved that DNA methylation inhibitors, such as 5-aza-2'-deoxycytidine (@COMPOUND$), can reverse @PROTEIN$ promoter methylation, but widespread clinical use of these inhibitors is limited by their toxicity and instability in aqueous solution.	1
397	Lastly, we found that the downstream metabolite of @COMPOUND$, 5alpha- androstane-3beta,17beta-diol (3betaAdiol), is estrogenic in breast cancer cells, and induces growth and ER-signaling via activation of @PROTEIN$.	1
398	Here, we constructed variants to test whether any of these motifs may explain why @PROTEIN$-DeltaN does not respond to stimulation with either ADP ribose or @COMPOUND$.	0
399	Accumulating evidence suggests that phosphatidylinositol (PI) pathways have been involved in the secretion of @COMPOUND$ (DA) and the regulation of @PROTEIN$, which is a target of methamphetamine (METH).	0
400	Accumulating evidence suggests that phosphatidylinositol (PI) pathways have been involved in the secretion of dopamine (DA) and the regulation of @PROTEIN$, which is a target of @COMPOUND$ (METH).	1
401	Accumulating evidence suggests that @COMPOUND$ (PI) pathways have been involved in the secretion of dopamine (DA) and the regulation of @PROTEIN$, which is a target of methamphetamine (METH).	1
402	@COMPOUND$ caused a 60% reduction in testicular interstitial fluid (IF) prostaglandin E(2) (PGE (2)) concentrations, accompanied by a compensatory increase in @PROTEIN$ mRNA expression.	1
403	@COMPOUND$ caused a 60% reduction in testicular interstitial fluid (IF) prostaglandin E(2) (@PROTEIN$ (2)) concentrations, accompanied by a compensatory increase in COX-2 mRNA expression.	1
404	However, @COMPOUND$ had no effect on @PROTEIN$ protein levels or LPS-induced expression of the inflammatory mediators interleukin-1beta, tumour necrosis factor-alpha or inducible nitric-oxide synthase.	0
405	However, @COMPOUND$ had no effect on COX-2 protein levels or LPS-induced expression of the inflammatory mediators interleukin-1beta, tumour necrosis factor-alpha or inducible @PROTEIN$.	0
406	These data indicate that @COMPOUND$ reduces intratesticular activity of @PROTEIN$ (as indicated by PGE (2) levels) and inhibits IF formation in the testis, but has no appreciable effect on steroidogenesis or spermatogenesis, at least in the short term.	1
407	These data indicate that @COMPOUND$ reduces intratesticular activity of COX-2 (as indicated by @PROTEIN$ (2) levels) and inhibits IF formation in the testis, but has no appreciable effect on steroidogenesis or spermatogenesis, at least in the short term.	1
408	These results indicate significant roles for products of the @PROTEIN$ pathway in testicular vascular control and steroidogenesis, which may have implications for men with marginal fertility taking @COMPOUND$ for extended periods, but also highlight the potential of this drug to ameliorate testicular damage caused by systemic or local inflammation.	1
409	Collectively, @PROTEIN$ supplementation increased concentrations of @COMPOUND$ in intestinal lumen, expression of proglucagon, GLP-2R, and eNOS genes, and net portal absorption of AA.	1
410	Collectively, HMB supplementation increased concentrations of @COMPOUND$ in intestinal lumen, expression of proglucagon, @PROTEIN$, and eNOS genes, and net portal absorption of AA.	0
411	Collectively, HMB supplementation increased concentrations of @COMPOUND$ in intestinal lumen, expression of proglucagon, GLP-2R, and @PROTEIN$ genes, and net portal absorption of AA.	0
412	Plasma @PROTEIN$ 0.05) following ingestion of GluF than after Glu alone, without any differences between the effects of either intervention on plasma @COMPOUND$ concentrations.	0
413	@PROTEIN$ deletion blocks extinction of @COMPOUND$ place preference conditioning.	1
414	Accordingly, to assess its potential role in the long-lasting behavioral effects of drugs of abuse, we have investigated the impact of @PROTEIN$ deletion on sustained behavioral responses elicited by repeated @COMPOUND$ administration.	0
415	Decreased @PROTEIN$ expression increases extracellular @COMPOUND$ and alters its regulation in mouse striatum.	1
416	In 17 adults on a fixed metabolic diet, an 11-day course of @COMPOUND$ increased serum @PROTEIN$ and basal gastric acid output, but not maximal gastric acid output, compared with a placebo.	1
417	Since @COMPOUND$ was found to be a weak inhibitor of CYP 3A4 and to have no inhibitory effects on esterases, @PROTEIN$, and glucuronyltransferases, it is suggested PSC-833 enhances intestinal mucosal permeation of these cyclic prodrugs by inhibiting their polarized efflux and not by inhibiting their metabolism.	0
418	Since @COMPOUND$ was found to be a weak inhibitor of CYP 3A4 and to have no inhibitory effects on @PROTEIN$, phenol sulfotransferases, and glucuronyltransferases, it is suggested PSC-833 enhances intestinal mucosal permeation of these cyclic prodrugs by inhibiting their polarized efflux and not by inhibiting their metabolism.	0
419	Tumor @PROTEIN$ differs from normal MUC1 by modified @COMPOUND$ side chains.	0
420	Mineralization and dehalogenation of @COMPOUND$ was evidenced by high @PROTEIN$ removal efficiencies (approximately 95%), and by the stoichiometric release of chloride ions from the halogenated compound (approximately 80%).	1
421	Mineralization and dehalogenation of 2,4,6-TCP was evidenced by high @PROTEIN$ removal efficiencies (approximately 95%), and by the stoichiometric release of @COMPOUND$ ions from the halogenated compound (approximately 80%).	0
422	@COMPOUND$ can change the conformation of the active sites and decrease obviously the affinities between gliclazide in the active site and enzymes when it is docked in the second active sites in CYP2C9 and @PROTEIN$.	1
423	Gliclazide can change the conformation of the active sites and decrease obviously the affinities between @COMPOUND$ in the active site and enzymes when it is docked in the second active sites in @PROTEIN$ and CYP2C19.	1
424	@COMPOUND$ can change the conformation of the active sites and decrease obviously the affinities between gliclazide in the active site and enzymes when it is docked in the second active sites in @PROTEIN$ and CYP2C19.	1
425	Gliclazide can change the conformation of the active sites and decrease obviously the affinities between @COMPOUND$ in the active site and enzymes when it is docked in the second active sites in CYP2C9 and @PROTEIN$.	1
426	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), @COMPOUND$ (vitamin B(1)) and riboflavin (vitamin B(2)).	1
427	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, @COMPOUND$, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
428	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, @COMPOUND$ (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
429	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, @COMPOUND$, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
430	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, @COMPOUND$, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
431	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), @COMPOUND$ (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
432	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (@COMPOUND$), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
433	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, @COMPOUND$, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
434	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of @COMPOUND$, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
435	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), @COMPOUND$ (2)), thiamin (vitamin B(1)) and riboflavin (vitamin B(2)).	1
436	Amyloglucosidase from Rhizopus mould and @PROTEIN$ from sweet almond were employed for the preparation of phenolic and vitamin glycosides of vanillin, N-vanillylnonanamide, DL-dopa, dopamine, curcumin, alpha-tocopherol (vitamin E), pyridoxine (vitamin B(6)), ergocalciferol (vitamin D (2)), thiamin (vitamin B(1)) and @COMPOUND$ (vitamin B(2)).	1
437	The aim of the present study was to investigate differences in the expression of mRNAs for @PROTEIN$, ERbeta and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of estradiol and @COMPOUND$.	0
438	The aim of the present study was to investigate differences in the expression of mRNAs for @PROTEIN$, ERbeta and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of @COMPOUND$ and progesterone.	0
439	The aim of the present study was to investigate differences in the expression of mRNAs for ERalpha, @PROTEIN$ and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of estradiol and @COMPOUND$.	0
440	The aim of the present study was to investigate differences in the expression of mRNAs for ERalpha, @PROTEIN$ and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of @COMPOUND$ and progesterone.	0
441	Increased incorporation of dietary plant sterols and @COMPOUND$ correlates with decreased expression of hepatic and intestinal Abcg5 and @PROTEIN$ in diabetic BB rats.	1
442	Increased incorporation of dietary plant sterols and @COMPOUND$ correlates with decreased expression of hepatic and intestinal @PROTEIN$ and Abcg8 in diabetic BB rats.	1
443	This increase in @COMPOUND$ and plant sterols and stanols was associated with a marked decrease in hepatic and intestinal Abcg5 (ATP-binding cassette transporter G5) and @PROTEIN$ (ATP-binding cassette transporter G8) expressions in diabetic rats, as well as decreased mRNA levels of several other genes involved in sterol regulation.	1
444	This increase in @COMPOUND$ and plant sterols and stanols was associated with a marked decrease in hepatic and intestinal @PROTEIN$ (ATP-binding cassette transporter G5) and Abcg8 (ATP-binding cassette transporter G8) expressions in diabetic rats, as well as decreased mRNA levels of several other genes involved in sterol regulation.	1
445	Therefore, lower expression levels of Abcg5/@PROTEIN$ in diabetic rats may account for the increased accumulation of plant sterols and @COMPOUND$ in these rats.	1
446	Therefore, lower expression levels of @PROTEIN$/Abcg8 in diabetic rats may account for the increased accumulation of plant sterols and @COMPOUND$ in these rats.	1
447	Gallic acid, @COMPOUND$ and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, @PROTEIN$ (GPx) and catalase (CAT.05).	1
448	@COMPOUND$, ferulic acid and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, @PROTEIN$ (GPx) and catalase (CAT.05).	1
449	Gallic acid, ferulic acid and @COMPOUND$ at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac @PROTEIN$, glutathione peroxidase (GPx) and catalase (CAT.05).	1
450	Gallic acid, ferulic acid and @COMPOUND$ at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, @PROTEIN$ (GPx) and catalase (CAT.05).	1
451	Gallic acid, @COMPOUND$ and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and catalase (@PROTEIN$.05).	1
452	@COMPOUND$, ferulic acid and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and catalase (@PROTEIN$.05).	1
453	@COMPOUND$, ferulic acid and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and @PROTEIN$ (CAT.05).	1
454	@COMPOUND$, ferulic acid and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac @PROTEIN$, glutathione peroxidase (GPx) and catalase (CAT.05).	1
455	Gallic acid, ferulic acid and @COMPOUND$ at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and catalase (@PROTEIN$.05).	1
456	Gallic acid, ferulic acid and @COMPOUND$ at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and @PROTEIN$ (CAT.05).	1
457	Gallic acid, @COMPOUND$ and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac superoxide dismutase, glutathione peroxidase (GPx) and @PROTEIN$ (CAT.05).	1
458	Gallic acid, @COMPOUND$ and p-coumaric acid at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac @PROTEIN$, glutathione peroxidase (GPx) and catalase (CAT.05).	1
459	The purpose of this study was to investigate the effect of three zinc salts (i.e., zinc oxide, @COMPOUND$, and zinc acetate) on @PROTEIN$ encapsulation efficiency (EE), stability, and in vitro release kinetics from poly(lactic-co-glycolic acid) (PLGA) microspheres.	0
460	The purpose of this study was to investigate the effect of three zinc salts (i.e., zinc oxide, zinc carbonate, and @COMPOUND$) on @PROTEIN$ encapsulation efficiency (EE), stability, and in vitro release kinetics from poly(lactic-co-glycolic acid) (PLGA) microspheres.	0
461	The purpose of this study was to investigate the effect of three zinc salts (i.e., zinc oxide, zinc carbonate, and zinc acetate) on @PROTEIN$ encapsulation efficiency (EE), stability, and in vitro release kinetics from poly(lactic-co-glycolic acid) (@COMPOUND$) microspheres.	0
462	The purpose of this study was to investigate the effect of three zinc salts (i.e., @COMPOUND$, zinc carbonate, and zinc acetate) on @PROTEIN$ encapsulation efficiency (EE), stability, and in vitro release kinetics from poly(lactic-co-glycolic acid) (PLGA) microspheres.	0
463	@COMPOUND$ inhibits serum amyloid a-induced @PROTEIN$ expression in human endothelial cells.	1
464	@COMPOUND$, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases @PROTEIN$ expression.	1
465	@COMPOUND$ is released from human monocyte-derived macrophages upon stimulation with @PROTEIN$ and is a sensitive indicator for cellular immune activation.	1
466	Both activity and expression of @PROTEIN$ and APS reductase in plants are modulated by the @COMPOUND$ status of the plant.	1
467	Patients under clozapine-@COMPOUND$ therapy developed a rise of serum @PROTEIN$ levels.	1
468	Patients under @COMPOUND$-risperidone therapy developed a rise of serum @PROTEIN$ levels.	1
469	Only the intracellular @PROTEIN$ response in the lower tertile of IL-2 production was improved with @COMPOUND$ indicating a small influence.	1
470	The elevation of @COMPOUND$ plasma levels by a perioperative intravenous infusion of L-alanyl-L-glutamine influenced the intracellular expression of @PROTEIN$ in the lower tertile only slightly.	1
471	Determination of bioactive matter by affinity adsorption solid substrate-room temperature phosphorimetry based on @PROTEIN$ labeled with self-ordered ring of @COMPOUND$.	0
472	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin @PROTEIN$ (Con A), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), alkaline phosphatase (ALP), @COMPOUND$ (G), respectively.	0
473	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (Con A), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), alkaline phosphatase (@PROTEIN$), @COMPOUND$ (G), respectively.	0
474	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (Con A), triticum vulgaris @PROTEIN$ (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), alkaline phosphatase (ALP), @COMPOUND$ (G), respectively.	0
475	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (Con A), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (@PROTEIN$-V), alkaline phosphatase (ALP), @COMPOUND$ (G), respectively.	0
476	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (Con A), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), @PROTEIN$ (ALP), @COMPOUND$ (G), respectively.	0
477	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (@PROTEIN$), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), alkaline phosphatase (ALP), @COMPOUND$ (G), respectively.	0
478	In this paper we demonstrate that hedgehog signaling antagonists, including @COMPOUND$, and a second compound, CUR0199691, can inhibit growth of @PROTEIN$ (ER)-positive and ER-negative tumorigenic breast cancer cells at elevated doses.	0
479	The equality of K (D) of @COMPOUND$ binding to blood platelet membranes and to membranes from nerve endings appears to encourage the use of such membranes as a model for brain @PROTEIN$.	0
480	With supplementation of @COMPOUND$ in diet, lower expression of GFAP and @PROTEIN$ while higher expression of GLAST, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).	1
481	With supplementation of @COMPOUND$ in diet, lower expression of @PROTEIN$ and VEGF while higher expression of GLAST, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).	1
482	With supplementation of @COMPOUND$ in diet, lower expression of GFAP and VEGF while higher expression of GLAST, GS and @PROTEIN$ in retina of diabetic rats were determinated by RT-PCR 0.05).	1
483	With supplementation of @COMPOUND$ in diet, lower expression of GFAP and VEGF while higher expression of @PROTEIN$, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).	1
484	@PROTEIN$, VEGF, GLAST, GS and GAD expressions in normal controls were not altered by @COMPOUND$ treatment.	0
485	GFAP, VEGF, @PROTEIN$, GS and GAD expressions in normal controls were not altered by @COMPOUND$ treatment.	0
486	GFAP, VEGF, GLAST, GS and @PROTEIN$ expressions in normal controls were not altered by @COMPOUND$ treatment.	0
487	GFAP, @PROTEIN$, GLAST, GS and GAD expressions in normal controls were not altered by @COMPOUND$ treatment.	0
488	Long intercalated defects in canine ribs can be repaired successfully using porous @COMPOUND$ (beta-TCP) cylinders, infused with a biodegradable polymer (poly D,L-lactic acid-polyethylene block copolymer) containing recombinant human bone @PROTEIN$-2 (rhBMP-2).	0
489	Ischaemia and @PROTEIN$, but not ischaemia and contraction, act synergistically in stimulating muscle @COMPOUND$ uptake in vivo in humans.	1
490	In summary, ischaemia and @PROTEIN$ independently stimulate skeletal muscle @COMPOUND$ uptake in vivo in humans, whereas ischaemia and contraction do not.	1
491	A comparison of the inhibitory effect of @COMPOUND$ on soluble and immobilized @PROTEIN$ showed that immobilization increased the linearity of the inhibition plot particularly in the range 0.1 nM-0.1 microM.	1
492	Extracellular lipase @PROTEIN$ prepared in our lab from the yeast Yarrowia lipolytica was used for the resolution of racemic @COMPOUND$.	1
493	Extracellular @PROTEIN$ LIP prepared in our lab from the yeast Yarrowia lipolytica was used for the resolution of racemic @COMPOUND$.	1
494	The high purity (@COMPOUND$ (ee = 0.98) was obtained using lipase @PROTEIN$ to catalyze hydrolysis of (S)-ester in 0.1 M phosphate buffer (pH = 8).	1
495	The high purity (S)-ibuprofen (ee = 0.98) was obtained using lipase @PROTEIN$ to catalyze hydrolysis of (S)-ester in 0.1 M @COMPOUND$ buffer (pH = 8).	0
496	The high purity (@COMPOUND$ (ee = 0.98) was obtained using @PROTEIN$ LIP to catalyze hydrolysis of (S)-ester in 0.1 M phosphate buffer (pH = 8).	1
497	The high purity (S)-ibuprofen (ee = 0.98) was obtained using @PROTEIN$ LIP to catalyze hydrolysis of (S)-ester in 0.1 M @COMPOUND$ buffer (pH = 8).	0
498	@COMPOUND$ perfusion marginally increased @PROTEIN$ levels to 7.3 fg/microg/ml on average in the upper arm and control axilla.	1
499	In contrast, perfusion of the inflamed axilla with @COMPOUND$ significantly enhanced the release of both @PROTEIN$ and BDNF.	1
500	In contrast, perfusion of the inflamed axilla with @COMPOUND$ significantly enhanced the release of both NGF and @PROTEIN$.	1
501	Inhibition of cyclooxygenase 2 expression by @COMPOUND$ on joint inflammation induced by urate crystal and @PROTEIN$.	0
502	Inhibition of @PROTEIN$ expression by @COMPOUND$ on joint inflammation induced by urate crystal and IL-1beta.	1
503	Investigation of the effects of @COMPOUND$ (DAS), a garlic sulfur compound, on joint tissue inflammatory responses induced by monosodium urate (MSU) crystals and interleukin-1beta (@PROTEIN$).	0
504	Investigation of the effects of diallyl sulfide (DAS), a garlic sulfur compound, on joint tissue inflammatory responses induced by @COMPOUND$ (MSU) crystals and interleukin-1beta (@PROTEIN$).	0
505	Genetic variants of @PROTEIN$ (CYP2C9) and vitamin K epoxide reductase (VKORC1) are known to influence @COMPOUND$ dose, but the effect of other genes has not been fully elucidated.	1
506	Genetic variants of cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (@PROTEIN$) are known to influence @COMPOUND$ dose, but the effect of other genes has not been fully elucidated.	1
507	Genetic variants of cytochrome P450 2C9 (@PROTEIN$) and vitamin K epoxide reductase (VKORC1) are known to influence @COMPOUND$ dose, but the effect of other genes has not been fully elucidated.	1
508	In conclusion, CYP2C9 and @PROTEIN$ significantly influenced @COMPOUND$ dose and predicted individuals predisposed to unstable anticoagulation.	1
509	In conclusion, @PROTEIN$ and VKORC1 significantly influenced @COMPOUND$ dose and predicted individuals predisposed to unstable anticoagulation.	1
510	Aim The present study sought insight into the effects of @COMPOUND$ and fentanyl on LPS-induced release of interleukin-6 (IL-6), tumor necrosis factor-alpha (@PROTEIN$) and IL-10 in human whole blood.	0
511	Aim The present study sought insight into the effects of @COMPOUND$ and fentanyl on LPS-induced release of interleukin-6 (@PROTEIN$), tumor necrosis factor-alpha (TNF-alpha) and IL-10 in human whole blood.	0
512	Aim The present study sought insight into the effects of @COMPOUND$ and fentanyl on LPS-induced release of interleukin-6 (IL-6), @PROTEIN$-alpha (TNF-alpha) and IL-10 in human whole blood.	0
513	Aim The present study sought insight into the effects of @COMPOUND$ and fentanyl on LPS-induced release of @PROTEIN$ (IL-6), tumor necrosis factor-alpha (TNF-alpha) and IL-10 in human whole blood.	0
514	Aim The present study sought insight into the effects of @COMPOUND$ and fentanyl on LPS-induced release of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha) and @PROTEIN$ in human whole blood.	0
515	Effects of @COMPOUND$ and fentanyl on spontaneous and endotoxin (lipopolysaccharide ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results IL-6, TNF-alpha and @PROTEIN$ 0.01).	0
516	Effects of @COMPOUND$ and fentanyl on spontaneous and endotoxin (lipopolysaccharide ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results IL-6, @PROTEIN$ and IL-10 0.01).	0
517	Effects of remifentanyl and fentanyl on spontaneous and @COMPOUND$ ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results IL-6, @PROTEIN$ and IL-10 0.01).	0
518	Effects of remifentanyl and fentanyl on spontaneous and @COMPOUND$ ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results @PROTEIN$, TNF-alpha and IL-10 0.01).	0
519	Effects of remifentanyl and fentanyl on spontaneous and @COMPOUND$ ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results IL-6, TNF-alpha and @PROTEIN$ 0.01).	0
520	Effects of @COMPOUND$ and fentanyl on spontaneous and endotoxin (lipopolysaccharide ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results @PROTEIN$, TNF-alpha and IL-10 0.01).	0
521	@COMPOUND$ and fentanyl could inhibit the expressions of IL-6, @PROTEIN$ and IL-10 induced by LPS.	1
522	@COMPOUND$ and fentanyl could inhibit the expressions of @PROTEIN$, TNF-alpha and IL-10 induced by LPS.	1
523	@COMPOUND$ and fentanyl could inhibit the expressions of IL-6, TNF-alpha and @PROTEIN$ induced by LPS.	1
524	These data provide evidence that CMEC express @PROTEIN$, which is able to respond to physiological agonists by mobilizing @COMPOUND$+) from intracellular InsP(3)-sensitive stores.	1
525	Inhibition of these enzymes shows that chagasic autoantibodies up-regulation of @PROTEIN$/iNOS mRNA level is under the control of endogenous iNO/@COMPOUND$ signaling system.	1
526	Inhibition of these enzymes shows that chagasic autoantibodies up-regulation of COX-2/@PROTEIN$ mRNA level is under the control of endogenous iNO/@COMPOUND$ signaling system.	1
527	The co-expression of @PROTEIN$ with M6B results in a significant decrease in SERT-mediated @COMPOUND$ uptake caused by a down-regulation of SERT surface expression.	1
528	The co-expression of SERT with @PROTEIN$ results in a significant decrease in SERT-mediated @COMPOUND$ uptake caused by a down-regulation of SERT surface expression.	1
529	Therefore, @COMPOUND$, which inhibit the production of @PROTEIN$ by negative feedback, was considered a treatment option to control the evolution of calciphylaxis in a dialysed patient suffering from cholangiocarcinoma.	1
530	@PROTEIN$ catalyze a calcium-dependent transamidation reaction that produces covalent cross-linking of available substrate @COMPOUND$ residues and modifies the extracellular matrix.	1
531	Site-directed mutation test and @COMPOUND$ treatment demonstrated that the ZNF230 promoter contained a functional @PROTEIN$ site.	1
532	Site-directed mutation test and @COMPOUND$ treatment demonstrated that the @PROTEIN$ promoter contained a functional Sp1 site.	1
533	For this purpose, on day 0, male Wistar rats received NTG (120 microg/kg, iv) with or without pre-administration of PKC inhibitor @COMPOUND$ (CHE), capsaicin (CAP) to deplete @PROTEIN$ from sensory nerves or mK(ATP) channel blocker 5-hydroxydecaonic acid (5HD).	0
534	For this purpose, on day 0, male Wistar rats received NTG (120 microg/kg, iv) with or without pre-administration of PKC inhibitor chelerythrine (CHE), capsaicin (CAP) to deplete @PROTEIN$ from sensory nerves or mK(ATP) channel blocker 5-hydroxydecaonic acid (@COMPOUND$).	0
535	For this purpose, on day 0, male Wistar rats received NTG (120 microg/kg, iv) with or without pre-administration of PKC inhibitor chelerythrine (CHE), @COMPOUND$ (CAP) to deplete @PROTEIN$ from sensory nerves or mK(ATP) channel blocker 5-hydroxydecaonic acid (5HD).	1
536	We systematically investigated whether PD-related stresses including MG132 and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and @COMPOUND$ (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 @PROTEIN$ ligases (dorfin, SIAH-1).	0
537	We systematically investigated whether PD-related stresses including MG132 and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and @COMPOUND$ (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 ubiquitin ligases (@PROTEIN$, SIAH-1).	0
538	We systematically investigated whether PD-related stresses including @COMPOUND$ and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and rotenone (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 ubiquitin ligases (@PROTEIN$, SIAH-1).	0
539	We systematically investigated whether PD-related stresses including @COMPOUND$ and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and rotenone (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 @PROTEIN$ ligases (dorfin, SIAH-1).	0
540	@COMPOUND$, a synthetic triterpenoid, inhibits expression of IL-6 and @PROTEIN$ phosphorylation in multi-drug resistant ovarian cancer cells.	1
541	@COMPOUND$, a synthetic triterpenoid, inhibits expression of @PROTEIN$ and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.	1
542	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of CDDO-Me, a synthetic triterpenoid, to inhibit IL-6 secretion, @PROTEIN$ phosphorylation, Stat3 nuclear translocation and @COMPOUND$ sensitivity in several cell line model systems.	0
543	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of @COMPOUND$, a synthetic triterpenoid, to inhibit @PROTEIN$ secretion, Stat3 phosphorylation, Stat3 nuclear translocation and paclitaxel sensitivity in several cell line model systems.	0
544	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of CDDO-Me, a synthetic triterpenoid, to inhibit @PROTEIN$ secretion, Stat3 phosphorylation, Stat3 nuclear translocation and @COMPOUND$ sensitivity in several cell line model systems.	0
545	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of @COMPOUND$, a synthetic triterpenoid, to inhibit IL-6 secretion, @PROTEIN$ phosphorylation, Stat3 nuclear translocation and paclitaxel sensitivity in several cell line model systems.	0
546	These studies demonstrated that @COMPOUND$ significantly inhibits IL-6 secretion in paclitaxel-resistant ovarian cancer cells and specifically suppresses IL-6-or oncostatin M-induced @PROTEIN$ nuclear translocation.	1
547	These studies demonstrated that @COMPOUND$ significantly inhibits @PROTEIN$ secretion in paclitaxel-resistant ovarian cancer cells and specifically suppresses IL-6-or oncostatin M-induced Stat3 nuclear translocation.	1
548	Treatment with @COMPOUND$ significantly decreases the levels of Stat3, @PROTEIN$, and Src phosphorylation in ovarian and breast cancer cell lines with constitutively activated Stat3.	1
549	Treatment with @COMPOUND$ significantly decreases the levels of Stat3, Jak2, and @PROTEIN$ phosphorylation in ovarian and breast cancer cell lines with constitutively activated Stat3.	1
550	Our data confirm that @COMPOUND$ interrupts the signaling of multiple kinases involved in the IL-6-@PROTEIN$ and Src signaling pathways.	1
551	Our data confirm that @COMPOUND$ interrupts the signaling of multiple kinases involved in the IL-6-Stat3 and @PROTEIN$ signaling pathways.	1
552	Our data confirm that @COMPOUND$ interrupts the signaling of multiple kinases involved in the @PROTEIN$-Stat3 and Src signaling pathways.	1
553	@COMPOUND$ regulates expressions of VEGF and @PROTEIN$ stimulated by STZ.	1
554	@COMPOUND$ regulates expressions of @PROTEIN$ and HIF-1alpha stimulated by STZ.	1
555	Parents (N = 19) of children with autism spectrum disorders (ASD) and adult controls (N = 17) underwent positron emission tomography (PET) using ((18)F) @COMPOUND$ to image cortical serotonin type-2 (@PROTEIN$) receptors.	1
556	These results highlight both the interactions between @PROTEIN$ and NMDA receptors in the determination of schizophreniform behaviours and the potential for the effects of @COMPOUND$ to be mediated by NMDA receptor regulation.	0
557	This additive effect was not observed when glioma cells were pre-treated with @COMPOUND$, which was unable to increase @PROTEIN$ expression in tumor.	0
558	Furthermore, the CD3(+) T cells co-cultured with @COMPOUND$ treated U-87 and autologous GBM tumor cells showed a significant increase in expression in @PROTEIN$, a key cytokine produced by activated T cells, and accordingly enhanced tumor cytotoxicity.	1
559	Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (@COMPOUND$) and tyrosine kinase inhibitors (herbimycin A and tyrphostin 46).	1
560	Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (Y27632) and tyrosine kinase inhibitors (@COMPOUND$ and tyrphostin 46).	1
561	Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (Y27632) and tyrosine kinase inhibitors (herbimycin A and @COMPOUND$).	1
562	Collectively, these results indicate that hypergravity induces @COMPOUND$ release and actin reorganization via RhoA activation and @PROTEIN$ phosphorylation, thereby activating cell proliferation and migration in BAECs.	1
563	Collectively, these results indicate that hypergravity induces @COMPOUND$ release and actin reorganization via @PROTEIN$ activation and FAK phosphorylation, thereby activating cell proliferation and migration in BAECs.	1
564	Collectively, these results indicate that hypergravity induces @COMPOUND$ release and @PROTEIN$ reorganization via RhoA activation and FAK phosphorylation, thereby activating cell proliferation and migration in BAECs.	0
565	Cell exposure to 250 microM @COMPOUND$ was able to induce @PROTEIN$ 2 up-regulation and increased in situ transglutaminase activity.	1
566	Cell exposure to 250 microM @COMPOUND$ was able to induce @PROTEIN$ up-regulation and increased in situ transglutaminase activity.	1
567	@COMPOUND$ also induced NF-kappaB activation that seemed associated with @PROTEIN$ 2 up-regulation since the specific NF-kappaB inhibition by SN50 was able to reduce transglutaminase expression and activity levels.	1
568	@COMPOUND$ also induced NF-kappaB activation that seemed associated with @PROTEIN$ up-regulation since the specific NF-kappaB inhibition by SN50 was able to reduce transglutaminase expression and activity levels.	1
569	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent @PROTEIN$ phosphorylation.	1
570	@COMPOUND$ inhibits @PROTEIN$-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.	0
571	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through @PROTEIN$-dependent AMPK phosphorylation.	1
572	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, @PROTEIN$ degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.	1
573	@COMPOUND$ inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and @PROTEIN$ production in endothelial cells through PI3K-dependent AMPK phosphorylation.	1
574	@COMPOUND$ inhibits TNF-alpha-induced @PROTEIN$ phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.	1
575	@PROTEIN$ treatment for 72 h also induced EMT in the A549 cells and this transition led to resistance to @COMPOUND$.	1
576	@PROTEIN$-antagonistic effects of hormones, cytokines and excess metabolic substrates such as @COMPOUND$ and fatty acids may be exerted via common mechanisms involving for example reactive oxygen species (ROS) accumulation and associated inflammatory responses.	1
577	Optimization of decolorization of @COMPOUND$ (MB) dye by @PROTEIN$ (LiP) enzyme produced by white-rot fungus Phanerochaete chrysosporium using sewage treatment plant (STP) sludge as a major substrate was carried out in the laboratory.	1
578	Glycine release was potentiated by the activation of @PROTEIN$ and diminished by increasing cyclic guanosine monophosphate levels with a phosphodiesterase inhibitor, @COMPOUND$.	0
579	Glycine release was potentiated by the activation of @PROTEIN$ and diminished by increasing @COMPOUND$ levels with a phosphodiesterase inhibitor, zaprinast.	0
580	@COMPOUND$ release was potentiated by the activation of @PROTEIN$ and diminished by increasing cyclic guanosine monophosphate levels with a phosphodiesterase inhibitor, zaprinast.	1
581	The second enzyme of @COMPOUND$ synthesis, GSH synthase (GS) is also regulated in a coordinated manner as @PROTEIN$ subunits and its up-regulation can further enhance the capacity of the cell to synthesize GSH.	1
582	SEMG I expression is upregulated by @PROTEIN$, IL-6 and @COMPOUND$.	0
583	@PROTEIN$ I expression is upregulated by IL-4, IL-6 and @COMPOUND$.	1
584	SEMG I expression is upregulated by IL-4, @PROTEIN$ and @COMPOUND$.	0
585	@COMPOUND$ down-regulates @PROTEIN$ transcript and protein levels in MCF-7 breast cancer cells.	1
586	@COMPOUND$ inhibited cell proliferation with IC(50) values at 24 and 48 h of 12.5 and 7.5 muM doses, respectively, and decreased @PROTEIN$ protein expression at concentrations between 2.5 and 30 muM.	1
587	30 muM, the SUL-induced suppression of @PROTEIN$ protein was reversed by preincubation with the proteasome inhibitor @COMPOUND$ and was accompanied by an increase in protein levels of the 20S catalytic core subunit PSMB5.	1
588	30 muM, the SUL-induced suppression of ERalpha protein was reversed by preincubation with the proteasome inhibitor @COMPOUND$ and was accompanied by an increase in protein levels of the 20S catalytic core subunit @PROTEIN$.	0
589	Of importance, treatment with @COMPOUND$ significantly improved endothelial dysfunction as assessed by the vasodilator response to acetylcholine, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial nitric oxide synthase (@PROTEIN$) mRNA in the aorta.	1
590	Of importance, treatment with ezetimibe significantly improved endothelial dysfunction as assessed by the vasodilator response to @COMPOUND$, accompanied by inhibition of @PROTEIN$ mRNA and an increase in endothelial nitric oxide synthase (eNOS) mRNA in the aorta.	0
591	Of importance, treatment with ezetimibe significantly improved endothelial dysfunction as assessed by the vasodilator response to @COMPOUND$, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial @PROTEIN$ (eNOS) mRNA in the aorta.	0
592	Of importance, treatment with @COMPOUND$ significantly improved endothelial dysfunction as assessed by the vasodilator response to acetylcholine, accompanied by inhibition of @PROTEIN$ mRNA and an increase in endothelial nitric oxide synthase (eNOS) mRNA in the aorta.	1
593	Of importance, treatment with ezetimibe significantly improved endothelial dysfunction as assessed by the vasodilator response to @COMPOUND$, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial nitric oxide synthase (@PROTEIN$) mRNA in the aorta.	0
594	Of importance, treatment with @COMPOUND$ significantly improved endothelial dysfunction as assessed by the vasodilator response to acetylcholine, accompanied by inhibition of interleukin-6 mRNA and an increase in endothelial @PROTEIN$ (eNOS) mRNA in the aorta.	1
595	A series of @COMPOUND$ derivatives of thiazolyl-N-substituted amides were synthesized in a three-step reaction and tested for anti-inflammatory activity as well as @PROTEIN$ and cycloxygenase inhibitory actions.	0
596	Plasma levels of @COMPOUND$, zinc and carotenoids did not vary across quintiles, but weak negative correlations were observed with serum ferritin and @PROTEIN$ saturation.	1
597	Plasma levels of @COMPOUND$, zinc and carotenoids did not vary across quintiles, but weak negative correlations were observed with serum @PROTEIN$ and transferrin saturation.	1
598	Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the Ah receptor (activated by aryl hydrocarbons and drugs such as omeprazole) and type 2 steroid receptors such as @PROTEIN$ and CAR, activated by drugs such as rifampicin, carbamazepin and @COMPOUND$.	1
599	Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the @PROTEIN$ (activated by aryl hydrocarbons and drugs such as omeprazole) and type 2 steroid receptors such as PXR and CAR, activated by drugs such as @COMPOUND$, carbamazepin and phenytoin.	0
600	Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the Ah receptor (activated by aryl hydrocarbons and drugs such as omeprazole) and type 2 steroid receptors such as @PROTEIN$ and CAR, activated by drugs such as @COMPOUND$, carbamazepin and phenytoin.	1
601	Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the Ah receptor (activated by aryl hydrocarbons and drugs such as @COMPOUND$) and type 2 steroid receptors such as @PROTEIN$ and CAR, activated by drugs such as rifampicin, carbamazepin and phenytoin.	0
602	Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the @PROTEIN$ (activated by aryl hydrocarbons and drugs such as omeprazole) and type 2 steroid receptors such as PXR and CAR, activated by drugs such as rifampicin, carbamazepin and @COMPOUND$.	0
603	Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the @PROTEIN$ (activated by aryl hydrocarbons and drugs such as @COMPOUND$) and type 2 steroid receptors such as PXR and CAR, activated by drugs such as rifampicin, carbamazepin and phenytoin.	1
604	Inhibition of protein synthesis by @COMPOUND$ reduces @PROTEIN$ expression in normoxic and hypoxic pancreatic cancer cells.	1
605	Western blot analyses of @COMPOUND$-treated cells demonstrated that imexon reduces @PROTEIN$ protein levels in both normoxic and hypoxic conditions in a time- and concentration-dependant fashion.	1
606	@COMPOUND$ did not similarly affect @PROTEIN$ levels.	0
607	Concurrently, the half-life of existing @PROTEIN$ protein was increased by @COMPOUND$, in association with a marked inhibition of chymotryptic activity in the 20S proteasome.	1
608	The inhibition of @PROTEIN$ translation was not specific, rather it was part of a general decrease in protein translation caused by @COMPOUND$.	1
609	Under the condition of delayed intervention (30 days after deafening) following @COMPOUND$+ furosemide deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of @PROTEIN$ (BDNF) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0
610	Under the condition of delayed intervention (30 days after deafening) following @COMPOUND$+ furosemide deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of brain-derived neurotrophic factor (@PROTEIN$) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0
611	Under the condition of delayed intervention (30 days after deafening) following gentamicin+ @COMPOUND$ deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of @PROTEIN$ (BDNF) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0
612	Under the condition of delayed intervention (30 days after deafening) following gentamicin+ @COMPOUND$ deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of brain-derived neurotrophic factor (@PROTEIN$) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0
613	For this purpose, human erythrocyte @PROTEIN$ was initially purified 2139-fold in a yield of 29% by using 2', 5'-ADP @COMPOUND$ 4B affinity gel and Sephadex G-200 gel filtration chromatography.	0
614	Adenosine deaminase (@PROTEIN$), an enzyme involved in purine metabolism, catalyzes the hydrolytic breakdown of @COMPOUND$ into inosine and free ammonia.	1
615	Adenosine deaminase (@PROTEIN$), an enzyme involved in purine metabolism, catalyzes the hydrolytic breakdown of adenosine into @COMPOUND$ and free ammonia.	1
616	Adenosine deaminase (@PROTEIN$), an enzyme involved in purine metabolism, catalyzes the hydrolytic breakdown of adenosine into inosine and free @COMPOUND$.	1
617	@PROTEIN$ (ADA), an enzyme involved in purine metabolism, catalyzes the hydrolytic breakdown of @COMPOUND$ into inosine and free ammonia.	1
618	@PROTEIN$ (ADA), an enzyme involved in purine metabolism, catalyzes the hydrolytic breakdown of adenosine into inosine and free @COMPOUND$.	1
619	@PROTEIN$ (ADA), an enzyme involved in purine metabolism, catalyzes the hydrolytic breakdown of adenosine into @COMPOUND$ and free ammonia.	1
620	Diastolic function and @PROTEIN$ changes during exercise predict @COMPOUND$ consumption in chronic heart failure patients.	1
621	Type I @PROTEIN$ (TG1), an enzyme that catalyzes the formation of epsilon-(gamma-glutamyl) @COMPOUND$ bonds, is the key protein responsible for generation of the crosslinks.	1
622	Caspase inhibition with z-@COMPOUND$ was unable to prevent @PROTEIN$ localization to the nucleus and subsequently unable to prevent cell death.	0
623	@PROTEIN$ inhibitory activity of @COMPOUND$ and synergistic effect with acarbose.	1
624	@PROTEIN$ inhibitory activity of cyanidin-3-galactoside and synergistic effect with @COMPOUND$.	1
625	Cyanidin-3-galactoside, a natural @COMPOUND$, was investigated for its @PROTEIN$ inhibitory activity.	0
626	@COMPOUND$, a natural anthocyanin, was investigated for its @PROTEIN$ inhibitory activity.	0
627	@PROTEIN$ act as crucial bacteriolytic enzymes in insect immune system by hydrolyzing the beta (1--&gt;4) bonds between @COMPOUND$ and N-acetylmuramic acid in the peptidoglycan of prokaryotic cell walls.	1
628	@PROTEIN$ act as crucial bacteriolytic enzymes in insect immune system by hydrolyzing the beta (1--&gt;4) bonds between N-acetylglucosamine and @COMPOUND$ in the peptidoglycan of prokaryotic cell walls.	1
629	@PROTEIN$ act as crucial bacteriolytic enzymes in insect immune system by hydrolyzing the beta (1--&gt;4) bonds between N-acetylglucosamine and N-acetylmuramic acid in the @COMPOUND$ of prokaryotic cell walls.	1
630	"These mRNAs no longer encode the @PROTEIN$ homology (PH) domain of collybistin, which we now show binds @COMPOUND$ (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
631	"These mRNAs no longer encode the pleckstrin homology (PH) domain of @PROTEIN$, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a @COMPOUND$ with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
632	"These mRNAs no longer encode the pleckstrin homology (PH) domain of @PROTEIN$, which we now show binds phosphatidylinositol-3-phosphate (PI3P/@COMPOUND$), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
633	"These mRNAs no longer encode the pleckstrin homology (PH) domain of @PROTEIN$, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than @COMPOUND$ (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
634	"These mRNAs no longer encode the @PROTEIN$ homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than @COMPOUND$ (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
635	"These mRNAs no longer encode the pleckstrin homology (PH) domain of @PROTEIN$, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/@COMPOUND$) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
636	"These mRNAs no longer encode the @PROTEIN$ homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/@COMPOUND$), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
637	"These mRNAs no longer encode the @PROTEIN$ homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/@COMPOUND$) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
638	"These mRNAs no longer encode the pleckstrin homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/@COMPOUND$) as previously suggested in the "" membrane activation model"" of @PROTEIN$ clustering."	0
639	"These mRNAs no longer encode the pleckstrin homology (PH) domain of @PROTEIN$, which we now show binds @COMPOUND$ (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
640	"These mRNAs no longer encode the @PROTEIN$ homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a @COMPOUND$ with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of gephyrin clustering."	1
641	"These mRNAs no longer encode the pleckstrin homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/@COMPOUND$), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of @PROTEIN$ clustering."	0
642	"These mRNAs no longer encode the pleckstrin homology (PH) domain of collybistin, which we now show binds @COMPOUND$ (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of @PROTEIN$ clustering."	0
643	"These mRNAs no longer encode the pleckstrin homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a @COMPOUND$ with an emerging role in membrane trafficking and signal transduction, rather than phosphatidylinositol 3,4,5-trisphosphate (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of @PROTEIN$ clustering."	0
644	"These mRNAs no longer encode the pleckstrin homology (PH) domain of collybistin, which we now show binds phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P), a phosphoinositide with an emerging role in membrane trafficking and signal transduction, rather than @COMPOUND$ (PIP3/PtdIns-3,4,5-P) as previously suggested in the "" membrane activation model"" of @PROTEIN$ clustering."	0
645	We investigated whether several different inflammatory markers including C-reactive protein (@PROTEIN$) and fibrinogen and white blood cells (WBCs) count, are associated with maximal @COMPOUND$ consumption (VO(2 max)) in women with polycystic ovary syndrome (PCOS).	0
646	We investigated whether several different inflammatory markers including C-reactive protein (CRP) and @PROTEIN$ and white blood cells (WBCs) count, are associated with maximal @COMPOUND$ consumption (VO(2 max)) in women with polycystic ovary syndrome (PCOS).	0
647	We have previously demonstrated that @COMPOUND$, a stable prostacyclin (PGI (2)) analogue, induces angiogenesis in vivo, through a vascular endothelial growth factor (@PROTEIN$)-dependent mechanism.	1
648	We have previously demonstrated that iloprost, a stable @COMPOUND$ (PGI (2)) analogue, induces angiogenesis in vivo, through a vascular endothelial growth factor (@PROTEIN$)-dependent mechanism.	0
649	In this study, we demonstrate that @COMPOUND$-induced angiogenesis and @PROTEIN$ upregulation are modulated by peroxisome proliferator-activated receptor-alpha (PPARalpha), a ligand-inducible transcription factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system.	1
650	In this study, we demonstrate that @COMPOUND$-induced angiogenesis and VEGF upregulation are modulated by peroxisome proliferator-activated receptor-alpha (@PROTEIN$), a ligand-inducible transcription factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system.	1
651	In this study, we demonstrate that @COMPOUND$-induced angiogenesis and VEGF upregulation are modulated by @PROTEIN$ (PPARalpha), a ligand-inducible transcription factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system.	1
652	In contrast, @COMPOUND$ induces a robust angiogenic response in wild-type mice, along with local upregulation of @PROTEIN$.	1
653	Importantly, mice lacking the PPARalpha gene exhibit a normal angiogenic response to @PROTEIN$, indicating that the absence of PPARalpha does not result in a general impairment of angiogenesis, but specifically affects the ability of @COMPOUND$ to induce angiogenesis.	1
654	In the hormone receptor-positive breast cancer cell line T47-D expression of @PROTEIN$ and its soluble isoforms was increased by treatment with estradiol and @COMPOUND$.	1
655	In the hormone receptor-positive breast cancer cell line T47-D expression of @PROTEIN$ and its soluble isoforms was increased by treatment with @COMPOUND$ and tamoxifen.	1
656	@PROTEIN$-alpha (TNF-alpha) levels were also investigated in rat serum, but there was no statistically significant difference between the TNF-alpha levels of the @COMPOUND$-treated rats groups and the control rats.	0
657	Tumor necrosis factor-alpha (@PROTEIN$) levels were also investigated in rat serum, but there was no statistically significant difference between the TNF-alpha levels of the @COMPOUND$-treated rats groups and the control rats.	0
658	Our study indicates that brain @PROTEIN$ activity decreases after @COMPOUND$ administration at doses of 30 mg/kg and 100 mg/kg.	1
659	These findings suggest that multiple variations in the @PROTEIN$ gene are associated with remission in white non-Hispanic depressed adults treated with @COMPOUND$.	1
660	The planar angle between the carbamoyl phosphate and @COMPOUND$ domains of the catalytic chain is more open at pH 8.5 than in @PROTEIN$ structures determined at lower pH values.	1
661	The planar angle between the @COMPOUND$ and aspartate domains of the catalytic chain is more open at pH 8.5 than in @PROTEIN$ structures determined at lower pH values.	1
662	At 0.15 microM @COMPOUND$+), ((35)S) CaM bound to @PROTEIN$ with decreased affinity and binding enthalpy compared with RyR1.	0
663	At 0.15 microM @COMPOUND$+), ((35)S) @PROTEIN$ bound to RyR2 with decreased affinity and binding enthalpy compared with RyR1.	0
664	At 0.15 microM @COMPOUND$+), ((35)S) CaM bound to RyR2 with decreased affinity and binding enthalpy compared with @PROTEIN$.	0
665	The rates of ((35)S) CaM dissociation from RyR1 increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from @PROTEIN$ was little affected.	0
666	The rates of ((35)S) CaM dissociation from @PROTEIN$ increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from RyR2 was little affected.	0
667	The rates of ((35)S) @PROTEIN$ dissociation from RyR1 increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from RyR2 was little affected.	0
668	In rats, infusion of angiotensin II increases @PROTEIN$ levels and arterial thickness which are reversed by treatment with the iron chelator @COMPOUND$.	1
669	Furthermore, @COMPOUND$ regulated endogenous survival signaling by up-regulating phosphorylated @PROTEIN$ that returned to its basal level later.	1
670	Furthermore, @COMPOUND$ induced nucleus translocalization of p53 and @PROTEIN$ and recruitment of autophagosomes.	1
671	Furthermore, @COMPOUND$ induced nucleus translocalization of @PROTEIN$ and Akt and recruitment of autophagosomes.	1
672	The ubiquitous enzyme dUTP nucleotidohydrolase (@PROTEIN$) catalyses the hydrolysis of dUTP to dUMP and can be considered as the first line of defence against incorporation of @COMPOUND$ into DNA.	0
673	Pretreatment with extracellular signal-regulated kinase (ERK) and Jun N-terminal kinase (JNK) inhibitors, but not p38 mitogen-activated protein kinase (p38MAPK) significantly decreased @PROTEIN$-induced @COMPOUND$ anion release from macrophages in vivo.	1
674	Pretreatment with extracellular signal-regulated kinase (ERK) and Jun N-terminal kinase (JNK) inhibitors, but not p38 mitogen-activated protein kinase (@PROTEIN$) significantly decreased CRP-induced @COMPOUND$ anion release from macrophages in vivo.	0
675	In the diabetic group, a decrease in the pancreatic @COMPOUND$ levels, glutathione peroxidase and superoxide dismutase activities and an increase in the pancreatic lipid peroxidation level and @PROTEIN$ activities were observed.	0
676	In the diabetic group, a decrease in the pancreatic @COMPOUND$ levels, glutathione peroxidase and @PROTEIN$ activities and an increase in the pancreatic lipid peroxidation level and catalase activities were observed.	0
677	In the diabetic group, a decrease in the pancreatic @COMPOUND$ levels, @PROTEIN$ and superoxide dismutase activities and an increase in the pancreatic lipid peroxidation level and catalase activities were observed.	0
678	The immunomodulatory effects of @COMPOUND$ are at least partially mediated through its ability to down-regulate the pathogenic over-production of tumor necrosis factor-alpha (@PROTEIN$).	1
679	The immunomodulatory effects of @COMPOUND$ are at least partially mediated through its ability to down-regulate the pathogenic over-production of @PROTEIN$-alpha (TNF-alpha).	1
680	In the central nervous system, @PROTEIN$ is involved in induction of a fever response and triggers the release of other cytokines, and may also influence transport of compounds into the brain, leading to cerebrospinal fluid leukocytosis, increased protein influx, and @COMPOUND$ accumulation.	1
681	@COMPOUND$ has been shown to down-regulate the production of @PROTEIN$.	1
682	The deduced amino acid sequence of Ai Lec was highly similar to those of the C-type @PROTEIN$ from other animals and contained a typical carbohydrate-recognition domain (CRD) of 131 residues, which has four conserved disulfide-bonded @COMPOUND$ residues that define the CRD and two additional cysteine residues at the amino terminus.	1
683	@PROTEIN$ kinases can be activated by trans-phosphorylation of a @COMPOUND$ located in the central activation loop of the catalytic domain.	1
684	However, because the required exposure of this @COMPOUND$ is not observed in the down-regulated X-ray structures of @PROTEIN$ kinases, transient partial opening of the activation loop appears to be necessary for such processes.	0
685	The stimulatory effects of stearic, palmitic and palmitoleic acids on resistin secretion and the stimulatory effect of @COMPOUND$ on @PROTEIN$ secretion are mediated via TLR-4.	1
686	The stimulatory effects of stearic, palmitic and palmitoleic acids on resistin secretion and the stimulatory effect of @COMPOUND$ on MCP-1 secretion are mediated via @PROTEIN$-4.	1
687	@COMPOUND$ increased the levels of CD95 (@PROTEIN$), CD95-ligand and Fas-associated death domain.	1
688	Since lithium and @COMPOUND$-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically @PROTEIN$ B, cdc2 and the phosphorylated form of this protein (tyr15-cdc2).	0
689	Since @COMPOUND$ and SB-415286-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically cyclin B, @PROTEIN$ and the phosphorylated form of this protein (tyr15-cdc2).	0
690	Since lithium and @COMPOUND$-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically cyclin B, @PROTEIN$ and the phosphorylated form of this protein (tyr15-cdc2).	0
691	Since @COMPOUND$ and SB-415286-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically @PROTEIN$ B, cdc2 and the phosphorylated form of this protein (tyr15-cdc2).	0
692	On the other hand, @COMPOUND$ increased the expression of @PROTEIN$, involved in the regulation of proliferation.	1
693	We conclude that inhibitors of GSK-3 induced cell-cycle arrest, mediated by the phosphorylation of cdc2 and, in the case of @COMPOUND$, @PROTEIN$ expression, which induced apoptosis in a caspase-independent manner.	1
694	We conclude that inhibitors of GSK-3 induced cell-cycle arrest, mediated by the phosphorylation of @PROTEIN$ and, in the case of @COMPOUND$, SIRT2 expression, which induced apoptosis in a caspase-independent manner.	0
695	In addition to transporting @COMPOUND$, @PROTEIN$ plays other roles in regulating GABA synthesis, reducing oxidative stress in neurons, and is important in supporting neuron viability.	1
696	In addition to transporting glutamate, @PROTEIN$ plays other roles in regulating @COMPOUND$ synthesis, reducing oxidative stress in neurons, and is important in supporting neuron viability.	1
697	Whereas both peptides @COMPOUND$ (17-30) and lactoferrampin (265-284) did not have bactericidal activity, 40 microM of @PROTEIN$ chimera (a fusion of the two peptides) inhibited the growth of all Vibrio tested to the same extent as the antibiotic gentamicin.	0
698	Whereas both peptides lactoferricin (17-30) and lactoferrampin (265-284) did not have bactericidal activity, 40 microM of @PROTEIN$ chimera (a fusion of the two peptides) inhibited the growth of all Vibrio tested to the same extent as the antibiotic @COMPOUND$.	0
699	We have recently shown that the antidepressant @COMPOUND$ enhances T cell proliferation and T(H)1 cytokine production in vivo, without changes on @PROTEIN$/CD8 subsets.	0
700	We found that @COMPOUND$ restored T cell proliferation and interleukin-2, @PROTEIN$ and tumor necrosis factor-alpha production by compensatory mechanisms.	1
701	We found that @COMPOUND$ restored T cell proliferation and interleukin-2, interferon-gamma and @PROTEIN$-alpha production by compensatory mechanisms.	1
702	In the present study, we screened the inhibitory effect of the extract from 50 Thai medicinal plants on an inducible-nitric oxide synthase (@PROTEIN$) expression induced by @COMPOUND$ (LPS) in mouse macrophages RAW 264.7.	1
703	In the present study, we screened the inhibitory effect of the extract from 50 Thai medicinal plants on an inducible-@PROTEIN$ (iNOS) expression induced by @COMPOUND$ (LPS) in mouse macrophages RAW 264.7.	1
704	These results are in contrast to postmortem findings in schizophrenia and suggest that reduced @PROTEIN$ protein levels in schizophrenia patients' postmortem brain do not result from perinatal @COMPOUND$ deprivation.	0
705	In aged animals, administration of @COMPOUND$ for 21 days significantly decreased the levels of lipid peroxides and improved the activities of antioxidant enzymes like superoxide dismutase, @PROTEIN$, glutathione peroxidase and glutathione reductase.	1
706	In aged animals, administration of @COMPOUND$ for 21 days significantly decreased the levels of lipid peroxides and improved the activities of antioxidant enzymes like superoxide dismutase, catalase, glutathione peroxidase and @PROTEIN$.	1
707	In aged animals, administration of @COMPOUND$ for 21 days significantly decreased the levels of lipid peroxides and improved the activities of antioxidant enzymes like superoxide dismutase, catalase, @PROTEIN$ and glutathione reductase.	1
708	In aged animals, administration of @COMPOUND$ for 21 days significantly decreased the levels of lipid peroxides and improved the activities of antioxidant enzymes like @PROTEIN$, catalase, glutathione peroxidase and glutathione reductase.	1
709	L-Carnitine enhanced T-cell proliferative responses as evaluated by T-cell proliferation assay using (3H) @COMPOUND$ incorporation and also significantly reduced DNA damage, apoptosis and @PROTEIN$ level in lymphocytes of aged animals.	0
710	@COMPOUND$ enhanced T-cell proliferative responses as evaluated by T-cell proliferation assay using (3H) thymidine incorporation and also significantly reduced DNA damage, apoptosis and @PROTEIN$ level in lymphocytes of aged animals.	1
711	In our microarray analysis we observed that Seven-in-Absentia Homolog 2 (SIAH2) levels were low in @PROTEIN$ (ER) positive breast tumors of patients resistant to first-line @COMPOUND$ therapy.	1
712	In our microarray analysis we observed that @PROTEIN$ (SIAH2) levels were low in estrogen receptor (ER) positive breast tumors of patients resistant to first-line @COMPOUND$ therapy.	1
713	In our microarray analysis we observed that Seven-in-Absentia Homolog 2 (@PROTEIN$) levels were low in estrogen receptor (ER) positive breast tumors of patients resistant to first-line @COMPOUND$ therapy.	1
714	Of various agents tested in HaCaT cell cultures, only @COMPOUND$ (10(-6) M) and staurosporine (2.5 x 10(-8) M) upregulated @PROTEIN$ mRNA and protein expression, whereas tumor promoters, hormones, or dexamethasone were without effect.	1
715	Of various agents tested in HaCaT cell cultures, only retinoic acid (10(-6) M) and @COMPOUND$ (2.5 x 10(-8) M) upregulated @PROTEIN$ mRNA and protein expression, whereas tumor promoters, hormones, or dexamethasone were without effect.	1
716	Of various agents tested in HaCaT cell cultures, only retinoic acid (10(-6) M) and staurosporine (2.5 x 10(-8) M) upregulated @PROTEIN$ mRNA and protein expression, whereas tumor promoters, hormones, or @COMPOUND$ were without effect.	0
717	By contrast, treatment of N2a cells with 1-10 microM @COMPOUND$ resulted in marked reductions in the expression of the axon growth-associated protein @PROTEIN$-43.	1
718	@COMPOUND$-treated cells also showed an increased expression of the heat shock protein @PROTEIN$ compared to controls.	1
719	Mean plasma levels of folic acid, @COMPOUND$, and vitamin B12 did not change, but there was a significant decrease of @PROTEIN$ at T1, 0.36 mg dl(-1) on average (P = 0.01), which was maintained at T2.	0
720	Mean plasma levels of @COMPOUND$, homocysteine, and vitamin B12 did not change, but there was a significant decrease of @PROTEIN$ at T1, 0.36 mg dl(-1) on average (P = 0.01), which was maintained at T2.	0
721	Chondrocytes grown in monolayer were treated with interleukin-1alpha (@PROTEIN$), insulin-like growth factor-I (IGF-I), C3 Transferase, @COMPOUND$, or transfected with Rho wild type or two constitutively active mutants of Rho (Q63L and G14V).	0
722	Chondrocytes grown in monolayer were treated with interleukin-1alpha (IL-1alpha), @PROTEIN$-like growth factor-I (IGF-I), C3 Transferase, @COMPOUND$, or transfected with Rho wild type or two constitutively active mutants of Rho (Q63L and G14V).	0
723	Chondrocytes grown in monolayer were treated with interleukin-1alpha (IL-1alpha), insulin-like growth factor-I (@PROTEIN$), C3 Transferase, @COMPOUND$, or transfected with Rho wild type or two constitutively active mutants of Rho (Q63L and G14V).	0
724	Affinity assays were performed to measure endogenous @COMPOUND$-bound @PROTEIN$, and confocal microscopy was used to assess changes in organization of the actin cytoskeleton.	1
725	Affinity assays were performed to measure endogenous @COMPOUND$-bound Rho, and confocal microscopy was used to assess changes in organization of the @PROTEIN$ cytoskeleton.	0
726	IL-1alpha and RhoG14V increased cytoplasmic @PROTEIN$ stress fiber formation, which was blocked by C3 Transferase, and @COMPOUND$.	1
727	@PROTEIN$ and RhoG14V increased cytoplasmic actin stress fiber formation, which was blocked by C3 Transferase, and @COMPOUND$.	1
728	Expression of RhoQ63L or RhoG14V resulted in increased MMP-13 expression; however, inhibition of Rho with @COMPOUND$ was unable to inhibit @PROTEIN$-induced MMP-13 expression.	0
729	Expression of @PROTEIN$Q63L or RhoG14V resulted in increased MMP-13 expression; however, inhibition of Rho with @COMPOUND$ was unable to inhibit IL-1alpha-induced MMP-13 expression.	1
730	Expression of RhoQ63L or RhoG14V resulted in increased @PROTEIN$ expression; however, inhibition of Rho with @COMPOUND$ was unable to inhibit IL-1alpha-induced MMP-13 expression.	0
731	Plasma total @COMPOUND$, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
732	Plasma total @COMPOUND$, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
733	Plasma total cholesterol, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
734	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
735	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
736	Plasma total @COMPOUND$, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
737	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
738	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
739	Plasma total cholesterol, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
740	The increase of mature @PROTEIN$ by macrophages was inhibited by @COMPOUND$ : caspase-1 is known to cleave the proform of IL-18 to produce active mature IL-18.	1
741	Using enzyme-linked immunosorbent assays, we showed @COMPOUND$ to inhibit LPS-induced secretion of @PROTEIN$ and TNF-alpha.	1
742	Using enzyme-linked immunosorbent assays, we showed @COMPOUND$ to inhibit LPS-induced secretion of IL-6 and @PROTEIN$.	1
743	Dopamine release and direct stimulation of dopamine D2 and serotonin @PROTEIN$ receptors also contributes to the overall action of @COMPOUND$.	1
744	Our findings suggest that @COMPOUND$ differentially affects higher cognitive functions, but does not support the hypothesis from animal studies, that some of the MDMA effects are causally mediated through action at the @PROTEIN$ receptor system.	0
745	In the present study, we measured plasma @PROTEIN$ levels by enzyme-linked immunosorbent assay in seven healthy volunteers after repeated experimental endotoxemia induced by 2 ng kg Escherichia coli @COMPOUND$ per day (to investigate inflammation-induced hepatic injury) and in 21 patients within 12 h after the occurrence of severe sepsis/septic shock (to investigate its ability to predict an increase of transaminases on day 7).	0
746	Furthermore, @PROTEIN$ levels did not correlate with IL-6 levels but did with @COMPOUND$ infusion rate (Spearman r = 0.94; P = 0.02), suggesting that the extent of hemodynamic instability and not the degree of inflammation could be of importance for the occurrence of liver damage.	1
747	Furthermore, GSTA1-1 levels did not correlate with @PROTEIN$ levels but did with @COMPOUND$ infusion rate (Spearman r = 0.94; P = 0.02), suggesting that the extent of hemodynamic instability and not the degree of inflammation could be of importance for the occurrence of liver damage.	0
748	Heparin (H), @COMPOUND$ (A), anti@PROTEIN$ III (ATIII), and recombinant human activated protein C (rhAPC) with and without thrombin were added to cells suspended in septic plasma and normal plasma.	0
749	Heparin (H), @COMPOUND$ (A), antithrombin III (ATIII), and recombinant human activated @PROTEIN$ (rhAPC) with and without thrombin were added to cells suspended in septic plasma and normal plasma.	0
750	Heparin (H), @COMPOUND$ (A), antithrombin III (@PROTEIN$), and recombinant human activated protein C (rhAPC) with and without thrombin were added to cells suspended in septic plasma and normal plasma.	0
751	Heparin (H), @COMPOUND$ (A), @PROTEIN$ (ATIII), and recombinant human activated protein C (rhAPC) with and without thrombin were added to cells suspended in septic plasma and normal plasma.	0
752	Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and @PROTEIN$ (ER), steroidogenic enzymes (P450scc and 3beta-HSD) and four regulatory factors (StAR, SF-1, GATA-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0
753	Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and estrogen receptors (ER), steroidogenic enzymes (P450scc and 3beta-HSD) and four regulatory factors (StAR, @PROTEIN$, GATA-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0
754	Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and estrogen receptors (ER), steroidogenic enzymes (P450scc and @PROTEIN$) and four regulatory factors (StAR, SF-1, GATA-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0
755	Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and estrogen receptors (ER), steroidogenic enzymes (P450scc and 3beta-HSD) and four regulatory factors (StAR, SF-1, @PROTEIN$-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0
756	Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and estrogen receptors (ER), steroidogenic enzymes (P450scc and 3beta-HSD) and four regulatory factors (@PROTEIN$, SF-1, GATA-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0
757	In utero exposure to @COMPOUND$ reduced intratesticular T of foetal males (significant at 0.3 microg/kg TCDD) and tended to reduce the protein expression of @PROTEIN$ and AR of foetal male rat testis.	1
758	mRNA expression of developmental regulatory factors was not influenced by foetal @COMPOUND$ exposure, except for significantly reduced adrenal @PROTEIN$.	1
759	@COMPOUND$-containing bisphosphonates were found to inhibit @PROTEIN$-an essential enzyme in the cholesterol biosynthesis pathway, but their effect on cholesterol synthesis per se in the central nervous system (CNS) remains unknown.	0
760	Nitrogen-containing bisphosphonates were found to inhibit @PROTEIN$-an essential enzyme in the @COMPOUND$ biosynthesis pathway, but their effect on cholesterol synthesis per se in the central nervous system (CNS) remains unknown.	1
761	hsBAFF-upregulated intracellular free @COMPOUND$+) homeostasis regulates @PROTEIN$/2 activity and cell proliferation in B cells in vitro.	1
762	Using immunocytochemistry and Western blot analysis, we found that the activation of @PROTEIN$/2 due to hsBAFF was triggered by a (@COMPOUND$+))(i)-dependent pathway, leading to elevation of B cell proliferation.	1
763	This is supported by the findings that intracellular Ca(2+) chelator @COMPOUND$ attenuated phosphorylated @PROTEIN$/2 expression and cell proliferation in hsBAFF-stimulated B cells.	1
764	Taken together, the main finding of this study is that hsBAFF elicits higher but homeostatic (@COMPOUND$+))(i) levels, which regulates @PROTEIN$/2 activity and cell proliferation in in vitro B cells.	1
765	In this study we have investigated a long-term pattern of expression and production of spinal COX-1 and @PROTEIN$ in the model of osteoarthritis induced in rats by injection of @COMPOUND$ (MIA) into the knee joint.	0
766	In this study we have investigated a long-term pattern of expression and production of spinal @PROTEIN$ and COX-2 in the model of osteoarthritis induced in rats by injection of @COMPOUND$ (MIA) into the knee joint.	0
767	The enzyme @PROTEIN$ (IDO) converts @COMPOUND$ to kynurenine, blocking T-cell activation and inducing immunosuppression.	1
768	The enzyme indoleamine 2,3-dioxygenase (@PROTEIN$) converts tryptophan to @COMPOUND$, blocking T-cell activation and inducing immunosuppression.	1
769	The enzyme indoleamine 2,3-dioxygenase (@PROTEIN$) converts @COMPOUND$ to kynurenine, blocking T-cell activation and inducing immunosuppression.	1
770	The enzyme @PROTEIN$ (IDO) converts tryptophan to @COMPOUND$, blocking T-cell activation and inducing immunosuppression.	1
771	Peripheral administration of the acetylcholinesterase inhibitor @COMPOUND$ significantly reduced serum @PROTEIN$ levels through vagus nerve signaling, and protected against lethality during murine endotoxemia.	1
772	Administration of a centrally-acting muscarinic receptor antagonist abolished the suppression of TNF by @COMPOUND$, indicating that suppressing @PROTEIN$ activity, coupled with central muscarinic receptors, controls peripheral cytokine responses.	1
773	Administration of a centrally-acting muscarinic receptor antagonist abolished the suppression of @PROTEIN$ by @COMPOUND$, indicating that suppressing acetylcholinesterase activity, coupled with central muscarinic receptors, controls peripheral cytokine responses.	1
774	Administration of @COMPOUND$ to alpha7nAChR knockout mice failed to suppress @PROTEIN$ levels, indicating that the alpha7nAChR-mediated cholinergic anti-inflammatory pathway is required for the anti-inflammatory effect of galantamine.	0
775	The involvement of @COMPOUND$ and nitric oxide was verified by the block of @PROTEIN$ using specific scavengers (tiron and PTIO, respectively).	0
776	The involvement of superoxide and nitric oxide was verified by the block of @PROTEIN$ using specific scavengers (@COMPOUND$ and PTIO, respectively).	1
777	The involvement of superoxide and @COMPOUND$ was verified by the block of @PROTEIN$ using specific scavengers (tiron and PTIO, respectively).	0
778	Accordingly, @PROTEIN$ were blocked by the peroxynitrite scavenger @COMPOUND$ and could be mimicked by application of exogenous peroxynitrite.	1
779	This conclusion is supported by our findings that @PROTEIN$ were suppressed by inhibitors of phospholipases but could be mimicked by exogenous phospholipases or by amphipaths (oleic acid, @COMPOUND$).	1
780	This conclusion is supported by our findings that @PROTEIN$ were suppressed by inhibitors of phospholipases but could be mimicked by exogenous phospholipases or by amphipaths (@COMPOUND$, Triton X-100).	1
781	In this study, we compared the effects of @PROTEIN$-like growth factor-I (IGF-I), basic fibroblast growth factor (bFGF), transforming growth factor beta1 (TGF-beta1), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0
782	In this study, we compared the effects of insulin-like growth factor-I (IGF-I), basic fibroblast growth factor (bFGF), transforming growth factor beta1 (@PROTEIN$), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0
783	In this study, we compared the effects of insulin-like growth factor-I (@PROTEIN$), basic fibroblast growth factor (bFGF), transforming growth factor beta1 (TGF-beta1), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0
784	In this study, we compared the effects of insulin-like growth factor-I (IGF-I), @PROTEIN$ (bFGF), transforming growth factor beta1 (TGF-beta1), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0
785	@PROTEIN$/Akt activity, analyzed by phosphatidylinositol trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with @COMPOUND$ or LY294002 improved apoptosis in the resistant cell lines.	1
786	@PROTEIN$/Akt activity, analyzed by phosphatidylinositol trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with wortmannin or @COMPOUND$ improved apoptosis in the resistant cell lines.	1
787	@PROTEIN$/Akt activity, analyzed by @COMPOUND$ trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with wortmannin or LY294002 improved apoptosis in the resistant cell lines.	1
788	Vincristine but not @COMPOUND$ increased p-@PROTEIN$ expression whereas co-treatment with PI3K inhibitors and vincristine increased apoptosis in the three cell lines.	0
789	@COMPOUND$ but not doxorubicin increased p-@PROTEIN$ expression whereas co-treatment with PI3K inhibitors and vincristine increased apoptosis in the three cell lines.	1
790	Vincristine but not doxorubicin increased p-@PROTEIN$ expression whereas co-treatment with PI3K inhibitors and @COMPOUND$ increased apoptosis in the three cell lines.	0
791	Wortmannin and @COMPOUND$ inhibited P-@PROTEIN$ (Pgp) function and also increased NF-kappaB activity.	1
792	@COMPOUND$ and LY294002 inhibited P-@PROTEIN$ (Pgp) function and also increased NF-kappaB activity.	1
793	Activation of these receptors can inhibit @PROTEIN$-release in primary cultured corticotroph adenomas and compounds that target either sst (5) (@COMPOUND$, or SOM230) or D(2) (cabergoline) have shown significant efficacy in subsets of patients in recent clinical studies.	0
794	Activation of these receptors can inhibit @PROTEIN$-release in primary cultured corticotroph adenomas and compounds that target either sst (5) (pasireotide, or SOM230) or D(2) (@COMPOUND$) have shown significant efficacy in subsets of patients in recent clinical studies.	0
795	Activation of these receptors can inhibit @PROTEIN$-release in primary cultured corticotroph adenomas and compounds that target either sst (5) (pasireotide, or @COMPOUND$) or D(2) (cabergoline) have shown significant efficacy in subsets of patients in recent clinical studies.	0
796	@COMPOUND$ in anionic DSPG liposomes stimulated murine @PROTEIN$ production in RAW 264 cells at concentrations 25-to 30-fold lower than free drug.	1
797	The @PROTEIN$ insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent @COMPOUND$ generation: potential implication in hypertension.	1
798	Administration of @COMPOUND$ to DMH treated rats significantly decreased the tumor incidence, the number of aberrant crypt foci with simultaneous enhancement of tissue lipid peroxidation, GST, GPx, @PROTEIN$, and CAT activities.	1
799	Administration of @COMPOUND$ to DMH treated rats significantly decreased the tumor incidence, the number of aberrant crypt foci with simultaneous enhancement of tissue lipid peroxidation, @PROTEIN$, GPx, SOD, and CAT activities.	1
800	Administration of @COMPOUND$ to DMH treated rats significantly decreased the tumor incidence, the number of aberrant crypt foci with simultaneous enhancement of tissue lipid peroxidation, GST, GPx, SOD, and @PROTEIN$ activities.	1
801	Culture of mid-segments of hair follicles in low calcium culture medium kept on @COMPOUND$ increased expression of filaggrin and Kdap, but downregulated expression of @PROTEIN$.	0
802	Culture of mid-segments of hair follicles in low calcium culture medium kept on @COMPOUND$ increased expression of @PROTEIN$ and Kdap, but downregulated expression of involucrin.	0
803	Culture of mid-segments of hair follicles in low calcium culture medium kept on @COMPOUND$ increased expression of filaggrin and @PROTEIN$, but downregulated expression of involucrin.	0
804	The p-hydroxyphenylpyruvate produced by the Escherichia coli host was converted to @COMPOUND$ through the oxidation reaction of introduced @PROTEIN$.	1
805	The @COMPOUND$ produced by the Escherichia coli host was converted to HGA through the oxidation reaction of introduced @PROTEIN$.	1
806	Activation of interleukin-6/@PROTEIN$ in rat cholangiocyte proliferation induced by @COMPOUND$.	1
807	Activation of @PROTEIN$/STAT3 in rat cholangiocyte proliferation induced by @COMPOUND$.	1
808	Methylation of these @COMPOUND$ sites may lead to reduced @PROTEIN$ expression in the lymphocytes of these former heroin addicts.	1
809	Functional analysis demonstrated that elkj encoded a @PROTEIN$-elongase that mediated the elongation of EPA into @COMPOUND$ (22:5n-3), confirming the two-step conversion from EPA to DHA in marine microalga.	1
810	The allatostatins (@PROTEIN$), with a Tyr/Phe-Xaa-Phe-Gly-Leu/Ile-amide C-terminus, are neuropeptides that occur in many orders of insects, but are known to inhibit @COMPOUND$ (JH) synthesis by corpora allata (CA) only in cockroaches, crickets, and termites.	1
811	The @PROTEIN$ (ASTs), with a Tyr/Phe-Xaa-Phe-Gly-Leu/Ile-amide C-terminus, are neuropeptides that occur in many orders of insects, but are known to inhibit @COMPOUND$ (JH) synthesis by corpora allata (CA) only in cockroaches, crickets, and termites.	1
812	The allatostatins (ASTs), with a Tyr/Phe-Xaa-Phe-Gly-Leu/Ile-amide C-terminus, are @PROTEIN$ that occur in many orders of insects, but are known to inhibit @COMPOUND$ (JH) synthesis by corpora allata (CA) only in cockroaches, crickets, and termites.	0
813	Lecithin:retinol acyltransferase (@PROTEIN$) catalyzes the esterification of retinol (@COMPOUND$).	1
814	@COMPOUND$ (RA) treatment increased this @PROTEIN$ promoter-luciferase activity in PrEC cells, but not in PC-3 cells.	1
815	@COMPOUND$ (RA) treatment increased this LRAT promoter-@PROTEIN$ activity in PrEC cells, but not in PC-3 cells.	1
816	Both MudPIT and cDNA microarray analyses indicate that @COMPOUND$ treatment caused elevated levels of @PROTEIN$.	1
817	The @COMPOUND$ functionalization was then used to immobilize bone @PROTEIN$ on the bioactive glasses.	1
818	@PROTEIN$ reduces antioxidant defense system and enhances kidney tissue damage in @COMPOUND$ and lead exposed rats.	1
819	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
820	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
821	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
822	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
823	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
824	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
825	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
826	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
827	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
828	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
829	We found that @PROTEIN$ expression in LH orexin neurons varied in proportion to preference for morphine, @COMPOUND$ or food.	1
830	We found that @PROTEIN$ expression in LH orexin neurons varied in proportion to preference for @COMPOUND$, cocaine or food.	1
831	Recent studies showed that LH orexin neurons that project to ventral tegmental area (VTA) have greater @PROTEIN$ induction in association with elevated @COMPOUND$ preference during protracted withdrawal than non-VTA-projecting orexin neurons, indicating that the VTA is an important site of action for orexin's role in reward processing.	0
832	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), @PROTEIN$ (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
833	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), @PROTEIN$ (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
834	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. @PROTEIN$ (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
835	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (@PROTEIN$), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
836	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), @PROTEIN$ (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
837	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. @PROTEIN$ (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
838	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), @PROTEIN$ (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
839	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (@PROTEIN$), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
840	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (@PROTEIN$), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
841	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), @PROTEIN$ (SOD), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
842	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (@PROTEIN$), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
843	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (@PROTEIN$), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
844	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (@PROTEIN$), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
845	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), @PROTEIN$ (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
846	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (@PROTEIN$), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
847	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. @PROTEIN$ (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (GST), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
848	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione S-transferase (@PROTEIN$), reduced glutathione (@COMPOUND$) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
849	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), @PROTEIN$ (SOD), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
850	The antioxidant roles of @COMPOUND$ (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (@PROTEIN$), glutathione S-transferase (GST), reduced glutathione (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
851	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), @PROTEIN$ (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
852	The antioxidant roles of selenium (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. Catalase (CAT), glutathione peroxidase (GPx), @PROTEIN$ (SOD), glutathione S-transferase (GST), @COMPOUND$ (GSH) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	0
853	MPc also increased @PROTEIN$ activity in all tissues with a concurrent decrease in @COMPOUND$ levels.	0
854	@COMPOUND$ reverses ET-1-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit @PROTEIN$-enzymes.	1
855	@COMPOUND$ reverses @PROTEIN$-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit ERK-enzymes.	1
856	Pretreatment with the MEK-ERK inhibitor (@COMPOUND$) appreciably reversed the mitogenic effects of @PROTEIN$.	1
857	On the other hand, pretreatment with the polyphenolic @COMPOUND$ resveratrol (RSVL, 1-100 microM) triggered more prominent inhibition of ET-1-evoked cell proliferation and @PROTEIN$/2 activation.	0
858	On the other hand, pretreatment with the polyphenolic stilbene @COMPOUND$ (RSVL, 1-100 microM) triggered more prominent inhibition of ET-1-evoked cell proliferation and @PROTEIN$/2 activation.	1
859	Further, pretreatment with the specific cGMP-phosphodiesterase inhibitor, @COMPOUND$ (10 microM) appreciably augmented RSVL-evoked cGMP formation, @PROTEIN$ inhibition, and cytostatic response.	1
860	Moreover, the RSVL-induced @PROTEIN$-inhibitory effects were significantly reversed by the kinase-G inhibitor, KT-5823 (10 microM; 69%), but not by the kinase-A inhibitor (@COMPOUND$).	0
861	Moreover, the RSVL-induced @PROTEIN$-inhibitory effects were significantly reversed by the kinase-G inhibitor, @COMPOUND$ (10 microM; 69%), but not by the kinase-A inhibitor (KT-5720).	1
862	Exposure to @COMPOUND$ for 6 h induced expression of both caveolin-1 and cyclooxygenase (@PROTEIN$)-2.	1
863	Exposure to @COMPOUND$ for 6 h induced expression of both @PROTEIN$ and cyclooxygenase (COX)-2.	1
864	Pretreatment with @COMPOUND$ blocked fatty-acid-induced @PROTEIN$ and COX-2 expression in a time- and concentration-dependent manner.	1
865	Pretreatment with @COMPOUND$ blocked fatty-acid-induced caveolin-1 and @PROTEIN$ expression in a time- and concentration-dependent manner.	1
866	Exposure to @COMPOUND$ rapidly increased phosphorylation of several kinases, including @PROTEIN$, extracellular signal regulated kinase 1/2 (ERK1/2) and amino kinase terminal (Akt), with maximal induction at about 10 min.	1
867	Exposure to @COMPOUND$ rapidly increased phosphorylation of several kinases, including p38 MAPK, extracellular signal regulated kinase 1/2 (ERK1/2) and amino kinase terminal (@PROTEIN$), with maximal induction at about 10 min.	1
868	Exposure to @COMPOUND$ rapidly increased phosphorylation of several kinases, including p38 MAPK, @PROTEIN$/2 (ERK1/2) and amino kinase terminal (Akt), with maximal induction at about 10 min.	1
869	Exposure to @COMPOUND$ rapidly increased phosphorylation of several kinases, including p38 MAPK, extracellular signal regulated kinase 1/2 (@PROTEIN$/2) and amino kinase terminal (Akt), with maximal induction at about 10 min.	1
870	Inhibitors of ERK1/2 and Akt down-regulated the @COMPOUND$-induced increase in @PROTEIN$ protein, which also occurred after pretreatment with EGCG.	1
871	Inhibitors of ERK1/2 and Akt down-regulated the linoleic-acid-induced increase in @PROTEIN$ protein, which also occurred after pretreatment with @COMPOUND$.	1
872	Caveolin-1 silencing blocked @COMPOUND$-induced phosphorylation of @PROTEIN$/2 and protein expression of COX-2, suggesting that specific MAPK signaling is caveolae dependent.	1
873	@PROTEIN$ silencing blocked @COMPOUND$-induced phosphorylation of ERK1/2 and protein expression of COX-2, suggesting that specific MAPK signaling is caveolae dependent.	0
874	Caveolin-1 silencing blocked @COMPOUND$-induced phosphorylation of ERK1/2 and protein expression of COX-2, suggesting that specific @PROTEIN$ signaling is caveolae dependent.	1
875	Caveolin-1 silencing blocked @COMPOUND$-induced phosphorylation of ERK1/2 and protein expression of @PROTEIN$, suggesting that specific MAPK signaling is caveolae dependent.	1
876	@COMPOUND$ causes G(2)/M arrest associated with the modulation of p21 (Cip1) and @PROTEIN$ and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.	1
877	@COMPOUND$ causes G(2)/M arrest associated with the modulation of p21 (Cip1) and Cdc2 and activates @PROTEIN$-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.	1
878	@COMPOUND$ causes G(2)/M arrest associated with the modulation of @PROTEIN$ (Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.	1
879	@COMPOUND$ causes G(2)/M arrest associated with the modulation of p21 (@PROTEIN$) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.	1
880	To investigate the regulatory proteins of cell cycle arrest affected by @COMPOUND$, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in @PROTEIN$ and cyclin E expression, with no change in CDK2 and CDK4.	1
881	To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. @COMPOUND$ caused a slight decrease in cyclin D and cyclin E expression, with no change in @PROTEIN$ and CDK4.	0
882	To investigate the regulatory proteins of cell cycle arrest affected by @COMPOUND$, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in cyclin D and cyclin E expression, with no change in CDK2 and @PROTEIN$.	0
883	To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. @COMPOUND$ caused a slight decrease in @PROTEIN$ and cyclin E expression, with no change in CDK2 and CDK4.	1
884	To investigate the regulatory proteins of cell cycle arrest affected by @COMPOUND$, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in cyclin D and cyclin E expression, with no change in @PROTEIN$ and CDK4.	0
885	To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. @COMPOUND$ caused a slight decrease in cyclin D and cyclin E expression, with no change in CDK2 and @PROTEIN$.	0
886	In addition, the @COMPOUND$-induced accumulation of the cell population in the G(2)/M phase resulted in a decrease in CDK1 together with @PROTEIN$ and cyclin B.	1
887	In addition, the @COMPOUND$-induced accumulation of the cell population in the G(2)/M phase resulted in a decrease in @PROTEIN$ together with cyclin A and cyclin B.	1
888	In an additional study, @COMPOUND$ also increased the accumulation of p53 and further enhanced the level of @PROTEIN$ (Cip1), with no change in p27 (Kip1).	1
889	In an additional study, @COMPOUND$ also increased the accumulation of p53 and further enhanced the level of p21 (@PROTEIN$), with no change in p27 (Kip1).	1
890	In an additional study, @COMPOUND$ also increased the accumulation of p53 and further enhanced the level of p21 (Cip1), with no change in @PROTEIN$ (Kip1).	0
891	In an additional study, @COMPOUND$ also increased the accumulation of @PROTEIN$ and further enhanced the level of p21 (Cip1), with no change in p27 (Kip1).	1
892	The expression of Bax and @PROTEIN$ of p53 downstream target was increased markedly at high concentration treatment over 50 microM @COMPOUND$.	1
893	The expression of Bax and cytochrome c of @PROTEIN$ downstream target was increased markedly at high concentration treatment over 50 microM @COMPOUND$.	1
894	The expression of @PROTEIN$ and cytochrome c of p53 downstream target was increased markedly at high concentration treatment over 50 microM @COMPOUND$.	1
895	Furthermore, restoration of KSR1 expression in KSR (-/-) MEFs following stable transduction of cells with a KSR1 expression vector, enhanced sensitivity of cells to tunicamycin and @COMPOUND$ and decreased @PROTEIN$/2 activation following exposure to these drugs.	0
896	Furthermore, restoration of @PROTEIN$ expression in KSR (-/-) MEFs following stable transduction of cells with a KSR1 expression vector, enhanced sensitivity of cells to tunicamycin and @COMPOUND$ and decreased ERK1/2 activation following exposure to these drugs.	1
897	GFP-fluorescent cells were slowly cycling, as shown by their long-term retention of @COMPOUND$, and less than 10% expressed the proliferative markers Ki67 and @PROTEIN$.	0
898	@PROTEIN$ gene polymorphisms and high levels of @COMPOUND$ are associated with a high degree of steatosis and fibrosis, conditions associated with a low sustained virological response (SVR) rate.	0
899	Hypothetically, @PROTEIN$ influences the transport of @COMPOUND$ across the blood-brain barrier.	1
900	In prolonged OJ with LPS administration, hepatocyte apoptosis depending on @PROTEIN$ expression significantly increased in association with a decrease in @COMPOUND$ contents, thus resulting in liver necrapoptosis.	0
901	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) @PROTEIN$ expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0
902	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, @PROTEIN$, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1
903	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and @PROTEIN$) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0
904	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) @PROTEIN$ expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1
905	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, @PROTEIN$, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0
906	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (@PROTEIN$-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0
907	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (@PROTEIN$-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1
908	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and @PROTEIN$) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1
909	As a result, combined @COMPOUND$ and @PROTEIN$ infusion significantly decreased plasma K+ concentration despite a significant decrease of urinary K+ excretion in sgk1+/+ but not in sgk1-/-mice.	0
910	While it is clearly demonstrated that members of the @PROTEIN$/6/7 subfamily are activated by @COMPOUND$, the mechanism by which phospholipase C activates members of the TRPC1/4/5 subfamily remains a mystery.	1
911	While it is clearly demonstrated that members of the TRPC3/6/7 subfamily are activated by @COMPOUND$, the mechanism by which phospholipase C activates members of the @PROTEIN$/4/5 subfamily remains a mystery.	0
912	Depletion of polyphosphatidylinositol 4-phosphate and @COMPOUND$ (PIP2) through inhibition of @PROTEIN$ activates calcium entry and membrane currents in TRPC5-expressing but not in TRPC3-or TRPC7-expressing cells.	1
913	Depletion of polyphosphatidylinositol 4-phosphate and @COMPOUND$ (PIP2) through inhibition of phosphatidylinositol 4-kinase activates calcium entry and membrane currents in TRPC5-expressing but not in @PROTEIN$-or TRPC7-expressing cells.	0
914	Depletion of polyphosphatidylinositol 4-phosphate and @COMPOUND$ (PIP2) through inhibition of phosphatidylinositol 4-kinase activates calcium entry and membrane currents in TRPC5-expressing but not in TRPC3-or @PROTEIN$-expressing cells.	0
915	Depletion of polyphosphatidylinositol 4-phosphate and @COMPOUND$ (PIP2) through inhibition of phosphatidylinositol 4-kinase activates calcium entry and membrane currents in @PROTEIN$-expressing but not in TRPC3-or TRPC7-expressing cells.	0
916	Inclusion of polyphosphatidylinositol 4-phosphate or PIP2, but not @COMPOUND$, in the patch pipette inhibited @PROTEIN$ currents.	0
917	@PROTEIN$ inhibits contraction and proliferation of human aortic smooth muscle cells by @COMPOUND$/PKA pathway activation.	1
918	@PROTEIN$ was able to inhibit angiotensin II-induced proliferation and contraction in a dose-response fashion via the @COMPOUND$/PKA pathway.	1
919	The results indicated that the backbone of @PROTEIN$ was composed of (1--&gt;6)-linked-alpha-D-galactopyranosyl and (1--&gt;2,6)-linked-alpha-D-galactopyranosyl residues, which were terminated with a single terminal (1--&gt;)-@COMPOUND$ residue at the O-2 position of galactosyl along the main chain in the ratio of 1:1:1.	1
920	The results indicated that the backbone of @PROTEIN$ was composed of (1--&gt;6)-linked-alpha-@COMPOUND$ and (1--&gt;2,6)-linked-alpha-D-galactopyranosyl residues, which were terminated with a single terminal (1--&gt;)-beta-D-glucose residue at the O-2 position of galactosyl along the main chain in the ratio of 1:1:1.	1
921	Preliminary tests in vitro showed POP is capable of enhancing concanavalin A (@PROTEIN$)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	0
922	Preliminary tests in vitro showed @PROTEIN$ is capable of enhancing concanavalin A (ConA)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	1
923	Preliminary tests in vitro showed POP is capable of enhancing @PROTEIN$ (ConA)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	0
924	Inhibition of the phosphatidyl-inositol-3 kinase/Akt pathway by @COMPOUND$ and specific abrogation of Akt1 protein using small-interfering RNA revealed a regulatory function of Akt1 in @PROTEIN$-mediated VEGF biosynthesis in keratinocytes.	0
925	Inhibition of the phosphatidyl-inositol-3 kinase/Akt pathway by @COMPOUND$ and specific abrogation of Akt1 protein using small-interfering RNA revealed a regulatory function of Akt1 in insulin-mediated @PROTEIN$ biosynthesis in keratinocytes.	0
926	Inhibition of the phosphatidyl-inositol-3 kinase/Akt pathway by @COMPOUND$ and specific abrogation of @PROTEIN$ protein using small-interfering RNA revealed a regulatory function of Akt1 in insulin-mediated VEGF biosynthesis in keratinocytes.	0
927	Cross-linked hydrogels showed increased resistance to digestion by testicular @PROTEIN$ and hyaluronidase SD with increasing @COMPOUND$ concentration.	1
928	@COMPOUND$ (CPF), a commonly used organophosphorus insecticide, induces @PROTEIN$ inhibition and cholinergic toxicity.	1
929	Role of @PROTEIN$ in apoptosis induced by @COMPOUND$.	1
930	@COMPOUND$ is known to have regulatory effects on gastrointestinal functions via the vanilloid receptor (@PROTEIN$).	1
931	Cholesteryl ester transfer protein (@PROTEIN$) is a plasma glycoprotein that facilitates the transfer of neutral lipids and phospholipids between lipoproteins and contributes to the regulation of the plasma concentration of high density lipoprotein @COMPOUND$ (HDL-C).	1
932	Cholesteryl ester transfer protein (CETP) is a plasma glycoprotein that facilitates the transfer of neutral lipids and phospholipids between lipoproteins and contributes to the regulation of the plasma concentration of @PROTEIN$ @COMPOUND$ (HDL-C).	1
933	Cholesteryl ester transfer protein (CETP) is a plasma @PROTEIN$ that facilitates the transfer of neutral lipids and phospholipids between lipoproteins and contributes to the regulation of the plasma concentration of high density lipoprotein @COMPOUND$ (HDL-C).	1
934	@PROTEIN$ (CETP) is a plasma glycoprotein that facilitates the transfer of neutral lipids and phospholipids between lipoproteins and contributes to the regulation of the plasma concentration of high density lipoprotein @COMPOUND$ (HDL-C).	1
935	DNA sequences of a calmodulin (@PROTEIN$)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the cytochrome b (cytb) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0
936	DNA sequences of a calmodulin (CaM)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the @PROTEIN$ (cytb) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0
937	DNA sequences of a calmodulin (CaM)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the cytochrome b (@PROTEIN$) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0
938	DNA sequences of a @PROTEIN$ (CaM)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the cytochrome b (cytb) and @COMPOUND$ 2 genes, were obtained from 49 Acropora species.	0
939	In this view, this study aimed at the investigating the use of a crude @PROTEIN$ preparation from onion solid by-products for oxidising @COMPOUND$, a widespread o-diphenol, whose various derivatives may occur in food industry wastes, such as olive mill waste waters.	1
940	@COMPOUND$ inhibited MIH induced Mos expression and its phosphorylation, which in turn reduced @PROTEIN$ phosphorylation and GVBD.	1
941	@COMPOUND$ inhibited MIH induced @PROTEIN$ expression and its phosphorylation, which in turn reduced Myt1 phosphorylation and GVBD.	1
942	@COMPOUND$ inhibited @PROTEIN$ induced Mos expression and its phosphorylation, which in turn reduced Myt1 phosphorylation and GVBD.	1
943	@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
944	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0
945	@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
946	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
947	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0
948	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	0
949	@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
950	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	0
951	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0
952	Hepatocytes exposed to resistin, but only in the presence of @PROTEIN$, show a decrease in insulin-stimulated @COMPOUND$ content.	1
953	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to @COMPOUND$ or fludarabine combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins @PROTEIN$ and/or Mcl 1.	0
954	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or fludarabine combined with @COMPOUND$, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins @PROTEIN$ and/or Mcl 1.	0
955	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or @COMPOUND$ combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins Bcl-2 and/or @PROTEIN$ 1.	0
956	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or fludarabine combined with @COMPOUND$, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins Bcl-2 and/or @PROTEIN$ 1.	0
957	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to cladribine or @COMPOUND$ combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins @PROTEIN$ and/or Mcl 1.	0
958	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to @COMPOUND$ or fludarabine combined with cyclophosphamide, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins Bcl-2 and/or @PROTEIN$ 1.	0
959	Exposure of erythrocytes to PGNs increased cytosolic Ca(2+) concentration, increased ceramide formation, enhanced the percentage of @PROTEIN$-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular @COMPOUND$ concentration.	0
960	Exposure of erythrocytes to @PROTEIN$ increased cytosolic Ca(2+) concentration, increased ceramide formation, enhanced the percentage of annexin V-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular @COMPOUND$ concentration.	1
961	Exposure of erythrocytes to PGNs increased cytosolic @COMPOUND$+) concentration, increased ceramide formation, enhanced the percentage of @PROTEIN$-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular ATP concentration.	0
962	Exposure of erythrocytes to @PROTEIN$ increased cytosolic @COMPOUND$+) concentration, increased ceramide formation, enhanced the percentage of annexin V-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular ATP concentration.	1
963	Inhibition of mitogen-activated protein kinase (MAPK) and @PROTEIN$ prevented the antiapoptotic effects of @COMPOUND$ and decreased chemotherapy-induced apoptosis.	1
964	Inhibition of mitogen-activated protein kinase (@PROTEIN$) and Akt prevented the antiapoptotic effects of @COMPOUND$ and decreased chemotherapy-induced apoptosis.	1
965	Inhibition of @PROTEIN$ (MAPK) and Akt prevented the antiapoptotic effects of @COMPOUND$ and decreased chemotherapy-induced apoptosis.	1
966	@COMPOUND$ up-regulated Akt-mediated antiapoptotic X-linked inhibitor of apoptosis protein and phosphorylated proapoptotic @PROTEIN$.	1
967	Elevated beta1,4-@PROTEIN$-I induced by the intraspinal injection of @COMPOUND$.	1
968	E-selectin, which ligand was modified by beta1,4-@PROTEIN$-I, was correlated with @COMPOUND$-containing glycans following injecting LPS into spinal cord.	0
969	As metabolic flux for the operation of the @COMPOUND$ pathway is maintained through the activities of @PROTEIN$ and C4H, thus, catechins biosynthesis in tea is critically dependent on the products of these enzymes.	1
970	As metabolic flux for the operation of the @COMPOUND$ pathway is maintained through the activities of PAL and @PROTEIN$, thus, catechins biosynthesis in tea is critically dependent on the products of these enzymes.	1
971	Activities of antioxidant enzymes (@PROTEIN$, catalase, glutathione peroxidase, glutathione reductase, glutatione-S-transferase, and @COMPOUND$) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.	0
972	Activities of antioxidant enzymes (superoxide dismutase, catalase, @PROTEIN$, glutathione reductase, glutatione-S-transferase, and @COMPOUND$) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.	0
973	Activities of antioxidant enzymes (superoxide dismutase, @PROTEIN$, glutathione peroxidase, glutathione reductase, glutatione-S-transferase, and @COMPOUND$) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.	0
974	Activities of antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase, @PROTEIN$, glutatione-S-transferase, and @COMPOUND$) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.	0
975	In this study, we report that AR-@COMPOUND$, a non-GalR1 agonist, inhibited plasma extravasation induced by substance P and @PROTEIN$ in a manner similar to galanin, confirming a non-GalR1-mediated effect.	0
976	In this study, we report that AR-@COMPOUND$, a non-GalR1 agonist, inhibited plasma extravasation induced by substance P and calcitonin gene-related peptide in a manner similar to @PROTEIN$, confirming a non-GalR1-mediated effect.	0
977	In this study, we report that AR-@COMPOUND$, a non-GalR1 agonist, inhibited plasma extravasation induced by @PROTEIN$ and calcitonin gene-related peptide in a manner similar to galanin, confirming a non-GalR1-mediated effect.	0
978	Enhancement of p53 expression in keratinocytes by the @COMPOUND$ apigenin is associated with RNA-binding protein @PROTEIN$.	0
979	Enhancement of @PROTEIN$ expression in keratinocytes by the @COMPOUND$ apigenin is associated with RNA-binding protein HuR.	0
980	Enhancement of p53 expression in keratinocytes by the bioflavonoid @COMPOUND$ is associated with @PROTEIN$ HuR.	0
981	Enhancement of p53 expression in keratinocytes by the bioflavonoid @COMPOUND$ is associated with RNA-binding protein @PROTEIN$.	1
982	Enhancement of @PROTEIN$ expression in keratinocytes by the bioflavonoid @COMPOUND$ is associated with RNA-binding protein HuR.	1
983	Enhancement of p53 expression in keratinocytes by the @COMPOUND$ apigenin is associated with @PROTEIN$ HuR.	0
984	We have reported previously that @COMPOUND$, a naturally occurring nonmutagenic flavonoid, increased wild-type @PROTEIN$ protein expression in the mouse keratinocyte 308 cell line by a mechanism involving p53 protein stabilization.	1
985	We have reported previously that apigenin, a naturally occurring nonmutagenic @COMPOUND$, increased wild-type @PROTEIN$ protein expression in the mouse keratinocyte 308 cell line by a mechanism involving p53 protein stabilization.	0
986	Instead, biosynthetic labeling showed that @COMPOUND$ increased nascent @PROTEIN$ protein synthesis by enhancing p53 translation.	1
987	Furthermore, @COMPOUND$ treatment increased the level of association of the RNA binding protein HuR with endogenous @PROTEIN$ mRNA.	1
988	Furthermore, @COMPOUND$ treatment increased the level of association of the RNA binding protein @PROTEIN$ with endogenous p53 mRNA.	1
989	Furthermore, @COMPOUND$ treatment increased the level of association of the @PROTEIN$ HuR with endogenous p53 mRNA.	0
990	@COMPOUND$ treatment also augmented @PROTEIN$ translocation into the cytoplasm.	1
991	Overall, these findings indicate that, in addition to modulating @PROTEIN$ protein stability, one of the mechanisms by which @COMPOUND$ induces p53 protein expression is enhancement of translation through the RNA binding protein HuR.	1
992	Overall, these findings indicate that, in addition to modulating p53 protein stability, one of the mechanisms by which @COMPOUND$ induces p53 protein expression is enhancement of translation through the RNA binding protein @PROTEIN$.	1
993	Overall, these findings indicate that, in addition to modulating p53 protein stability, one of the mechanisms by which @COMPOUND$ induces p53 protein expression is enhancement of translation through the @PROTEIN$ HuR.	0
994	@PROTEIN$ resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon alpha-2b plus @COMPOUND$.	1
995	Aim To investigate retrospectively the impact of @PROTEIN$ resistance on treatment response in Chinese genotype 1 CHC patients receiving a 24-week course therapy with peginterferon alpha-2b/@COMPOUND$.	1
996	Bone marrow cells were obtained from 5-day-old Muscovy ducks and cultured with (Group A) No added factors, (B) 30ng/mL soluble @PROTEIN$ (sRANKL), (C) 30ng/mL sRANKL and 10ng/mL OPG, (D) 10ng/mL OPG, (E) 50ng/mL OPG, (F) 100ng/mL OPG and (G) 30ng/mL sRANKL, 6mmol/@COMPOUND$ and 3mmol/L P. sRANKL promoted the survival of OCs on day 2, whereas the number of OCs decreased with addition of OPG in a dose-dependent manner.	0
997	Bone marrow cells were obtained from 5-day-old Muscovy ducks and cultured with (Group A) No added factors, (B) 30ng/mL soluble RANKL (sRANKL), (C) 30ng/mL sRANKL and 10ng/mL @PROTEIN$, (D) 10ng/mL OPG, (E) 50ng/mL OPG, (F) 100ng/mL OPG and (G) 30ng/mL sRANKL, 6mmol/@COMPOUND$ and 3mmol/L P. sRANKL promoted the survival of OCs on day 2, whereas the number of OCs decreased with addition of OPG in a dose-dependent manner.	0
998	Furthermore, HA induced dose-dependent elevation of reactive @COMPOUND$ species (ROS) level in SMCs, and antioxidant vitamin C and Trolox effectively suppressed HA-induced DNA damage and dysregulation of @PROTEIN$/Bax.	0
999	Furthermore, HA induced dose-dependent elevation of reactive oxygen species (ROS) level in SMCs, and antioxidant vitamin C and @COMPOUND$ effectively suppressed HA-induced DNA damage and dysregulation of Bcl-2/@PROTEIN$.	1
1000	Furthermore, HA induced dose-dependent elevation of reactive oxygen species (ROS) level in SMCs, and antioxidant vitamin C and @COMPOUND$ effectively suppressed HA-induced DNA damage and dysregulation of @PROTEIN$/Bax.	1
1001	Furthermore, HA induced dose-dependent elevation of reactive oxygen species (ROS) level in SMCs, and antioxidant @COMPOUND$ and Trolox effectively suppressed HA-induced DNA damage and dysregulation of @PROTEIN$/Bax.	1
1002	Furthermore, HA induced dose-dependent elevation of reactive oxygen species (ROS) level in SMCs, and antioxidant @COMPOUND$ and Trolox effectively suppressed HA-induced DNA damage and dysregulation of Bcl-2/@PROTEIN$.	1
1003	Furthermore, HA induced dose-dependent elevation of reactive @COMPOUND$ species (ROS) level in SMCs, and antioxidant vitamin C and Trolox effectively suppressed HA-induced DNA damage and dysregulation of Bcl-2/@PROTEIN$.	0
1004	The culture tests using MSCs show that the level of alkaline phosphatase (@PROTEIN$) activity in the cells cultured on SPV-H increased during the 21-day culture in a medium without Dex and @COMPOUND$.	1
1005	The culture tests using MSCs show that the level of @PROTEIN$ (ALP) activity in the cells cultured on SPV-H increased during the 21-day culture in a medium without Dex and @COMPOUND$.	1
1006	The level was unchanged in MSCs cultured on PV-H. In the case of supplementing Dex and @COMPOUND$ to the medium, the level of @PROTEIN$ activity in MSCs cultured on SPV-H was higher than that on PV-H at all time points during the 21-day culture.	1
1007	Expression was performed in fusion to @COMPOUND$ binding protein using chemically defined minimal medium, followed by a single-step affinity capture and enzymatic cleavage using tobacco etch virus @PROTEIN$.	0
1008	Treatment of dermal fibroblasts with @COMPOUND$) induced expression of @PROTEIN$ (1.2+/-0.2, 1.7+/-0.2, and 1.8+/-0.2 relative fold increase) and BMP-6 (9.1+/-0.3, 23.3+/-2.1, and 30.4+/-3.0 relative fold increase) at 3, 14, and 21 days, respectively.	1
1009	Treatment of dermal fibroblasts with @COMPOUND$) induced expression of BMP-4 (1.2+/-0.2, 1.7+/-0.2, and 1.8+/-0.2 relative fold increase) and @PROTEIN$ (9.1+/-0.3, 23.3+/-2.1, and 30.4+/-3.0 relative fold increase) at 3, 14, and 21 days, respectively.	1
1010	@COMPOUND$) was also shown to induce the expression of the osteoblast-specific markers, @PROTEIN$ and osteocalcin, in a dose-dependent manner in human dermal fibroblasts.	1
1011	@COMPOUND$) was also shown to induce the expression of the osteoblast-specific markers, alkaline phosphatase and @PROTEIN$, in a dose-dependent manner in human dermal fibroblasts.	1
1012	A 3-fold increase in the expression of the @PROTEIN$ gene was associated with decreased @COMPOUND$ methylation of the analysed promoter region in the vegetarian group compared with the age-matched omnivores group.	0
1013	ALK2 (R206H) with @PROTEIN$ or Smad5 induced osteoblastic differentiation that could be inhibited by Smad7 or @COMPOUND$.	1
1014	ALK2 (R206H) with Smad1 or Smad5 induced osteoblastic differentiation that could be inhibited by @PROTEIN$ or @COMPOUND$.	0
1015	ALK2 (R206H) with Smad1 or @PROTEIN$ induced osteoblastic differentiation that could be inhibited by Smad7 or @COMPOUND$.	1
1016	@PROTEIN$ (R206H) with Smad1 or Smad5 induced osteoblastic differentiation that could be inhibited by Smad7 or @COMPOUND$.	1
1017	Studies suggest that @PROTEIN$ activation in osteoblasts is the underlying cause of glucocorticoid- and estrogen deficiency-mediated osteoporosis, and at least partially underlies the teratogenic effects of @COMPOUND$ on limb development.	1
1018	Macrophages isolated from iron deficient rats, or pregnant rats at day 21 of gestation, either supplemented with a single dose of @COMPOUND$, 10 mg, at the commencement of pregnancy, or not, showed significant increases of macrophage ferroportin mRNA expression, which was paralleled by significant decreases in hepatic @PROTEIN$ mRNA expression.	1
1019	Two related polytopic @PROTEIN$ of the major facilitator family, NarK and NarU, catalyse @COMPOUND$ uptake, nitrite export and nitrite uptake across the Escherichia coli cytoplasmic membrane by an unknown mechanism.	0
1020	Two related polytopic membrane proteins of the major facilitator family, NarK and @PROTEIN$, catalyse @COMPOUND$ uptake, nitrite export and nitrite uptake across the Escherichia coli cytoplasmic membrane by an unknown mechanism.	1
1021	Two related polytopic membrane proteins of the major facilitator family, @PROTEIN$ and NarU, catalyse @COMPOUND$ uptake, nitrite export and nitrite uptake across the Escherichia coli cytoplasmic membrane by an unknown mechanism.	1
1022	Intracellular interleukin-4 (Th2 cytokine) and @PROTEIN$ (Th1 cytokine) production was assessed in CD4+ T lymphocytes activated by phorbol 12-myristate 13-acetate and @COMPOUND$ using flow cytometry.	1
1023	Intracellular interleukin-4 (Th2 cytokine) and interferon-gamma (@PROTEIN$ cytokine) production was assessed in CD4+ T lymphocytes activated by @COMPOUND$ and ionomycin using flow cytometry.	1
1024	Intracellular interleukin-4 (Th2 cytokine) and @PROTEIN$ (Th1 cytokine) production was assessed in CD4+ T lymphocytes activated by @COMPOUND$ and ionomycin using flow cytometry.	1
1025	Intracellular interleukin-4 (Th2 cytokine) and interferon-gamma (@PROTEIN$ cytokine) production was assessed in CD4+ T lymphocytes activated by phorbol 12-myristate 13-acetate and @COMPOUND$ using flow cytometry.	1
1026	This signaling system is engaged by the active component of cannabis, Delta9-tetrahydrocannabinol (@COMPOUND$), which exerts its pharmacological effects by activation of G protein-coupled type-1 (CB1) and type-2 (@PROTEIN$) cannabinoid receptors.	1
1027	This signaling system is engaged by the active component of cannabis, @COMPOUND$ (Delta9-THC), which exerts its pharmacological effects by activation of G protein-coupled type-1 (CB1) and type-2 (@PROTEIN$) cannabinoid receptors.	1
1028	This signaling system is engaged by the active component of cannabis, @COMPOUND$ (Delta9-THC), which exerts its pharmacological effects by activation of G protein-coupled type-1 (@PROTEIN$) and type-2 (CB2) cannabinoid receptors.	1
1029	This signaling system is engaged by the active component of cannabis, Delta9-tetrahydrocannabinol (@COMPOUND$), which exerts its pharmacological effects by activation of G protein-coupled type-1 (@PROTEIN$) and type-2 (CB2) cannabinoid receptors.	1
1030	Ligand-induced @PROTEIN$-downregulation modulates cell death associated proteins and enhances chemosensitivity to @COMPOUND$ in THP-1 acute myeloid leukemia cells.	1
1031	Calcineurin inhibitors (CsA, @COMPOUND$ and pimecrolimus) inhibited NO production and @PROTEIN$ expression in a concentration-dependent manner, CsA being more potent than FK-506 and pimecrolimus.	1
1032	Calcineurin inhibitors (CsA, FK-506 and @COMPOUND$) inhibited NO production and @PROTEIN$ expression in a concentration-dependent manner, CsA being more potent than FK-506 and pimecrolimus.	1
1033	In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, tacrolimus (FK-506) and @COMPOUND$ inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
1034	In conclusion, the results suggest that calcineurin inhibitors @COMPOUND$, tacrolimus (FK-506) and pimecrolimus inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
1035	In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, @COMPOUND$ (FK-506) and pimecrolimus inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
1036	In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, tacrolimus (@COMPOUND$) and pimecrolimus inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
1037	The activity of guanylyl @PROTEIN$ was determined by the amount of @COMPOUND$ generated in responses to sodium nitroprusside (SNP) or ANP.	1
1038	Both SAHA and @COMPOUND$ induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of @PROTEIN$/Bcl-2 expression.	1
1039	Both @COMPOUND$ and MS-275 induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of @PROTEIN$/Bcl-2 expression.	1
1040	Both SAHA and @COMPOUND$ induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of Bax/@PROTEIN$ expression.	1
1041	Both @COMPOUND$ and MS-275 induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of Bax/@PROTEIN$ expression.	1
1042	E(2) increased the expression of @PROTEIN$ and caveolin-2 mRNA and proteins, but pre-treatment with @COMPOUND$ (an estrogen receptor (ER) antagonist) inhibited E(2)-induced increase in caveolin-1 and caveolin-2 proteins expression.	1
1043	E(2) increased the expression of caveolin-1 and @PROTEIN$ mRNA and proteins, but pre-treatment with @COMPOUND$ (an estrogen receptor (ER) antagonist) inhibited E(2)-induced increase in caveolin-1 and caveolin-2 proteins expression.	1
1044	Phospho-@PROTEIN$ was significantly blocked by @COMPOUND$ or pyrazolopyrimidine 2 (PP2 ; a Src-kinase inhibitor).	1
1045	Phospho-@PROTEIN$ was significantly blocked by ICI 182,780 or @COMPOUND$ 2 (PP2 ; a Src-kinase inhibitor).	1
1046	LY 294002 (a PI3K inhibitor) or PD 98059 (an ERK1/2 inhibitor) prevented E(2)-induced increase in @PROTEIN$ expression and the accompanying ((3)H)-@COMPOUND$ incorporation.	1
1047	LY 294002 (a PI3K inhibitor) or @COMPOUND$ (an ERK1/2 inhibitor) prevented E(2)-induced increase in @PROTEIN$ expression and the accompanying ((3)H)-thymidine incorporation.	1
1048	@COMPOUND$ (a PI3K inhibitor) or PD 98059 (an ERK1/2 inhibitor) prevented E(2)-induced increase in @PROTEIN$ expression and the accompanying ((3)H)-thymidine incorporation.	1
1049	Furthermore, inhibition of caveolin-1 expression using a caveolin-1 siRNA significantly attenuated E(2)-induced up-regulation of proto-oncogenes, @PROTEIN$, ((3)H)-@COMPOUND$ incorporation, overall cell number, and percent of the cell population in S phase, while mediating a concomitant increase in the G0/G1 population.	0
1050	Almost all @PROTEIN$ kinase that translocates to the nucleus shows a marked phosphorylation on @COMPOUND$ 473.	1
1051	During the early response in AR, @COMPOUND$ has been found to be the most abundant mediator and it is associated with many symptoms of this disease mediated through the @PROTEIN$.	1
1052	During the incubation of @COMPOUND$ with para-hydroquinones using @PROTEIN$ as biocatalyst, one or two main products were formed.	1
1053	The effect on activation voltage but not that on amplitude was absent when expressing a cAMP-insensitive mutant (@PROTEIN$R/E), while a C-terminal truncated form of HCN2 (HCN2DeltaCx) exhibited only the voltage dependent but not the amplitude effect of @COMPOUND$.	1
1054	Thus, the action of erbstatin on the activation relation and current amplitude are distinct and separable in newborn myocytes, and the effect on activation voltage depends on the @COMPOUND$ status of @PROTEIN$ channels.	1
1055	Thus, the action of @COMPOUND$ on the activation relation and current amplitude are distinct and separable in newborn myocytes, and the effect on activation voltage depends on the cAMP status of @PROTEIN$ channels.	1
1056	In contrast to newborn myocytes, @COMPOUND$ had no effect on @PROTEIN$ under control conditions in adult myocytes but induced a negative shift with no change in amplitude when saturated cAMP was added to the pipette solution.	0
1057	In contrast to newborn myocytes, erbstatin had no effect on @PROTEIN$ under control conditions in adult myocytes but induced a negative shift with no change in amplitude when saturated @COMPOUND$ was added to the pipette solution.	0
1058	Arginine-specific @PROTEIN$ (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of NAD to the @COMPOUND$ residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	1
1059	@COMPOUND$-specific @PROTEIN$ (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of NAD to the arginine residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	1
1060	Arginine-specific @PROTEIN$ (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of @COMPOUND$ to the arginine residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	1
1061	In response to a @COMPOUND$-containing atherogenic diet, C57BL/6J mice significantly increased expression of @PROTEIN$ in the aorta, while mice lacking UCP2, in the absence of any other genetic modification, displayed significant endothelial dysfunction following the atherogenic diet.	1
1062	These data establish that in the vasculature @PROTEIN$ functions as an adaptive antioxidant defense to protect against the development of atherosclerosis in response to a fat and @COMPOUND$ diet.	1
1063	To confirm that mouse @PROTEIN$-PG possesses a single GAG chain attached to Ser (89), we substituted Ser (89) by @COMPOUND$ (89).	1
1064	PC-1 is the primary generator of @COMPOUND$ in osteoblastic cells; therefore, regulated expression of PC-1 by @PROTEIN$s may be a principal mechanism by which FGF signaling affects bone mineralization.	1
1065	PC-1 is the primary generator of @COMPOUND$ in osteoblastic cells; therefore, regulated expression of PC-1 by @PROTEIN$ may be a principal mechanism by which FGF signaling affects bone mineralization.	1
1066	In analogy to the reduction of @COMPOUND$+) oscillation frequency, the blockers impaired HCEC contraction, NF-kappaB activation, and @PROTEIN$ expression.	1
1067	Cisternal SAH-CSF induces cytosolic @COMPOUND$+) oscillations in HCEC that results in cellular constriction, NF-kappaB activation, and @PROTEIN$ expression.	1
1068	In the process studied, the enzyme cellobiose dehydrogenase (@PROTEIN$) oxidizes lactose at the C-1 position of the reducing sugar moiety to lactobionolactone, which spontaneously hydrolyzes to @COMPOUND$.	1
1069	In the process studied, the enzyme cellobiose dehydrogenase (@PROTEIN$) oxidizes @COMPOUND$ at the C-1 position of the reducing sugar moiety to lactobionolactone, which spontaneously hydrolyzes to lactobionic acid.	1
1070	@COMPOUND$ served as the terminal electron acceptor of the reaction and was fully reduced to water by @PROTEIN$.	1
1071	Immunocytochemical localization of cell surface markers like SSEA-3, SSEA-4, @COMPOUND$-1-60, and TRA-1-81, staining for alkaline phosphatase and @PROTEIN$ polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0
1072	Immunocytochemical localization of cell surface markers like @COMPOUND$, SSEA-4, TRA-1-60, and TRA-1-81, staining for alkaline phosphatase and @PROTEIN$ polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0
1073	Immunocytochemical localization of cell surface markers like SSEA-3, SSEA-4, @COMPOUND$-1-60, and TRA-1-81, staining for @PROTEIN$ and reverse transcriptase polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0
1074	Immunocytochemical localization of cell surface markers like SSEA-3, SSEA-4, @COMPOUND$-1-60, and TRA-1-81, staining for alkaline phosphatase and reverse transcriptase polymerase chain reaction (RT-@PROTEIN$) analysis of pluripotency state markers viz.	0
1075	Immunocytochemical localization of cell surface markers like @COMPOUND$, SSEA-4, TRA-1-60, and TRA-1-81, staining for alkaline phosphatase and reverse transcriptase polymerase chain reaction (RT-@PROTEIN$) analysis of pluripotency state markers viz.	0
1076	Immunocytochemical localization of cell surface markers like @COMPOUND$, SSEA-4, TRA-1-60, and TRA-1-81, staining for @PROTEIN$ and reverse transcriptase polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0
1077	The effects of @PROTEIN$ were reversed by the mitochondrial KATP blocker, @COMPOUND$, indicating that mitochondrial KATP channels participate in the regulation of astrocyte activation.	1
1078	The cell proliferation, the up-regulation of pS2, and the down-regulation of @PROTEIN$ and ERbeta gene expressions induced by the racemate and enantiomers of o,p'-DDT were all reversed by cotreatment with 10(-6) mol/L @COMPOUND$.	1
1079	The cell proliferation, the up-regulation of pS2, and the down-regulation of ERalpha and @PROTEIN$ gene expressions induced by the racemate and enantiomers of o,p'-DDT were all reversed by cotreatment with 10(-6) mol/L @COMPOUND$.	1
1080	While bass in all @COMPOUND$ treatment groups had significantly inhibited brain @PROTEIN$ activity, only the medium and high treatment groups showed a dose- and time-dependent increase in time to capture prey.	1
1081	The @COMPOUND$ mutation at amino acid location 164 significantly reduced the initial hydrolysis of either the @PROTEIN$ in solution or the proteins bound on HAP, which was confirmed by amelogenin oligopeptide assays.	1
1082	In conclusion, dentin mineralization in a corrected @COMPOUND$ and vitamin D environment compensates the adverse effect of @PROTEIN$ mutation.	0
1083	In conclusion, dentin mineralization in a corrected phosphate and @COMPOUND$ environment compensates the adverse effect of @PROTEIN$ mutation.	0
1084	The considered biological model system consisted of a coating antibody (goat IgG), bovine serum albumin (@PROTEIN$) as blocking agent, and a complementary antibody labelled with @COMPOUND$ (anti-goat IgG).	0
1085	The considered biological model system consisted of a coating antibody (goat IgG), bovine @PROTEIN$ (BSA) as blocking agent, and a complementary antibody labelled with @COMPOUND$ (anti-goat IgG).	0
1086	Using a set of experiments aimed at manipulate a putative @COMPOUND$/NMDA/NO signal transduction pathway, we have demonstrated, by quantitative real-time PCR, that NMDA enhances the expression of @PROTEIN$ mRNA in a dose-response manner.	1
1087	Using a set of experiments aimed at manipulate a putative l-glutamate/@COMPOUND$/NO signal transduction pathway, we have demonstrated, by quantitative real-time PCR, that NMDA enhances the expression of @PROTEIN$ mRNA in a dose-response manner.	1
1088	Reaction parameters for the production of XOS from corncob using @PROTEIN$ from Aspergillus oryzae MTCC 5154 were optimized and an XOS yield of 10.2+/-0.14 mg ml(-1) corresponding to 81+/-3.9% with 73.5% @COMPOUND$ was obtained.	0
1089	Serum @COMPOUND$ (E2) levels were not altered at any time point after @PROTEIN$, demonstrating that the increased KiSS-1 expression observed was not caused by an elevation in E2.	0
1090	A2aR stimulation inhibits HA fragment-induced pro-fibrotic genes @PROTEIN$, keratinocyte chemoattractant (KC), macrophage inflammatory protein (MIP)-2, and MIP-1alpha while simultaneously synergizing with @COMPOUND$ fragments to up-regulate the TH1 cytokine IL-12.	0
1091	A2aR stimulation inhibits HA fragment-induced pro-fibrotic genes TNF-alpha, keratinocyte chemoattractant (KC), macrophage inflammatory protein (@PROTEIN$)-2, and MIP-1alpha while simultaneously synergizing with @COMPOUND$ fragments to up-regulate the TH1 cytokine IL-12.	0
1092	A2aR stimulation inhibits HA fragment-induced pro-fibrotic genes TNF-alpha, keratinocyte chemoattractant (KC), macrophage inflammatory protein (MIP)-2, and @PROTEIN$ while simultaneously synergizing with @COMPOUND$ fragments to up-regulate the TH1 cytokine IL-12.	0
1093	These data confirm that endogenous miR-34a regulates @PROTEIN$ levels and supports the notion that miR-34a contributes to the effects of @COMPOUND$ and VPA on GRM7.	1
1094	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1095	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1096	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (@PROTEIN$) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1097	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1098	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (@PROTEIN$), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1099	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (@PROTEIN$) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1100	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1101	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (@PROTEIN$), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1102	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (@PROTEIN$) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1103	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1104	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (@PROTEIN$) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1105	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1106	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1107	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker @PROTEIN$ (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1108	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (@PROTEIN$), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1109	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1110	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1111	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker @PROTEIN$ (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1112	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker @PROTEIN$ (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1113	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), @PROTEIN$ (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1114	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (@PROTEIN$), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1115	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1116	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), @PROTEIN$ (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1117	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like @PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1118	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like @PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1119	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1120	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like @PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1121	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (@PROTEIN$) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1122	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (@PROTEIN$) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1123	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1124	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1125	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1126	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), @PROTEIN$ (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1127	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like @PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1128	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1129	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (@PROTEIN$) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1130	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), @PROTEIN$ (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1131	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1132	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker @PROTEIN$ (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1133	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (@PROTEIN$) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1134	Achieving CCgR within 12 months and maintaining it without an increase in @PROTEIN$-ABL transcripts might indicate that low-dose @COMPOUND$ therapy can produce acceptable outcomes without excess toxicity.	1
1135	Achieving CCgR within 12 months and maintaining it without an increase in BCR-@PROTEIN$ transcripts might indicate that low-dose @COMPOUND$ therapy can produce acceptable outcomes without excess toxicity.	1
1136	@PROTEIN$ 13910 CC genotype is associated with @COMPOUND$ intolerance, a condition often resulting in reduced milk intake.	1
1137	Four MPTP monkeys received L-DOPA/@COMPOUND$ plus CI-1041 an NMDA antagonist selective for @PROTEIN$/NR2B and four were treated with L-DOPA/Benserazide plus a small dose of cabergoline ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
1138	Four MPTP monkeys received L-DOPA/Benserazide plus CI-1041 an NMDA antagonist selective for @PROTEIN$/NR2B and four were treated with L-DOPA/Benserazide plus a small dose of @COMPOUND$ ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
1139	Four MPTP monkeys received L-DOPA/@COMPOUND$ plus CI-1041 an NMDA antagonist selective for NR1/@PROTEIN$ and four were treated with L-DOPA/Benserazide plus a small dose of cabergoline ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
1140	Four MPTP monkeys received @COMPOUND$/Benserazide plus CI-1041 an NMDA antagonist selective for @PROTEIN$/NR2B and four were treated with L-DOPA/Benserazide plus a small dose of cabergoline ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
1141	Four MPTP monkeys received L-DOPA/Benserazide plus CI-1041 an NMDA antagonist selective for NR1/@PROTEIN$ and four were treated with L-DOPA/Benserazide plus a small dose of @COMPOUND$ ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
1142	Four MPTP monkeys received @COMPOUND$/Benserazide plus CI-1041 an NMDA antagonist selective for NR1/@PROTEIN$ and four were treated with L-DOPA/Benserazide plus a small dose of cabergoline ; one monkey of each group developed mild dyskinesias at the end of treatment.	0
1143	Hence, MPTP lesion, L-DOPA treatment and prevention of LID with CI-1041 and cabergoline, or reduction with @COMPOUND$ were associated with modulation of @PROTEIN$/NMDA glutamate receptors.	1
1144	Hence, MPTP lesion, @COMPOUND$ treatment and prevention of LID with CI-1041 and cabergoline, or reduction with Ro 61-8048 were associated with modulation of @PROTEIN$/NMDA glutamate receptors.	1
1145	Hence, MPTP lesion, L-DOPA treatment and prevention of LID with CI-1041 and @COMPOUND$, or reduction with Ro 61-8048 were associated with modulation of @PROTEIN$/NMDA glutamate receptors.	1
1146	@PROTEIN$ (UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase), a three-domain bacterial protein, catalyses a highly specific incorporation of D-glutamate to the cytoplasmic intermediate UDP-N-acetyl-muramoyl-L-alanine (@COMPOUND$) utilizing ATP hydrolysis to ADP and P(i).	1
1147	On the basis of structural studies of @PROTEIN$ complexes, a stepwise catalytic mechanism was proposed that commences with a formation of the acyl-phosphate intermediate, followed by a nucleophilic attack of @COMPOUND$ that, through the formation of a tetrahedral reaction intermediate and subsequent phosphate dissociation, affords the final product, UDP-N-acetyl-muramoyl-L-alanine-D-glutamate (UMAG).	1
1148	Although the overall amino acid identity between @PROTEIN$ and the LeuT(Aa) is only 17%, it increases to above 50% in the first shell of the putative 5-HT binding site, allowing de novo computational docking of @COMPOUND$ derivatives in atomic detail.	0
1149	Mal-@PROTEIN$, prepared by conjugating sCT via thio-ether bonds with aqueous-soluble palmitic acid derivative at Cys 1 and Cys 7, was reacted with mPEG-@COMPOUND$ (mPEG-Suc, 5 kDa).	1
1150	Mal-@PROTEIN$, prepared by conjugating sCT via thio-ether bonds with aqueous-soluble @COMPOUND$ derivative at Cys 1 and Cys 7, was reacted with mPEG-succinimide (mPEG-Suc, 5 kDa).	1
1151	Mal-@PROTEIN$, prepared by conjugating sCT via thio-ether bonds with aqueous-soluble palmitic acid derivative at Cys 1 and Cys 7, was reacted with @COMPOUND$-succinimide (mPEG-Suc, 5 kDa).	1
1152	The antidepressant @COMPOUND$ blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (@PROTEIN$) expression in the hippocampus of rats.	1
1153	@PROTEIN$ activity was also inhibited for all the soils treated with @COMPOUND$ (from 0.1 to 50mg/kg dry soil), but a declining inhibition was observed after 2 days of incubation.	1
1154	Intravenous @COMPOUND$ enhances @PROTEIN$ activity giving cardioprotection.	1
1155	We investigated whether acute intravenous @COMPOUND$, through an effect on cyclooxygenase (COX)-2 and heat shock protein (@PROTEIN$) 72, might induce preconditioning.	1
1156	We investigated whether acute intravenous @COMPOUND$, through an effect on cyclooxygenase (@PROTEIN$)-2 and heat shock protein (HSP) 72, might induce preconditioning.	1
1157	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher @PROTEIN$ content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, glucokinase, Glut-2, proconvertase and pancreas duodenum homeobox-1 (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1158	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, glucokinase, @PROTEIN$, proconvertase and pancreas duodenum homeobox-1 (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1159	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, glucokinase, Glut-2, proconvertase and @PROTEIN$ (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1160	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, @PROTEIN$, Glut-2, proconvertase and pancreas duodenum homeobox-1 (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1161	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, sulfonylurea receptor-1, glucokinase, Glut-2, proconvertase and pancreas duodenum homeobox-1 (@PROTEIN$) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1162	Islets from @COMPOUND$-supplemented mice had: (i) significantly higher insulin content, (ii) increased insulin secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced insulin release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ((Ca2+)i) oscillations in response to stimulatory glucose concentrations; (vi) increased insulin, @PROTEIN$, glucokinase, Glut-2, proconvertase and pancreas duodenum homeobox-1 (PDX-1) gene expression and (vii) increased PDX-1 expression in the nucleus.	1
1163	Moreover, @COMPOUND$ supplementation significantly increased both basal and @PROTEIN$ stimulated tyrosine phosphorylation of the insulin receptor in skeletal muscle and liver tissues.	0
1164	Moreover, @COMPOUND$ supplementation significantly increased both basal and insulin stimulated tyrosine phosphorylation of the @PROTEIN$ in skeletal muscle and liver tissues.	1
1165	Moreover, taurine supplementation significantly increased both basal and insulin stimulated @COMPOUND$ phosphorylation of the @PROTEIN$ in skeletal muscle and liver tissues.	1
1166	Moreover, taurine supplementation significantly increased both basal and @PROTEIN$ stimulated @COMPOUND$ phosphorylation of the insulin receptor in skeletal muscle and liver tissues.	1
1167	These results indicate that @COMPOUND$ controls glucose homeostasis by regulating the expression of genes required for glucose-stimulated @PROTEIN$ secretion.	1
1168	These results indicate that taurine controls @COMPOUND$ homeostasis by regulating the expression of genes required for glucose-stimulated @PROTEIN$ secretion.	1
1169	In addition, @COMPOUND$ enhances peripheral @PROTEIN$ sensitivity.	1
1170	Amino acids (@COMPOUND$, aspartic acid, glutamic acid) and @PROTEIN$ (GOx) were adsorbed on CNF and the results were compared with those obtained when activated carbon (AC) was used as support.	0
1171	Amino acids (alanine, aspartic acid, glutamic acid) and @PROTEIN$ (GOx) were adsorbed on CNF and the results were compared with those obtained when @COMPOUND$ (AC) was used as support.	0
1172	Amino acids (alanine, @COMPOUND$, glutamic acid) and @PROTEIN$ (GOx) were adsorbed on CNF and the results were compared with those obtained when activated carbon (AC) was used as support.	0
1173	Both 17alpha- and @COMPOUND$ elicited rapid phosphorylation of p42/44MAPK, @PROTEIN$, and GSK-3beta within 8 min.	1
1174	Both 17alpha- and @COMPOUND$ elicited rapid phosphorylation of p42/44MAPK, Akt, and @PROTEIN$ within 8 min.	1
1175	Both 17alpha- and @COMPOUND$ elicited rapid phosphorylation of @PROTEIN$/44MAPK, Akt, and GSK-3beta within 8 min.	1
1176	Whereas Zn2+-dependent upregulation of @PROTEIN$ may help to counteract excessive astrocyte swelling and production of reactive oxygen and @COMPOUND$ species, stimulation of PBR expression may augment HE development.	1
1177	Whereas Zn2+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive oxygen and @COMPOUND$ species, stimulation of @PROTEIN$ expression may augment HE development.	0
1178	Whereas @COMPOUND$+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive oxygen and nitrogen oxide species, stimulation of @PROTEIN$ expression may augment HE development.	0
1179	Whereas Zn2+-dependent upregulation of @PROTEIN$ may help to counteract excessive astrocyte swelling and production of reactive @COMPOUND$ and nitrogen oxide species, stimulation of PBR expression may augment HE development.	1
1180	Whereas Zn2+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive @COMPOUND$ and nitrogen oxide species, stimulation of @PROTEIN$ expression may augment HE development.	0
1181	Whereas @COMPOUND$+-dependent upregulation of @PROTEIN$ may help to counteract excessive astrocyte swelling and production of reactive oxygen and nitrogen oxide species, stimulation of PBR expression may augment HE development.	1
1182	High-level toxin production occurred after detectable spore germination in all experiments except those with C. difficile PCR ribotype 027 and @COMPOUND$, in which marked @PROTEIN$ production preceded detectable germination, which coincided with isolate recovery on fluoroquinolone-containing medium.	0
1183	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (@PROTEIN$) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1184	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (@PROTEIN$) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1185	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and @PROTEIN$ in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1186	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (@PROTEIN$) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1187	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (@PROTEIN$) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1188	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and @PROTEIN$ in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1189	We tested the hypothesis that a nitric oxide donor, @COMPOUND$, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (@PROTEIN$) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (CXCR4) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1190	We tested the hypothesis that a @COMPOUND$ donor, DETA-NONOate, up-regulates stromal cell-derived factor-1 (SDF1) and angiopoietin 1 (Ang1) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (@PROTEIN$) and Tie2 in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	1
1191	To elucidate whether @PROTEIN$/CXCR4 and Ang1/Tie2 pathways mediate DETA-NONOate-induced SVZ migration after stroke, SDF1alpha, Ang1 peptide, a specific antagonist of CXCR4 (@COMPOUND$), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	1
1192	To elucidate whether @PROTEIN$/CXCR4 and Ang1/Tie2 pathways mediate @COMPOUND$-induced SVZ migration after stroke, SDF1alpha, Ang1 peptide, a specific antagonist of CXCR4 (AMD3100), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	1
1193	To elucidate whether @PROTEIN$/CXCR4 and Ang1/Tie2 pathways mediate DETA-NONOate-induced SVZ migration after stroke, SDF1alpha, Ang1 @COMPOUND$ specific antagonist of CXCR4 (AMD3100), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	1
1194	@COMPOUND$ significantly increased the expression of SDF1 and Ang1 in the ischemic border and up-regulated @PROTEIN$ and Tie2 in the SVZ compared with MCAo control.	1
1195	@COMPOUND$ significantly increased the expression of SDF1 and Ang1 in the ischemic border and up-regulated CXCR4 and @PROTEIN$ in the SVZ compared with MCAo control.	1
1196	@COMPOUND$ significantly increased the expression of @PROTEIN$ and Ang1 in the ischemic border and up-regulated CXCR4 and Tie2 in the SVZ compared with MCAo control.	1
1197	@COMPOUND$ significantly increased the expression of SDF1 and @PROTEIN$ in the ischemic border and up-regulated CXCR4 and Tie2 in the SVZ compared with MCAo control.	1
1198	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates SDF1/CXCR4 and Ang1/@PROTEIN$ pathways and thereby likely increases SVZ neuroblast cell migration.	1
1199	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates SDF1/CXCR4 and @PROTEIN$/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.	1
1200	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates @PROTEIN$/CXCR4 and Ang1/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.	1
1201	Our data indicate that treatment of stroke with a @COMPOUND$ donor up-regulates SDF1/@PROTEIN$ and Ang1/Tie2 pathways and thereby likely increases SVZ neuroblast cell migration.	1
1202	The MEK inhibitor @COMPOUND$ did not inhibit neurite outgrowth, and Y-27632 and staurosporine did not induce @PROTEIN$ phosphorylation, suggesting that the inhibitory effect of ODQ on neurite outgrowth is independent of the ERK signaling pathway.	0
1203	The MEK inhibitor PD98059 did not inhibit neurite outgrowth, and Y-27632 and staurosporine did not induce @PROTEIN$ phosphorylation, suggesting that the inhibitory effect of @COMPOUND$ on neurite outgrowth is independent of the ERK signaling pathway.	0
1204	The MEK inhibitor PD98059 did not inhibit neurite outgrowth, and Y-27632 and @COMPOUND$ did not induce @PROTEIN$ phosphorylation, suggesting that the inhibitory effect of ODQ on neurite outgrowth is independent of the ERK signaling pathway.	0
1205	Rapid determination of @COMPOUND$ using engineered Escherichia coli overexpressing @PROTEIN$.	1
1206	The @COMPOUND$ (the final product of ATP hydrolysis by @PROTEIN$), have a recognized neuroprotective actions in the central nervous system (CNS) in pathological conditions.	1
1207	Also, @PROTEIN$ induction and concomitant @COMPOUND$ generation appear to participate in the cytotoxicity of excessive portal pressure after extended hepatectomy.	1
1208	As one of the very few repair systems for oxidized proteins, @PROTEIN$ and MsrB enzymes play a major role in protein homeostasis during aging and have also been involved in cellular defenses against oxidative stress, by scavenging reactive @COMPOUND$ species.	1
1209	As one of the very few repair systems for oxidized proteins, MsrA and @PROTEIN$ enzymes play a major role in protein homeostasis during aging and have also been involved in cellular defenses against oxidative stress, by scavenging reactive @COMPOUND$ species.	1
1210	@PROTEIN$-@COMPOUND$ levels increase with age in American women but not in Hong Kong Chinese women.	1
1211	@PROTEIN$ (HDL) @COMPOUND$ is a powerful cardiovascular risk factor.	1
1212	C18 and C20Gb(3) were, in mixtures without @COMPOUND$ :1Gb(3), dominant negative for @PROTEIN$ vesicle binding.	0
1213	@PROTEIN$/VT1bound C18 and @COMPOUND$ :1Gb(3) mixtures, although neither isoform bound alone.	1
1214	Monolayer surface pressure measurement showed VT1, but not VT2, bound @COMPOUND$) at cellular DRM surface pressures, and confirmed loss of VT1 and @PROTEIN$ (but not VT2) specific C18Gb(3) binding.	0
1215	@PROTEIN$ inhibition in chlorpyrifos workers: Characterization of biomarkers of exposure and response in relation to urinary @COMPOUND$.	0
1216	The objective of this study was to evaluate the quantitative relation between measured red blood cell @PROTEIN$ (RBC AChE) and plasma butyrylcholinesterase (BuChE) activities with exposure to @COMPOUND$ (CPF) as assessed by measurement of urinary 3,5,6-trichloro-2-pyridinol (TCPy) in a study group of workers occupationally exposed in the manufacture of CPF and a referent group of chemical manufacturing workers.	1
1217	The objective of this study was to evaluate the quantitative relation between measured red blood cell @PROTEIN$ (RBC AChE) and plasma butyrylcholinesterase (BuChE) activities with exposure to chlorpyrifos (CPF) as assessed by measurement of urinary 3,5,6-trichloro-2-pyridinol (@COMPOUND$) in a study group of workers occupationally exposed in the manufacture of CPF and a referent group of chemical manufacturing workers.	1
1218	The objective of this study was to evaluate the quantitative relation between measured red blood cell @PROTEIN$ (RBC AChE) and plasma butyrylcholinesterase (BuChE) activities with exposure to chlorpyrifos (CPF) as assessed by measurement of urinary @COMPOUND$ (TCPy) in a study group of workers occupationally exposed in the manufacture of CPF and a referent group of chemical manufacturing workers.	1
1219	A role for @PROTEIN$ in @COMPOUND$-induced fever in Pekin ducks (Anas platyrhynchos): is natriuretic peptide an endogenous antipyretic in birds.	0
1220	We induced fever in Pekin ducks with @COMPOUND$ and, at the same time, treated the animals with @PROTEIN$ antiserum at a dose that effectively inhibited the known renal actions of endogenously secreted natriuretic peptide.	0
1221	The data presented here show that NH4Cl (5 mM) mediates astroglial cell swelling, and that treatment with NH4Cl or @COMPOUND$ (25 mM) causes rearrangements of @PROTEIN$ filaments and reduces astroglial glutamate uptake capacity.	1
1222	In this research, the effects of pH, temperature, and @COMPOUND$ on growth kinetics of a newly isolated strain of Bacillus circulans from the Amazon and their correlations with @PROTEIN$ (TGase) production and cell sporulation were investigated.	1
1223	In this research, the effects of pH, temperature, and @COMPOUND$ on growth kinetics of a newly isolated strain of Bacillus circulans from the Amazon and their correlations with transglutaminase (@PROTEIN$) production and cell sporulation were investigated.	1
1224	Activation of c-@PROTEIN$ N-terminal kinase is essential for oxidative stress-induced Jurkat cell apoptosis by @COMPOUND$.	1
1225	Within 10min of NH(2) Cl treatment, c-Jun N-terminal kinase (@PROTEIN$) activation and elevation of cytosolic @COMPOUND$+) were observed.	0
1226	Within 10min of NH(2) @COMPOUND$ treatment, c-Jun N-terminal kinase (@PROTEIN$) activation and elevation of cytosolic Ca(2+) were observed.	0
1227	Within 10min of NH(2) Cl treatment, c-@PROTEIN$ N-terminal kinase (JNK) activation and elevation of cytosolic @COMPOUND$+) were observed.	0
1228	Within 10min of NH(2) @COMPOUND$ treatment, c-@PROTEIN$ N-terminal kinase (JNK) activation and elevation of cytosolic Ca(2+) were observed.	0
1229	Treatment with @COMPOUND$ resulted in dose- and time-dependent inhibition of growth of BeWo cells with IC(50) values of 2.01 and 1.19 microM for 7 and 24 h respectively, accompanied by downregulation of @PROTEIN$.	1
1230	In all cases, the phenotype of SVQ524 was nearly overcome by the addition of @COMPOUND$ or cobalamin to the plant growth media or by the presence of a copy of the @PROTEIN$ gene in cosmid pMUS756.	0
1231	In all cases, the phenotype of SVQ524 was nearly overcome by the addition of methionine or @COMPOUND$ to the plant growth media or by the presence of a copy of the @PROTEIN$ gene in cosmid pMUS756.	0
1232	We examined the substrates of cannabinoid-mediated inhibition of both the emetic phases via immunolabeling for @COMPOUND$, Substance P, cannabinoid receptors 1 and 2 (CB(1), CB(2)), and the neuronal activation marker @PROTEIN$ in the least shrew (Cryptotis parva).	0
1233	We examined the substrates of cannabinoid-mediated inhibition of both the emetic phases via immunolabeling for @COMPOUND$, @PROTEIN$, cannabinoid receptors 1 and 2 (CB(1), CB(2)), and the neuronal activation marker Fos in the least shrew (Cryptotis parva).	0
1234	We examined the substrates of cannabinoid-mediated inhibition of both the emetic phases via immunolabeling for @COMPOUND$, Substance P, @PROTEIN$ and 2 (CB(1), CB(2)), and the neuronal activation marker Fos in the least shrew (Cryptotis parva).	0
1235	To observe the inhibitory effects of TSP-1 functional fragments, critical for @PROTEIN$ binding, on the activation of L-TGF-beta1, we isolated alveolar macrophages from Wistar rat lungs 7 days after @COMPOUND$ administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.	0
1236	To observe the inhibitory effects of @PROTEIN$ functional fragments, critical for CD36 binding, on the activation of L-TGF-beta1, we isolated alveolar macrophages from Wistar rat lungs 7 days after @COMPOUND$ administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.	0
1237	To observe the inhibitory effects of TSP-1 functional fragments, critical for CD36 binding, on the activation of L-@PROTEIN$, we isolated alveolar macrophages from Wistar rat lungs 7 days after @COMPOUND$ administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.	0
1238	Two patients presented a heterozygous T-to-G transversion in exon 2 (c.518T&gt;G) of the @PROTEIN$, which results in a leucine-to-@COMPOUND$ substitution at codon 173.	1
1239	Two patients presented a heterozygous T-to-G transversion in exon 2 (c.518T&gt;G) of the @PROTEIN$, which results in a @COMPOUND$-to-arginine substitution at codon 173.	1
1240	Angiotensin II (@PROTEIN$) stimulation of water and @COMPOUND$ intake is a classic model of the behavioural effects of hormones.	1
1241	@PROTEIN$ (AngII) stimulation of water and @COMPOUND$ intake is a classic model of the behavioural effects of hormones.	1
1242	Previous studies support the hypotheses that @PROTEIN$ is involved in AngII-induced water, but not @COMPOUND$ intake and that MAP kinase plays a role in NaCl consumption, but not water intake, after injection of AngII.	0
1243	Pretreatment with the PKC inhibitor chelerythrine attenuated @PROTEIN$-induced water intake, but @COMPOUND$ intake was unaffected.	0
1244	Pretreatment with the PKC inhibitor @COMPOUND$ attenuated @PROTEIN$-induced water intake, but NaCl intake was unaffected.	1
1245	In contrast, pretreatment with U0126, a MAP kinase inhibitor, had no effect on @PROTEIN$-induced water intake, but attenuated @COMPOUND$ intake.	0
1246	The prevalence rates of elevated blood pressure and hypertriglyceridemia were significantly higher among HCT recipients than among controls, but the prevalence rates of abdominal obesity, elevated blood @COMPOUND$ and low @PROTEIN$ cholesterol were not.	0
1247	The prevalence rates of elevated blood pressure and hypertriglyceridemia were significantly higher among HCT recipients than among controls, but the prevalence rates of abdominal obesity, elevated blood glucose and low @PROTEIN$ @COMPOUND$ were not.	1
1248	Specific neurochemical elements in these structures include not only decreases in reward neurotransmission, such as decreases in @COMPOUND$ and opioid peptide function in the ventral striatum, but also recruitment of brain stress systems, such as corticotropin-releasing factor (@PROTEIN$), in the extended amygdala.	1
1249	Specific neurochemical elements in these structures include not only decreases in reward neurotransmission, such as decreases in @COMPOUND$ and opioid peptide function in the ventral striatum, but also recruitment of brain stress systems, such as @PROTEIN$ (CRF), in the extended amygdala.	1
1250	Although the TO2 hamster heart exhibits normal function at 1 month of age (presymptomatic stage), elevated levels of myeloperoxidase, monocyte chemotactic protein-1, @COMPOUND$, osteopontin, and @PROTEIN$ were evident, indicating the presence of inflammation, oxidative stress, and osteogenic phenotype.	0
1251	Although the TO2 hamster heart exhibits normal function at 1 month of age (presymptomatic stage), elevated levels of myeloperoxidase, @PROTEIN$, @COMPOUND$, osteopontin, and alkaline phosphatase were evident, indicating the presence of inflammation, oxidative stress, and osteogenic phenotype.	0
1252	In order to determine the possible effects of hemolysate on brain microvascular endothelial cells (BMECs), we examined the effects of hemolysate on the expression of intercellular adhesion molecule-1 (ICAM-1) and @PROTEIN$ (MCP-1), generation of reactive @COMPOUND$ species (ROS), and NF-kappaB activation in rat BMECs.	0
1253	In order to determine the possible effects of hemolysate on brain microvascular endothelial cells (BMECs), we examined the effects of hemolysate on the expression of intercellular adhesion molecule-1 (@PROTEIN$) and monocyte chemoattractant protein-1 (MCP-1), generation of reactive @COMPOUND$ species (ROS), and NF-kappaB activation in rat BMECs.	0
1254	In order to determine the possible effects of hemolysate on brain microvascular endothelial cells (BMECs), we examined the effects of hemolysate on the expression of intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (@PROTEIN$), generation of reactive @COMPOUND$ species (ROS), and NF-kappaB activation in rat BMECs.	0
1255	Bone formation and maturation processes were evaluated by double staining for alkaline @PROTEIN$ and tartrate-resistant acid phosphatase, immunohistochemistry for bone matrix proteins, vital staining with @COMPOUND$, and elemental mapping with an electron probe microanalyzer.	0
1256	Bone formation and maturation processes were evaluated by double staining for alkaline phosphatase and tartrate-resistant acid phosphatase, immunohistochemistry for bone @PROTEIN$, vital staining with @COMPOUND$, and elemental mapping with an electron probe microanalyzer.	0
1257	Bone formation and maturation processes were evaluated by double staining for @PROTEIN$ and tartrate-resistant acid phosphatase, immunohistochemistry for bone matrix proteins, vital staining with @COMPOUND$, and elemental mapping with an electron probe microanalyzer.	0
1258	In the present study the effect of the convulsant drug @COMPOUND$ (MP) repetitive administration (4-7 days) on the hippocampal @PROTEIN$ subunit was studied.	1
1259	A significant decrease in @PROTEIN$ in the whole hippocampus was observed after MP4 with a tendency to recover to normal values in @COMPOUND$ by western blot assay.	1
1260	The relationship between prolactin (@PROTEIN$), leptin, @COMPOUND$ (NO), and cytokines in patients with hyperprolactinemia.	0
1261	The relationship between @PROTEIN$ (PRL), leptin, @COMPOUND$ (NO), and cytokines in patients with hyperprolactinemia.	0
1262	The relationship between prolactin (PRL), @PROTEIN$, @COMPOUND$ (NO), and cytokines in patients with hyperprolactinemia.	0
1263	The aim of this study was to determine the changes in serum @PROTEIN$, tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
1264	The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (@PROTEIN$), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
1265	The aim of this study was to determine the changes in serum leptin, @PROTEIN$-alpha (TNF-alpha), interleukin-6 (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
1266	The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (@PROTEIN$), interleukin-6 (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
1267	The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (TNF-alpha), @PROTEIN$ (IL-6), @COMPOUND$ (NO) levels in patients with hyperprolactinemia.	0
1268	Tissues were stained for BrdU, @PROTEIN$, vimentin, and @COMPOUND$ and eosin staining.	0
1269	Tissues were stained for @COMPOUND$, @PROTEIN$, vimentin, and haematoxylin and eosin staining.	0
1270	Tissues were stained for @COMPOUND$, Pax-7, @PROTEIN$, and haematoxylin and eosin staining.	0
1271	Tissues were stained for BrdU, Pax-7, @PROTEIN$, and @COMPOUND$ and eosin staining.	0
1272	Regulation of the phosphoinositide-3 kinase and @PROTEIN$ signaling pathways by @COMPOUND$ and its reduced metabolites in the rat brain.	1
1273	Several growth factors, such as vascular endothelial growth factor, @PROTEIN$, and insulin-like growth factor-I are involved in the actions of @COMPOUND$ in the central nervous system.	1
1274	Several growth factors, such as vascular endothelial growth factor, brain-derived neurotrophic factor, and @PROTEIN$-like growth factor-I are involved in the actions of @COMPOUND$ in the central nervous system.	1
1275	Significant increases in the phosphorylation of @PROTEIN$, in the expression of the catalytic (p110) and the regulatory (p85) subunits of PI3K and in the phosphorylation of Akt were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1
1276	Significant increases in the phosphorylation of ERK, in the expression of the catalytic (p110) and the regulatory (@PROTEIN$) subunits of PI3K and in the phosphorylation of Akt were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1
1277	Significant increases in the phosphorylation of ERK, in the expression of the catalytic (@PROTEIN$) and the regulatory (p85) subunits of PI3K and in the phosphorylation of Akt were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1
1278	Significant increases in the phosphorylation of ERK, in the expression of the catalytic (p110) and the regulatory (p85) subunits of PI3K and in the phosphorylation of @PROTEIN$ were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1
1279	Significant increases in the phosphorylation of ERK, in the expression of the catalytic (p110) and the regulatory (p85) subunits of @PROTEIN$ and in the phosphorylation of Akt were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1
1280	Here, the @PROTEIN$-mediated (45)Ca(2+) uptake was compared in @COMPOUND$ (+)-loaded pig coronary artery smooth muscle and endothelial cells.	0
1281	The concept of a linkage between NCX and SERCA in smooth muscle was also confirmed by similar distribution of NCX and @PROTEIN$ proteins when detergent-treated microsomes were fractionated by flotation on @COMPOUND$ density gradients.	0
1282	The concept of a linkage between @PROTEIN$ and SERCA in smooth muscle was also confirmed by similar distribution of NCX and SERCA2 proteins when detergent-treated microsomes were fractionated by flotation on @COMPOUND$ density gradients.	0
1283	Here we report identification of the first three in vivo non-histone protein substrates of @COMPOUND$ propionylation in eukaryotic cells: p53, p300, and @PROTEIN$.	1
1284	Here we report identification of the first three in vivo non-histone protein substrates of @COMPOUND$ propionylation in eukaryotic cells: @PROTEIN$, p300, and CREB-binding protein.	1
1285	Here we report identification of the first three in vivo non-histone protein substrates of @COMPOUND$ propionylation in eukaryotic cells: p53, @PROTEIN$, and CREB-binding protein.	1
1286	@PROTEIN$ was able to perform autopropionylation on @COMPOUND$ residues in cells.	1
1287	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (@PROTEIN$, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
1288	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, @PROTEIN$, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
1289	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (@PROTEIN$ and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
1290	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) @PROTEIN$ in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
1291	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and @PROTEIN$) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	1
1292	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon tau (@PROTEIN$) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	0
1293	This study determined the effects of the estrous cycle, pregnancy, @COMPOUND$ (P4), and interferon @PROTEIN$ (IFNT) on expression of both facilitative (SLC2A1, SLC2A3, and SLC2A4) and sodium-dependent (SLC5A1 and SLC5A11) glucose transporters in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	0
1294	In @PROTEIN$-D patients, plasma triglycerides, apolipoprotein B-48 (apoB-48), free fatty acids (FFAs), and free @COMPOUND$ levels were much higher after OFL than those of controls, along with increases in chylomicron (CM) remnants and small dense low-density lipoprotein (sdLDL) particles.	0
1295	In CD36-D patients, plasma triglycerides, apolipoprotein B-48 (@PROTEIN$), free fatty acids (FFAs), and free @COMPOUND$ levels were much higher after OFL than those of controls, along with increases in chylomicron (CM) remnants and small dense low-density lipoprotein (sdLDL) particles.	0
1296	In CD36-D patients, plasma triglycerides, @PROTEIN$ (apoB-48), free fatty acids (FFAs), and free @COMPOUND$ levels were much higher after OFL than those of controls, along with increases in chylomicron (CM) remnants and small dense low-density lipoprotein (sdLDL) particles.	0
1297	@COMPOUND$ is a strong correlate of @PROTEIN$ levels in men and postmenopausal women.	1
1298	To investigate any similarities in the inhibition of @PROTEIN$ by quinacrine and @COMPOUND$, molecular modeling techniques were adopted and revealed that quinacrine molecule anchors inside the same binding pocket of the protein where disulfiram is also attached.	1
1299	H2S can be produced from @COMPOUND$ by enzymes such as @PROTEIN$.	1
1300	The influence of carbon sources on rhGH (recombinant human @PROTEIN$) production by two Pichia pastoris strains having different @COMPOUND$ utilization phenotypes (P. pastoris-hGH-Mut (+) and P. pastoris-hGH-Mut (s)) was investigated using batch bioreactors.	0
1301	Insulin-like growth factor-I (@PROTEIN$) is neuroprotective against @COMPOUND$-related toxicity and promotes white matter production following a number of insults.	1
1302	@PROTEIN$-like growth factor-I (IGF-I) is neuroprotective against @COMPOUND$-related toxicity and promotes white matter production following a number of insults.	1
1303	These data indicate that @PROTEIN$ may be a potential treatment for some of @COMPOUND$'s damaging effects, a finding that has important implications for children of women who drink alcohol during pregnancy.	1
1304	SWCNT coatings were thus functionalized with poly(@COMPOUND$-pyrrole) and applied to the anchoring of glucose oxidase (@PROTEIN$), modified with beta-cyclodextrin.	1
1305	SWCNT coatings were thus functionalized with poly(@COMPOUND$-pyrrole) and applied to the anchoring of @PROTEIN$ (GOX), modified with beta-cyclodextrin.	1
1306	This allows the immobilization of @COMPOUND$-tagged @PROTEIN$.	1
1307	Although we reported that 8-Cl-cAMP induces growth inhibition via p38 mitogen-activated protein kinase (@PROTEIN$) and a metabolite of 8-Cl-cAMP, 8-Cl-@COMPOUND$ mediates this process, the action mechanism of 8-Cl-cAMP is still uncertain.	1
1308	@COMPOUND$, @PROTEIN$ and CRP as markers of silent brain infarction.	0
1309	@COMPOUND$, IL-6 and @PROTEIN$ as markers of silent brain infarction.	0
1310	We found previously that increased levels of polyamine oxidase (PAO) (acetylpolyamine oxidase (AcPAO) plus spermine oxidase (@PROTEIN$)), and @COMPOUND$ (CH(2)CHCHO) are good markers of stroke.	0
1311	We found previously that increased levels of polyamine oxidase (@PROTEIN$) (acetylpolyamine oxidase (AcPAO) plus spermine oxidase (SMO)), and @COMPOUND$ (CH(2)CHCHO) are good markers of stroke.	0
1312	We found previously that increased levels of @PROTEIN$ (PAO) (acetylpolyamine oxidase (AcPAO) plus spermine oxidase (SMO)), and @COMPOUND$ (CH(2)CHCHO) are good markers of stroke.	0
1313	We found previously that increased levels of polyamine oxidase (PAO) (acetylpolyamine oxidase (AcPAO) plus @PROTEIN$ (SMO)), and @COMPOUND$ (CH(2)CHCHO) are good markers of stroke.	0
1314	We then investigated whether silent brain infarction (SBI) can be detected by measuring @COMPOUND$, @PROTEIN$, or other biomarkers.	0
1315	It was found that the levels of protein-conjugated @COMPOUND$ (PC-Acro), @PROTEIN$ (IL-6) and C-reactive protein (CRP) were significantly higher in SBI than in normal subjects.	0
1316	It was found that the levels of protein-conjugated @COMPOUND$ (PC-Acro), interleukin-6 (@PROTEIN$) and C-reactive protein (CRP) were significantly higher in SBI than in normal subjects.	0
1317	It was found that the levels of protein-conjugated @COMPOUND$ (PC-Acro), interleukin-6 (IL-6) and C-reactive protein (@PROTEIN$) were significantly higher in SBI than in normal subjects.	0
1318	Estrogenic effect was determined by the change of uterine weight, and oxidant effects were determined by the content of SOD, @COMPOUND$-Px, @PROTEIN$ and MDA.	0
1319	Estrogenic effect was determined by the change of uterine weight, and oxidant effects were determined by the content of @PROTEIN$, @COMPOUND$-Px, CAT and MDA.	0
1320	The intake of formononetin increased the uterine weight of the mice significantly as well as the content of SOD, @COMPOUND$-Px, @PROTEIN$, and reduced MDA in body.	0
1321	The intake of formononetin increased the uterine weight of the mice significantly as well as the content of @PROTEIN$, @COMPOUND$-Px, CAT, and reduced MDA in body.	0
1322	Alkaline phosphatase activity and @PROTEIN$ expression of the osteoblasts cultured on the @COMPOUND$ scaffolds remained stable over three weeks, whilst expression of collagen type I and osteopontin decreased.	0
1323	@PROTEIN$ activity and osteonectin expression of the osteoblasts cultured on the @COMPOUND$ scaffolds remained stable over three weeks, whilst expression of collagen type I and osteopontin decreased.	0
1324	The @PROTEIN$ activity of osteoblasts cultured on @COMPOUND$ scaffolds is comparable with that from two commercially-available scaffolds-OPLA and collagen scaffolds (Becton-Dickinson (BD) Inc., Franklin Lakes, NJ, USA).	0
1325	@PROTEIN$ and P53 play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to rapamycin and @COMPOUND$.	1
1326	P27 and @PROTEIN$ play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to @COMPOUND$ and paclitaxel.	1
1327	@PROTEIN$ and P53 play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to @COMPOUND$ and paclitaxel.	1
1328	P27 and @PROTEIN$ play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to rapamycin and @COMPOUND$.	1
1329	Involvement of @PROTEIN$ in TPA-potentiated apoptosis induction during @COMPOUND$-mediated erythroid differentiation in K562 cells.	0
1330	To better understand the mechanisms underlying differentiation-mediated regulation of apoptosis, we have studied the effects of @PROTEIN$ pathway with an activator of the protein kinase C, 12-O-tetradecanoylphorbol-13-acetate (TPA), during @COMPOUND$-induced erythroid differentiation of K562 erythroleukemia cells.	0
1331	To better understand the mechanisms underlying differentiation-mediated regulation of apoptosis, we have studied the effects of @PROTEIN$ pathway with an activator of the protein kinase C, @COMPOUND$ (TPA), during hemin-induced erythroid differentiation of K562 erythroleukemia cells.	1
1332	Taken together, our results suggested the involvement of @PROTEIN$ in TPA-potentiated apoptosis induction during @COMPOUND$-mediated erythroid differentiation in K562 cells.	0
1333	At glutamatergic synapses, increased binding to the @COMPOUND$-B site located in the @PROTEIN$ (NMDAR) can enhance neurotransmission via NMDARs.	1
1334	The most common adverse events were mild and transient gastrointestinal disturbances, skin rash, nonprogressive transient increases in serum @COMPOUND$ and urine @PROTEIN$, and a temporary reduction of the creatinine clearance.	0
1335	The optimal condition for the labeling of cypate to @PROTEIN$ was 4 h reaction duration at 4 degrees C and pH 8.5 under catalysis by HOBt/@COMPOUND$.	1
1336	The optimal condition for the labeling of cypate to @PROTEIN$ was 4 h reaction duration at 4 degrees C and pH 8.5 under catalysis by @COMPOUND$/HBTU.	1
1337	Effects of insulin and @COMPOUND$ on expression of @PROTEIN$ family proteins and caspase-3 activity in hippocampus of diabetic rats were evaluated in this study.	1
1338	Effects of @PROTEIN$ and @COMPOUND$ on expression of Bcl-2 family proteins and caspase-3 activity in hippocampus of diabetic rats were evaluated in this study.	0
1339	@COMPOUND$ (CVF) is a structural and functional analog of @PROTEIN$ isolated from cobra venom.	1
1340	This paper investigates the effect of sterilisation by gamma irradiation (dose 2.5Mrad) on the following properties of @COMPOUND$ (PCL): (1) degradation rate (catalysed by @PROTEIN$), (2) mechanical properties, (3) the ability of cells to attach and subsequently grow on its surface.	1
1341	Inhibition in the brain is dominated by the neurotransmitter @COMPOUND$ (GABA); operating through @PROTEIN$.	1
1342	Inhibition in the brain is dominated by the neurotransmitter gamma-aminobutyric acid (@COMPOUND$); operating through @PROTEIN$.	1
1343	The 5-HT2AR response dominated the @PROTEIN$ signaling pathway when co-expressed with 5-HT1AR, and diminution of the response by the 5-HT2AR antagonist @COMPOUND$ could not be rescued by the 5-HT1AR agonist.	1
1344	Novel homo- and hetero-nuclear @COMPOUND$ (II) complexes of tetradentate Schiff bases: synthesis, characterization, solvent-extraction and @PROTEIN$-like activity studies.	1
1345	The laboratory findings of the cases were compatible with VDDR; serum calcium (Ca) 7.5+/-1.9 mg/dL, PO4 4.4+/-1.3 mg/dL, alkaline phosphatase (@PROTEIN$) 1,341+/-823, @COMPOUND$ (25 (OH) D) 5.8+/-2.9 ng/mL, intact parathyroid hormone (iPTH) 240+/-106 pg/mL.	0
1346	The laboratory findings of the cases were compatible with VDDR; serum calcium (Ca) 7.5+/-1.9 mg/dL, PO4 4.4+/-1.3 mg/dL, @PROTEIN$ (ALP) 1,341+/-823, @COMPOUND$ (25 (OH) D) 5.8+/-2.9 ng/mL, intact parathyroid hormone (iPTH) 240+/-106 pg/mL.	0
1347	The laboratory findings of the cases were compatible with VDDR; serum calcium (Ca) 7.5+/-1.9 mg/dL, @COMPOUND$ 4.4+/-1.3 mg/dL, alkaline phosphatase (@PROTEIN$) 1,341+/-823, 25-hydroxyvitamin D (25 (OH) D) 5.8+/-2.9 ng/mL, intact parathyroid hormone (iPTH) 240+/-106 pg/mL.	0
1348	The laboratory findings of the cases were compatible with VDDR; serum calcium (Ca) 7.5+/-1.9 mg/dL, @COMPOUND$ 4.4+/-1.3 mg/dL, @PROTEIN$ (ALP) 1,341+/-823, 25-hydroxyvitamin D (25 (OH) D) 5.8+/-2.9 ng/mL, intact parathyroid hormone (iPTH) 240+/-106 pg/mL.	0
1349	The aqueous extract was found to be more effective than @COMPOUND$, a classical anticarcinogenic drug, with respect to its action on antioxidant enzymes and @PROTEIN$ in the liver of mice with developing lymphomas.	1
1350	Cu,Zn-@PROTEIN$-driven free radical modifications: @COMPOUND$- and carbonate radical anion-initiated protein radical chemistry.	0
1351	The understanding of the mechanism, oxidant(s) involved and how and what protein radicals are produced during the reaction of wild-type @PROTEIN$ (Cu,Zn-superoxide dismutase) with @COMPOUND$ and their fate is incomplete, but a better understanding of the role of this reaction is needed.	1
1352	The understanding of the mechanism, oxidant(s) involved and how and what protein radicals are produced during the reaction of wild-type SOD1 (Cu,Zn-@PROTEIN$) with @COMPOUND$ and their fate is incomplete, but a better understanding of the role of this reaction is needed.	1
1353	In the absence of (bi)carbonate, site-specific radical-mediated fragmentation is produced by @PROTEIN$ active-site @COMPOUND$.	1
1354	Finally, we propose a biochemical mechanism to explain CO(*-) production from CO2, enhanced protein radical formation and protection by (bi)carbonate against @COMPOUND$-induced fragmentation of the @PROTEIN$ active site.	1
1355	In permeabilized muscle fibers, we observed, a strong inhibition of both state 3 mitochondrial respiration and functionally isolated maximal cytochrome c oxidase (@PROTEIN$) activity after 49 days of @COMPOUND$ exposure.	1
1356	In permeabilized muscle fibers, we observed, a strong inhibition of both state 3 mitochondrial respiration and functionally isolated maximal @PROTEIN$ oxidase (COX) activity after 49 days of @COMPOUND$ exposure.	1
1357	The dominant positive regulator of mTORC1 is the @COMPOUND$-charged form of the @PROTEIN$-like GTPase Rheb.	1
1358	The dominant positive regulator of mTORC1 is the @COMPOUND$-charged form of the ras-like GTPase @PROTEIN$.	1
1359	In contrast, amino acids, especially leucine, regulate mTORC1 by controlling the ability of @PROTEIN$-@COMPOUND$ to activate mTORC1.	1
1360	At 2 h in suspension, keratinocytes that had become committed to terminal differentiation had increased side scatter, were @COMPOUND$ (7-@PROTEIN$) positive and annexin V negative; they exhibited loss of mitochondrial membrane potential and increased cardiolipin oxidation, but with no increase in reactive oxygen species.	0
1361	At 2 h in suspension, keratinocytes that had become committed to terminal differentiation had increased side scatter, were @COMPOUND$ (7-AAD) positive and @PROTEIN$ negative; they exhibited loss of mitochondrial membrane potential and increased cardiolipin oxidation, but with no increase in reactive oxygen species.	0
1362	Compared with nonperfused constructs, flow perfused constructs demonstrated improved cells proliferation and differentiation according to cell viability, @COMPOUND$ consumption, @PROTEIN$ activity, and osteopontin.	0
1363	One of the best triads for bone engineering is bone marrow stromal cells, @COMPOUND$ ceramics, and bone @PROTEIN$ (BMP).	0
1364	One of the best triads for bone engineering is bone marrow stromal cells, @COMPOUND$ ceramics, and bone morphogenetic protein (@PROTEIN$).	0
1365	The cells were mixed with @COMPOUND$ (beta-TCP) granules followed by osteoblast induction with recombinant human @PROTEIN$ (rhBMP-2) (first mixture), or were first induced with rhBMP-2 on plastic dishes and then mixed with the beta-TCP granules (last mixture) just prior to the operation.	0
1366	We characterized this selenoprotein @PROTEIN$ which had a single Sec residue at the catalytic site but no @COMPOUND$ (Cys) residues in the protein sequence.	0
1367	Zn2+-linked dimerization of @PROTEIN$ from Helicobacter pylori, a chaperone involved in @COMPOUND$ trafficking and urease activation.	1
1368	Zn2+-linked dimerization of UreG from Helicobacter pylori, a chaperone involved in @COMPOUND$ trafficking and @PROTEIN$ activation.	0
1369	The biosynthesis of the active metal-bound form of the nickel-dependent enzyme @PROTEIN$ involves the formation of a @COMPOUND$-carbamate functional group concomitantly with the delivery of two Ni(2+) ions into the precast active site of the apoenzyme and with GTP hydrolysis.	1
1370	The biosynthesis of the active metal-bound form of the nickel-dependent enzyme @PROTEIN$ involves the formation of a lysine-carbamate functional group concomitantly with the delivery of two @COMPOUND$+) ions into the precast active site of the apoenzyme and with GTP hydrolysis.	1
1371	The biosynthesis of the active metal-bound form of the nickel-dependent enzyme @PROTEIN$ involves the formation of a lysine-@COMPOUND$ functional group concomitantly with the delivery of two Ni(2+) ions into the precast active site of the apoenzyme and with GTP hydrolysis.	1
1372	Mechanistically, we showed EphA2 knockdown suppressed @PROTEIN$-induced @COMPOUND$ 536 phosphorylation of NFkappaB, an event critical of ICAM-1 transcriptional upregulation.	1
1373	Mechanistically, we showed EphA2 knockdown suppressed thrombin-induced @COMPOUND$ 536 phosphorylation of NFkappaB, an event critical of @PROTEIN$ transcriptional upregulation.	1
1374	Total antioxidant capacity, catalase, @COMPOUND$-reactive substances, hemoglobin, transferrin saturation and @PROTEIN$ did not change significantly.	0
1375	Total antioxidant capacity, catalase, @COMPOUND$-reactive substances, hemoglobin, @PROTEIN$ saturation and ferritin did not change significantly.	0
1376	Total antioxidant capacity, @PROTEIN$, @COMPOUND$-reactive substances, hemoglobin, transferrin saturation and ferritin did not change significantly.	0
1377	Total antioxidant capacity, catalase, @COMPOUND$-reactive substances, @PROTEIN$, transferrin saturation and ferritin did not change significantly.	0
1378	Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of cholesterol to @COMPOUND$ by cholesterol side-chain cleavage enzyme (@PROTEIN$).	1
1379	Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of @COMPOUND$ to pregnenolone by @PROTEIN$ (CYP11A).	1
1380	Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of @COMPOUND$ to pregnenolone by cholesterol side-chain cleavage enzyme (@PROTEIN$).	1
1381	Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of cholesterol to @COMPOUND$ by @PROTEIN$ (CYP11A).	1
1382	Finally, HA increased @PROTEIN$ (NOS) activity, and the NOS inhibitor NG-nitro-@COMPOUND$ (L-NAME) markedly attenuated the effect of the amine on steroid synthesis.	0
1383	LH, FSH, 17 @COMPOUND$, progesterone, aldosterone and @PROTEIN$ were assayed at the seventh, fourteenth, twenty-first and twenty-eighth days of the cycle after 30 min of recumbency.	0
1384	LH, FSH, 17 beta-estradiol, @COMPOUND$, aldosterone and @PROTEIN$ were assayed at the seventh, fourteenth, twenty-first and twenty-eighth days of the cycle after 30 min of recumbency.	0
1385	Aldosterone was positively related to @PROTEIN$ and @COMPOUND$.	0
1386	Induction of the spliced form of @PROTEIN$ as well as total XBP1 by @COMPOUND$ was significantly attenuated in patients with BD.	1
1387	Induction of @PROTEIN$ by @COMPOUND$ was also decreased in the BD group.	1
1388	Efforts in the field of synthetic vaccine carriers are focussing on decorating the particle surface with ligands for DC receptors such as heparan @COMPOUND$ glycosaminoglycan structures, integrins, Siglecs, ga@PROTEIN$, C-type lectins and toll-like receptors.	0
1389	Efforts in the field of synthetic vaccine carriers are focussing on decorating the particle surface with ligands for DC receptors such as heparan @COMPOUND$ glycosaminoglycan structures, integrins, Siglecs, @PROTEIN$, C-type lectins and toll-like receptors.	0
1390	Reversal of the inhibitory effect of @COMPOUND$ on @PROTEIN$ generation by rFVIIa, aPCC and PCC.	1
1391	Reversal of the inhibitory effect of fondaparinux on @PROTEIN$ generation by rFVIIa, a@COMPOUND$ and PCC.	1
1392	We conclude that gastrocnemius, heart, and liver mitochondria of streptozotocin diabetic rats are not irrevocably altered toward excess @COMPOUND$ production either by @PROTEIN$ or complex III.	1
1393	Consequently, the primary mechanism of resistance to @COMPOUND$ is a function of the activity of the DNA repair enzyme O(6)-methylguanine DNA @PROTEIN$ (MGMT).	1
1394	Consequently, the primary mechanism of resistance to @COMPOUND$ is a function of the activity of the DNA repair enzyme O(6)-methylguanine DNA methyltransferase (@PROTEIN$).	1
1395	Despite their inhibitory effects on inflammatory gene expression, loss of @PROTEIN$ or LXRs in macrophages did not exert major effects on obesity or @COMPOUND$ tolerance induced by a high-fat diet.	0
1396	Our results do not exclude a contribution of macrophage @PROTEIN$ and LXR expression to systemic metabolism in certain contexts, but these factors do not appear to be dominant contributors to @COMPOUND$ tolerance in a high-fat-fed Th1-biased bone marrow transplant model.	0
1397	Effects of conjugated linoleic acid plus n-3 @COMPOUND$ on @PROTEIN$ secretion and estimated insulin sensitivity in men.	1
1398	Effects of @COMPOUND$ plus n-3 polyunsaturated fatty acids on @PROTEIN$ secretion and estimated insulin sensitivity in men.	1
1399	A mechanism for the bioreduction of H2PtCl6 and PtCl2 into @COMPOUND$ nanoparticles by a @PROTEIN$ enzyme from Fusarium oxysporum is proposed.	1
1400	Radioisotopic localization of (90) @COMPOUND$-ibritumomab tiuxetan in patients with @PROTEIN$+ non-Hodgkin's lymphoma.	1
1401	We solved the crystal structures of Aquifex aeolicus @PROTEIN$ and its complex with adenosine 5 '-(alpha,beta-methylene) triphosphate (@COMPOUND$).	1
1402	We solved the crystal structures of Aquifex aeolicus @PROTEIN$ and its complex with adenosine 5 '-(alpha,beta-@COMPOUND$) triphosphate (AMPCPP).	1
1403	To identify the amino-acid residues that contribute to @PROTEIN$ activity, we prepared six mutants of SPS and examined their @COMPOUND$-dependent ATP consumption.	1
1404	"In @PROTEIN$. @COMPOUND$, the N-terminal loop, including the two residues, assumes different conformations (""open"" and ""closed"") between the two subunits."	1
1405	The results indicated that @PROTEIN$ receptors within the nucleus accumbens are involved in the acquisition and expression of @COMPOUND$-induced CPP in sensitized rats.	1
1406	The Arg105 in @PROTEIN$ is highly conserved across species and its replacement with @COMPOUND$ is predicted to be pathogenic.	1
1407	We also assess prostaglandin (PGE (2)) and thromboxane (@COMPOUND$ (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for COX-1 and @PROTEIN$.	0
1408	We also assess prostaglandin (PGE (2)) and thromboxane (@COMPOUND$ (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for @PROTEIN$ and COX-2.	0
1409	We also assess prostaglandin (PGE (2)) and @COMPOUND$ (TXB (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for COX-1 and @PROTEIN$.	0
1410	We also assess prostaglandin (PGE (2)) and @COMPOUND$ (TXB (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for @PROTEIN$ and COX-2.	0
1411	We also assess prostaglandin (@PROTEIN$ (2)) and thromboxane (@COMPOUND$ (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for COX-1 and COX-2.	0
1412	We also assess prostaglandin (@PROTEIN$ (2)) and @COMPOUND$ (TXB (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for COX-1 and COX-2.	0
1413	0.05 vs. aortic IR) plasma levels of @COMPOUND$, P-selectin, intercellular adhesion molecule-1 (ICAM-I), and tissue levels of malondialdehyde and @PROTEIN$.	0
1414	Memory impairment in young women at increased risk of depression: influence of @COMPOUND$ and 5-@PROTEIN$ genotype.	0
1415	The aim of the present study was to determine whether memory impairments were present in young women at increased familial risk of depression and whether memory performance was related either to @COMPOUND$ secretion or to allelic variation in the promoter region of the serotonin transporter gene (5-@PROTEIN$).	0
1416	These include typical G-protein (Galphaq/11)-coupled cascades, such as activation of phospholipase C (PLC), and subsequent accumulation of inositol-(1,4,5)-triphosphate (IP3), intracellular @COMPOUND$+) mobilization, and activation of @PROTEIN$.	0
1417	Polymorphism in the @PROTEIN$ gene, plasma lipoprotein(a), cardiovascular disease, and low-dose @COMPOUND$ therapy.	0
1418	We investigated whether this allele was associated with elevated @PROTEIN$ and cardiovascular risk in the Women's Health Study, a randomized trial of low-dose @COMPOUND$, and whether aspirin reduced cardiovascular risk in minor allele carriers.	0
1419	Drosophila responds to detection of diamonopimelic-type microbial @COMPOUND$ through activation of the immune deficiency (Imd) pathway, a signaling pathway with numerous similarities to the mammalian pro-inflammatory @PROTEIN$ pathway.	1
1420	In the current study, we found that treatment of peripheral blood mononuclear cells with combination IL-2/IL-4 for 48 hours, but not with IL-2 or IL-4 alone, abrogated @COMPOUND$ (DEX)-induced @PROTEIN$ (GCR)-alpha nuclear translocation in both CD4 (+) and CD8(+) T cells.	1
1421	In the current study, we found that treatment of peripheral blood mononuclear cells with combination IL-2/IL-4 for 48 hours, but not with IL-2 or IL-4 alone, abrogated @COMPOUND$ (DEX)-induced glucocorticoid receptor (GCR)-alpha nuclear translocation in both @PROTEIN$ (+) and CD8(+) T cells.	1
1422	@COMPOUND$-mediated inflammation and @PROTEIN$ resistance in human adipocytes are attenuated by resveratrol.	0
1423	Conjugated linoleic acid-mediated inflammation and @PROTEIN$ resistance in human adipocytes are attenuated by @COMPOUND$.	1
1424	Inflammation plays a role in trans-10, cis-12 (10,12)-@COMPOUND$ (CLA)-mediated delipidation and @PROTEIN$ resistance in adipocytes.	0
1425	Given the anti-inflammatory role of @COMPOUND$ (RSV), we hypothesized that RSV would attenuate inflammation and @PROTEIN$ resistance caused by 10,12 CLA in human adipocytes.	1
1426	Wheat germ @PROTEIN$ had a high activity and enantioselectivity only in n-hexane with a high initial water activity (alpha(w) = 0.97), especially with @COMPOUND$ (C 32%, E &gt; 200).	1
1427	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines @PROTEIN$ (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1428	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines @PROTEIN$ (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1429	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-@PROTEIN$ (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1430	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (@PROTEIN$), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1431	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (@PROTEIN$), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1432	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (@PROTEIN$)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1433	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (@PROTEIN$)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1434	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (@PROTEIN$), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1435	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and @PROTEIN$, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1436	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (@PROTEIN$), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1437	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (@PROTEIN$)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1438	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (@PROTEIN$)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1439	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and @PROTEIN$, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1440	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-@PROTEIN$ (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1441	The results suggest that modulation of matrix @PROTEIN$, oxidants, cytokines, and NOSs with omapatrilat and @COMPOUND$ contribute to reversal of adverse collagen and LV remodeling and attenuation of LV dysfunction during healing after RMI.	1
1442	The results suggest that modulation of matrix @PROTEIN$, oxidants, cytokines, and NOSs with @COMPOUND$ and candesartan contribute to reversal of adverse collagen and LV remodeling and attenuation of LV dysfunction during healing after RMI.	1
1443	We recently reported @COMPOUND$ (Hcy)-induced @PROTEIN$-phosphorylation was suppressed by pertussis toxin (PTX), which suggested the involvement of GPCRs in initiating signal transduction.	1
1444	We have discovered multiple genetic and biochemical differences between humans and these other hominids, in relation to @COMPOUND$ and in Siglecs (Sia-recognizing Ig superfamily @PROTEIN$).	0
1445	The proteins identified belong to the photosynthesis, carbohydrate and @COMPOUND$ metabolism, and @PROTEIN$ functional categories.	0
1446	Spectrofluorimetric determination of vitamin B(1) using horseradish @PROTEIN$ as catalyst in the presence of @COMPOUND$.	1
1447	In this work a new spectrofluorimetric method for the determination of vitamin B(1), based on the catalytic activity of horseradish peroxidase (@PROTEIN$) in the presence of hydrogen peroxide (@COMPOUND$), has been developed.	1
1448	In this work a new spectrofluorimetric method for the determination of vitamin B(1), based on the catalytic activity of horseradish @PROTEIN$ (HRP) in the presence of hydrogen peroxide (@COMPOUND$), has been developed.	1
1449	In this work a new spectrofluorimetric method for the determination of vitamin B(1), based on the catalytic activity of horseradish peroxidase (@PROTEIN$) in the presence of @COMPOUND$ (H2O2), has been developed.	1
1450	In this work a new spectrofluorimetric method for the determination of vitamin B(1), based on the catalytic activity of horseradish @PROTEIN$ (HRP) in the presence of @COMPOUND$ (H2O2), has been developed.	1
1451	So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: @PROTEIN$, lpa2 and lpa3.	1
1452	So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: lpa1, @PROTEIN$ and lpa3.	1
1453	So far, in maize, three classes of mutants involved in @COMPOUND$ biosynthesis have been isolated: lpa1, lpa2 and @PROTEIN$.	1
1454	Bevacizumab (Avastin), ranibizumab (Lucentis) and pegaptanib sodium (@COMPOUND$) are anti-@PROTEIN$ medications that have been used in the treatment of CNV.	1
1455	Bevacizumab (Avastin), ranibizumab (Lucentis) and @COMPOUND$ (Macugen) are anti-@PROTEIN$ medications that have been used in the treatment of CNV.	1
1456	Blood samples were collected to assay for biomarkers of oxidative stress (malondialdehyde and carbonyl groups) and antioxidants (@PROTEIN$, @COMPOUND$, alpha-tocopherol, and beta-carotene).	0
1457	Blood samples were collected to assay for biomarkers of oxidative stress (@COMPOUND$ and carbonyl groups) and antioxidants (@PROTEIN$, reduced glutathione, alpha-tocopherol, and beta-carotene).	0
1458	Some of the peptide derivatives inhibited @PROTEIN$-mediated uptake of ((3)H) @COMPOUND$-Sar.	1
1459	Effect of enzyme supplementation at moderate @PROTEIN$ loadings on initial @COMPOUND$ and xylose release from corn stover solids pretreated by leading technologies.	0
1460	For a combined mass loading of cellulase and @PROTEIN$ of 16.1 mg/g original @COMPOUND$ (about 7.5 FPU/g), glucose release from pretreated solids ranged from 50% to75% of the theoretical maximum and was greater for all pretreatments at all protein loadings compared to pure Avicel cellulose except for solids from controlled pH pretreatment and from dilute acid pretreatment by the Sunds pilot unit.	1
1461	For a combined mass loading of cellulase and @PROTEIN$ of 16.1 mg/g original glucan (about 7.5 FPU/g), @COMPOUND$ release from pretreated solids ranged from 50% to75% of the theoretical maximum and was greater for all pretreatments at all protein loadings compared to pure Avicel cellulose except for solids from controlled pH pretreatment and from dilute acid pretreatment by the Sunds pilot unit.	1
1462	For a combined mass loading of @PROTEIN$ and beta-glucosidase of 16.1 mg/g original @COMPOUND$ (about 7.5 FPU/g), glucose release from pretreated solids ranged from 50% to75% of the theoretical maximum and was greater for all pretreatments at all protein loadings compared to pure Avicel cellulose except for solids from controlled pH pretreatment and from dilute acid pretreatment by the Sunds pilot unit.	1
1463	For a combined mass loading of @PROTEIN$ and beta-glucosidase of 16.1 mg/g original glucan (about 7.5 FPU/g), @COMPOUND$ release from pretreated solids ranged from 50% to75% of the theoretical maximum and was greater for all pretreatments at all protein loadings compared to pure Avicel cellulose except for solids from controlled pH pretreatment and from dilute acid pretreatment by the Sunds pilot unit.	1
1464	PCFT/@PROTEIN$ could therefore play a physiological role in Fe nutrition and the data highlight the potential for the interaction of @COMPOUND$ and haem at the level of intestinal absorption.	1
1465	Following an oral @COMPOUND$ challenge, there was a weak trend for glucose-stimulated @PROTEIN$ release to be increased in the offspring of dams fed the folate-deficient diet.	1
1466	By using the system, we obtained four event timing data sets (stimulation by @PROTEIN$ with and without @COMPOUND$ at the concentrations of 0.01, 0.1, and 1 microM).	0
1467	Using newly designed degenerate primers targeting the @PROTEIN$ gene we analysed the potential for @COMPOUND$ utilization in DNA and cDNA libraries constructed from a phytoplankton bloom in the Western English Channel during July 2006.	1
1468	Finally, we show that Vcx1 helps return cytosolic @COMPOUND$+) toward resting levels after shock with high extracellular Ca(2+) much more effectively than @PROTEIN$ and that calcineurin, a protein phosphatase regulator of Vcx1 and Pmc1, had no detectable effects on these factors within the first few minutes of its activation.	0
1469	It is a serious problem that effective treatment choices to T315I, in the @PROTEIN$ kinase domain that shows a strong tolerance in @COMPOUND$ do not exist clinically.	1
1470	Long-term blinded placebo-controlled study of SNT-MC17/@COMPOUND$ in the @PROTEIN$ deficient mdx mouse: cardiac protection and improved exercise performance.	1
1471	Long-term blinded placebo-controlled study of @COMPOUND$/idebenone in the @PROTEIN$ deficient mdx mouse: cardiac protection and improved exercise performance.	1
1472	The study aim was to determine whether urine albumin/@COMPOUND$ ratio (UACR), high-sensitivity C-reactive protein (hsCRP) or N-terminal pro-@PROTEIN$ (Nt-proBNP) added to risk prediction based on HeartScore and history of diabetes or cardiovascular disease.	0
1473	Transgene optimization significantly improves SIN vector titers, @PROTEIN$ expression and reconstitution of @COMPOUND$ production in X-CGD cells.	0
1474	Quantitative evaluation of @PROTEIN$ contribution to oral absorption of @COMPOUND$ in rats.	1
1475	@COMPOUND$ concentration in the liver and in plasma alanine aminotransferase (ALT) and aspartate transaminase (@PROTEIN$) activities were determined.	1
1476	In brain tissue, Cu concentration, superoxide dismutase (@PROTEIN$) activities, @COMPOUND$ (MDA) levels and glutathione (GSH) concentrations were determined.	0
1477	In brain tissue, Cu concentration, @PROTEIN$ (SOD) activities, @COMPOUND$ (MDA) levels and glutathione (GSH) concentrations were determined.	0
1478	In brain tissue, @COMPOUND$ concentration, @PROTEIN$ (SOD) activities, malondialdehyde (MDA) levels and glutathione (GSH) concentrations were determined.	0
1479	In brain tissue, @COMPOUND$ concentration, superoxide dismutase (@PROTEIN$) activities, malondialdehyde (MDA) levels and glutathione (GSH) concentrations were determined.	0
1480	@PROTEIN$ is also important in the regulation of @COMPOUND$ signaling, a second messenger implicated in learning, memory, and mood.	1
1481	The mitochondrial membrane potential (Delta psi (mit)) was also tested with @COMPOUND$ 30 min after SI challenge, and was shown to have collapsed in the incompatible pollen tubes after exposure to @PROTEIN$.	1
1482	In conclusion, female rats undernourished in utero had normophagic obesity as adults but had an absence of @COMPOUND$-induced hypophagia and low hypothalamic levels of the @PROTEIN$ receptor.	0
1483	Compensatory adaptations for the functional serotonergic impairment were evidenced, such as an enhanced release of @COMPOUND$ in response to a meal allied to up-regulated hypothalamic @PROTEIN$ and transporter expression.	1
1484	The proliferation of the parental cell line was most efficiently stimulated by @COMPOUND$ (DHT), but the LNCaP(@PROTEIN$) cells were equally stimulated by Adione, indicating that 17beta-HSD3 efficiently converts Adione to T in this model.	0
1485	The proliferation of the parental cell line was most efficiently stimulated by 5alpha-dihydrotestosterone (@COMPOUND$), but the LNCaP(@PROTEIN$) cells were equally stimulated by Adione, indicating that 17beta-HSD3 efficiently converts Adione to T in this model.	0
1486	Levels of endothelial @PROTEIN$ and inducible nitric oxide synthase did not differ among the groups, nor did total nitrite plus @COMPOUND$ levels.	0
1487	@COMPOUND$ controls cytosolic Ca2+ and @PROTEIN$ secretion in mouse islets lacking adenosine triphosphate-sensitive K+ channels owing to a knockout of the pore-forming subunit Kir6.2.	1
1488	Glucose controls cytosolic Ca2+ and @PROTEIN$ secretion in mouse islets lacking @COMPOUND$-sensitive K+ channels owing to a knockout of the pore-forming subunit Kir6.2.	1
1489	Lung injury was assessed by measuring vascular permeability (via @COMPOUND$), edema, neutrophil infiltration (via myeloperoxidase (@PROTEIN$), and expression of proinflammatory cytokines.	0
1490	Regulation of muscle protein degradation, not synthesis, by dietary @COMPOUND$ in rats fed @PROTEIN$-deficient diet.	0
1491	The @COMPOUND$/@PROTEIN$ (PKA) signaling cascade is crucial for synaptic plasticity in a wide variety of species.	1
1492	Every 12 weeks intestinal permeability (@COMPOUND$/mannitol ratio), haemoglobin, plasma albumin, alpha-1-acid @PROTEIN$, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	0
1493	Every 12 weeks intestinal permeability (lactulose/@COMPOUND$ ratio), haemoglobin, plasma albumin, @PROTEIN$-acid glycoprotein, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	0
1494	Every 12 weeks intestinal permeability (@COMPOUND$/mannitol ratio), haemoglobin, plasma albumin, @PROTEIN$-acid glycoprotein, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	0
1495	Every 12 weeks intestinal permeability (lactulose/@COMPOUND$ ratio), haemoglobin, plasma albumin, alpha-1-acid @PROTEIN$, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	0
1496	As such, the aim of the present study was to investigate whether @PROTEIN$-inhibition with @COMPOUND$, a molecule distinctly different from torcetrapib, impacts on vascular function, a well-established surrogate of atherosclerotic vascular disease, as well as markers of inflammation and oxidative stress in patients with type II hyperlipidemia.	1
1497	Since stellate cells have been found to express the beta but not the alpha isoform of the @PROTEIN$, it can be predicted that nutritional intakes of the soy isoflavone @COMPOUND$-a selective agonist for ERbeta in the low nanomolar plasma concentrations achievable with these intakes-have potential for suppressing hepatic fibrosis, in both men and women.	0
1498	Since stellate cells have been found to express the beta but not the alpha isoform of the @PROTEIN$, it can be predicted that nutritional intakes of the soy @COMPOUND$ genistein-a selective agonist for ERbeta in the low nanomolar plasma concentrations achievable with these intakes-have potential for suppressing hepatic fibrosis, in both men and women.	1
1499	To investigate the effects of selenium on mRNA expressions of proinflammatory cytokines and inducible nitric oxide synthase (@PROTEIN$) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a @COMPOUND$-treated diabetes mellitus group.	0
1500	To investigate the effects of selenium on mRNA expressions of proinflammatory cytokines and inducible @PROTEIN$ (iNOS) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a @COMPOUND$-treated diabetes mellitus group.	0
1501	To investigate the effects of @COMPOUND$ on mRNA expressions of proinflammatory cytokines and inducible @PROTEIN$ (iNOS) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a selenite-treated diabetes mellitus group.	1
1502	To investigate the effects of @COMPOUND$ on mRNA expressions of proinflammatory cytokines and inducible nitric oxide synthase (@PROTEIN$) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a selenite-treated diabetes mellitus group.	1
1503	The results showed that pancreatic @COMPOUND$ content and @PROTEIN$.05), respectively, in selenite-treated diabetes mellitus group compared with untreated diabetes mellitus group.	0
1504	The results showed that pancreatic selenium content and @PROTEIN$.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	0
1505	Meanwhile, pancreatic mRNA expressions of proinflammatory cytokines interleukin-1beta, @PROTEIN$-alpha and interferon-gamma ; mRNA expression and activity of iNOS.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	1
1506	Meanwhile, pancreatic mRNA expressions of proinflammatory cytokines interleukin-1beta, tumor necrosis factor-alpha and interferon-gamma ; mRNA expression and activity of @PROTEIN$.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	1
1507	Meanwhile, pancreatic mRNA expressions of proinflammatory cytokines interleukin-1beta, tumor necrosis factor-alpha and @PROTEIN$ ; mRNA expression and activity of iNOS.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	1
1508	Cells were exposed to native low-density lipoprotein (LDL), acetylated LDL, and LDL that had been modified by oxidation with @COMPOUND$ or ferrous ions or by exposure to auto-oxidation products of arachidonic acid for 16h, and @PROTEIN$ was then assayed in medium.	0
1509	Cells were exposed to native low-density lipoprotein (LDL), acetylated LDL, and LDL that had been modified by oxidation with copper or ferrous ions or by exposure to auto-oxidation products of @COMPOUND$ for 16h, and @PROTEIN$ was then assayed in medium.	0
1510	Cells were exposed to native low-density lipoprotein (LDL), acetylated LDL, and LDL that had been modified by oxidation with copper or @COMPOUND$ or by exposure to auto-oxidation products of arachidonic acid for 16h, and @PROTEIN$ was then assayed in medium.	0
1511	"Participating in a significant fraction of the fundamental paths connecting the ligands to the phenotypes, cofactor @COMPOUND$ and complex Gbeta/Ggamma were identified as ""housekeeping"" molecules, through which all pathways of @PROTEIN$ network are cross-talking."	1
1512	This initiates a @COMPOUND$ signalling cascade resulting in the translocation of @PROTEIN$-bearing vesicles to the apical membrane.	1
1513	The objective of this study was to examine the effect of level and duration of feeding of an n-3 PUFA-enriched fish oil (@COMPOUND$) supplement in combination with soybean oil (SO) on the transcriptional regulation of @PROTEIN$ gene expression in bovine muscle.	1
1514	The DEP-induced increases in peribronchial eosinophils and mucous goblet cells in the lung tissues, and of @PROTEIN$ and IL-13 in the BAL fluid, were significantly attenuated by the antioxidant @COMPOUND$.	1
1515	The DEP-induced increases in peribronchial eosinophils and mucous goblet cells in the lung tissues, and of IL-5 and @PROTEIN$ in the BAL fluid, were significantly attenuated by the antioxidant @COMPOUND$.	1
1516	Each of the developed consortium has a phosphate solubilizer, @COMPOUND$ fixer, @PROTEIN$ producer, heterotrophic member and an antagonist.	0
1517	Each of the developed consortium has a @COMPOUND$ solubilizer, nitrogen fixer, @PROTEIN$ producer, heterotrophic member and an antagonist.	0
1518	Promoter analysis of the @PROTEIN$, 4, and 11 genes in HeLa cells did not reveal a cis-regulatory element responsive to @COMPOUND$ in their 5'-flanking sequences.	0
1519	@PROTEIN$- and caspase-3-mediated superoxide-induced apoptosis of rat hepatic stellate cells: reversal by @COMPOUND$.	1
1520	In vivo administration of a synthetic phospholipid, named hereafter phospho-ceramide analogue-1 (PCERA-1), was previously found to suppress @COMPOUND$ (LPS)-induced @PROTEIN$ blood levels.	1
1521	In conclusion, the anti-inflammatory activity of PCERA-1 seems to be mediated by a cell membrane receptor, upstream of @COMPOUND$ production, and eventually TNF-alpha suppression and @PROTEIN$ induction.	0
1522	In conclusion, the anti-inflammatory activity of PCERA-1 seems to be mediated by a cell membrane receptor, upstream of @COMPOUND$ production, and eventually @PROTEIN$ suppression and IL-10 induction.	0
1523	Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of @PROTEIN$-II, Beclin-1, BAG-1 and cardioprotection.	1
1524	Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of LC3-II, Beclin-1, @PROTEIN$ and cardioprotection.	1
1525	Inhibition of autophagy by treating rats with @COMPOUND$ (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of LC3-II, @PROTEIN$, BAG-1 and cardioprotection.	1
1526	When myosin molecules work as an aggregate, the sliding movement of a myosin filament driven by the power strokes of some myosin heads makes other myosin heads that have completed their power strokes detach from the @PROTEIN$ without consuming @COMPOUND$.	0
1527	A critical requirement for this mechanism is that @COMPOUND$ must preferentially facilitate the detachment of myosins that have completed their power strokes, but are still strongly attached to the @PROTEIN$.	0
1528	Efficacy, safety and patient-reported outcomes of combination @PROTEIN$ and @COMPOUND$ versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study.	0
1529	To determine the efficacy and safety of @PROTEIN$ and etanercept plus @COMPOUND$ versus sulfasalazine in patients with rheumatoid arthritis (RA) despite sulfasalazine therapy.	0
1530	Functional analysis of rat liver @PROTEIN$ promoter: differential responsiveness to @COMPOUND$.	1
1531	Due to its faculty to protect @PROTEIN$ (ChE) activity against irreversible inactivation by OP, @COMPOUND$ (PB) was used as a prophylaxis treatment during the first Persian Gulf War.	1
1532	In contrast, Notch-signaling inhibition by the @COMPOUND$ (GSI ; z-Leu-Leu-Nle-CHO) and the specific @PROTEIN$ down-regulation by small-interfering RNA accelerate spontaneous B-CLL cell apoptosis.	0
1533	Effects of exhaustion and calcium supplementation on @PROTEIN$ and @COMPOUND$ levels in athletes.	0
1534	The present study was performed to investigate the effects of strenuous exercise and calcium supplementation on @COMPOUND$ and @PROTEIN$ levels in athletes at rest and exhaustion.	0
1535	One-month supplementation with calcium does not influence the @COMPOUND$ and @PROTEIN$ 0.05).	0
1536	Later-onset congenital central hypoventilation syndrome due to a heterozygous 24-@COMPOUND$ repeat expansion mutation in the @PROTEIN$ gene.	1
1537	to describe a family with later onset congenital central hypoventilation syndrome (LO-CCHS) and heterozygosity for a 24-@COMPOUND$ repeat expansion mutation in the @PROTEIN$ gene, rendered phenotypically apparent with exposure to anesthetics.	1
1538	Effects of @COMPOUND$ on breast cancer cell migration and invasion through the @PROTEIN$ cytoskeleton.	1
1539	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), glucagon, motilin, polypeptide YY (@PROTEIN$) and insulin.	0
1540	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), @PROTEIN$, motilin, polypeptide YY (PYY) and insulin.	0
1541	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), glucagon, motilin, polypeptide YY (PYY) and @PROTEIN$.	0
1542	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), glucagon, @PROTEIN$, polypeptide YY (PYY) and insulin.	0
1543	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), glucagon, @PROTEIN$, polypeptide YY (PYY) and insulin.	0
1544	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), @PROTEIN$, motilin, polypeptide YY (PYY) and insulin.	0
1545	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), glucagon, motilin, polypeptide YY (PYY) and @PROTEIN$.	0
1546	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), glucagon, motilin, polypeptide YY (@PROTEIN$) and insulin.	0
1547	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), @PROTEIN$, motilin, polypeptide YY (PYY) and insulin.	0
1548	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), glucagon, motilin, polypeptide YY (PYY) and @PROTEIN$.	0
1549	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), glucagon, motilin, polypeptide YY (@PROTEIN$) and insulin.	0
1550	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), glucagon, @PROTEIN$, polypeptide YY (PYY) and insulin.	0
1551	In the gizzard, endocrine cells secreting @COMPOUND$, 5-HT and @PROTEIN$ were detected, while those secreting glucagon and insulin were not.	0
1552	In the gizzard, endocrine cells secreting somatostatin, @COMPOUND$ and PYY were detected, while those secreting glucagon and @PROTEIN$ were not.	0
1553	In the gizzard, endocrine cells secreting @COMPOUND$, 5-HT and PYY were detected, while those secreting @PROTEIN$ and insulin were not.	0
1554	In the gizzard, endocrine cells secreting somatostatin, @COMPOUND$ and PYY were detected, while those secreting @PROTEIN$ and insulin were not.	0
1555	In the gizzard, endocrine cells secreting somatostatin, @COMPOUND$ and @PROTEIN$ were detected, while those secreting glucagon and insulin were not.	0
1556	In the gizzard, endocrine cells secreting @COMPOUND$, 5-HT and PYY were detected, while those secreting glucagon and @PROTEIN$ were not.	0
1557	In the final part of the gizzard, endocrine cells secreting @COMPOUND$ were more frequent, and cells secreting somatostatin and @PROTEIN$ were not detected.	0
1558	In the final part of the gizzard, endocrine cells secreting 5-HT were more frequent, and cells secreting @COMPOUND$ and @PROTEIN$ were not detected.	0
1559	methoxyphenoxy)benzyl) @COMPOUND$) is a positron emission tomography (PET) radioligand recently applied in clinical studies of norepinephrine transporters (@PROTEIN$) in the human brain in vivo.	1
1560	methoxyphenoxy)benzyl) @COMPOUND$) is a positron emission tomography (PET) radioligand recently applied in clinical studies of @PROTEIN$ (NETs) in the human brain in vivo.	1
1561	The most predictive model of @PROTEIN$ response for the pediatric cohort had, as the major variables, @COMPOUND$ clearance x dialysis duration/total body water (Kt/V), urea reduction ratio (URR), intact parathyroid hormone (iPTH), blood loss, normalized protein catabolic rates (nPCR) and indices of malnutrition and inflammation, whereas adults had iron and folate deficiencies as the dominant variables.	1
1562	The most predictive model of @PROTEIN$ response for the pediatric cohort had, as the major variables, urea clearance x dialysis duration/total body water (Kt/V), urea reduction ratio (URR), intact parathyroid hormone (iPTH), blood loss, normalized protein catabolic rates (nPCR) and indices of malnutrition and inflammation, whereas adults had iron and @COMPOUND$ deficiencies as the dominant variables.	1
1563	In summary @PROTEIN$ resistance in the pediatric dialysis cohort was predicted by nutritional deficits, inflammation, poor dialysis, and hyperparathyroidism, while iron and @COMPOUND$ deficits were the major determinants in adults.	1
1564	@COMPOUND$ selectively causes Bax- and @PROTEIN$-mediated apoptosis in human lung cancer cells.	1
1565	@COMPOUND$ selectively causes @PROTEIN$- and Bak-mediated apoptosis in human lung cancer cells.	1
1566	The @COMPOUND$-mediated G2-M phase cell cycle arrest was explained by down-regulation of cyclin-dependent kinase 1 (@PROTEIN$) and cell division cycle 25C protein expression leading to accumulation of Tyr15 phosphorylated (inactive) Cdk1.	1
1567	The @COMPOUND$-mediated G2-M phase cell cycle arrest was explained by down-regulation of @PROTEIN$ (Cdk1) and cell division cycle 25C protein expression leading to accumulation of Tyr15 phosphorylated (inactive) Cdk1.	1
1568	Knockdown of Bax and @PROTEIN$ proteins conferred significant protection against @COMPOUND$-induced apoptotic cytoplasmic histone-associated DNA fragmentation.	0
1569	Knockdown of @PROTEIN$ and Bak proteins conferred significant protection against @COMPOUND$-induced apoptotic cytoplasmic histone-associated DNA fragmentation.	0
1570	In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (@COMPOUND$) are able to stimulate, in the presence of interferon-gamma (@PROTEIN$), both arginase and inducible nitric oxide synthase (iNOS) in murine Mphi.	0
1571	In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (@COMPOUND$) are able to stimulate, in the presence of interferon-gamma (IFN-gamma), both @PROTEIN$ and inducible nitric oxide synthase (iNOS) in murine Mphi.	1
1572	In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (@COMPOUND$) are able to stimulate, in the presence of @PROTEIN$ (IFN-gamma), both arginase and inducible nitric oxide synthase (iNOS) in murine Mphi.	0
1573	In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (@COMPOUND$) are able to stimulate, in the presence of interferon-gamma (IFN-gamma), both arginase and inducible @PROTEIN$ (iNOS) in murine Mphi.	1
1574	In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (@COMPOUND$) are able to stimulate, in the presence of interferon-gamma (IFN-gamma), both arginase and inducible nitric oxide synthase (@PROTEIN$) in murine Mphi.	1
1575	A significant increase in @PROTEIN$ activity was observed upon a short pre-incubation (1 hr) with IFN-gamma and subsequent @COMPOUND$ stimulation.	1
1576	A significant increase in arginase activity was observed upon a short pre-incubation (1 hr) with @PROTEIN$ and subsequent @COMPOUND$ stimulation.	0
1577	Therefore, a very interesting observation of this study was that the @COMPOUND$-mediated arginase activity is dependent on @PROTEIN$ priming.	1
1578	Therefore, a very interesting observation of this study was that the @COMPOUND$-mediated @PROTEIN$ activity is dependent on IFN-gamma priming.	1
1579	This report reveals a singular effect of the combination of @COMPOUND$ and @PROTEIN$, one of the mayor cytokines produced in response to CpG administration in vivo.	1
1580	@COMPOUND$ has a three-fold higher binding affinity for ERalpha than for @PROTEIN$.	1
1581	@COMPOUND$ has a three-fold higher binding affinity for @PROTEIN$ than for ERbeta.	1
1582	In the present study, we examined the effect of gliclazide, a second generation @COMPOUND$ with antioxidant properties, on LOX-1 expression and LOX-1-mediated @PROTEIN$ expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	0
1583	In the present study, we examined the effect of @COMPOUND$, a second generation sulfonylurea with antioxidant properties, on LOX-1 expression and LOX-1-mediated @PROTEIN$ expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	1
1584	In the present study, we examined the effect of @COMPOUND$, a second generation sulfonylurea with antioxidant properties, on @PROTEIN$ expression and LOX-1-mediated MMP-9 expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	1
1585	In the present study, we examined the effect of gliclazide, a second generation @COMPOUND$ with antioxidant properties, on @PROTEIN$ expression and LOX-1-mediated MMP-9 expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	0
1586	This was achieved by (1) direct comparison of the sensitivity of ASIC1, ASIC2, @PROTEIN$ and TRPV1 knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or @COMPOUND$.	0
1587	This was achieved by (1) direct comparison of the sensitivity of ASIC1, @PROTEIN$, ASIC3 and TRPV1 knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or @COMPOUND$.	0
1588	This was achieved by (1) direct comparison of the sensitivity of @PROTEIN$, ASIC2, ASIC3 and TRPV1 knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or @COMPOUND$.	0
1589	This was achieved by (1) direct comparison of the sensitivity of ASIC1, ASIC2, ASIC3 and @PROTEIN$ knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or @COMPOUND$.	0
1590	Following @COMPOUND$ injection, ASIC1 (-/-) and ASIC2 (-/-), but not @PROTEIN$ (-/-) or TRPV1 (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	0
1591	Following @COMPOUND$ injection, ASIC1 (-/-) and @PROTEIN$ (-/-), but not ASIC3 (-/-) or TRPV1 (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	1
1592	Following @COMPOUND$ injection, ASIC1 (-/-) and ASIC2 (-/-), but not ASIC3 (-/-) or @PROTEIN$ (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	0
1593	Following @COMPOUND$ injection, @PROTEIN$ (-/-) and ASIC2 (-/-), but not ASIC3 (-/-) or TRPV1 (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	1
1594	Circulating oxidized LDL (oxLDL) levels are strongly correlated to LDL-@COMPOUND$ (LDL-c) and apolipoprotein-B100 (@PROTEIN$), making it difficult to disentangle their independent contributions to cardiovascular risk.	0
1595	FMD of the brachial artery and plasma concentrations of oxLDL, LDL-@COMPOUND$, and @PROTEIN$ were measured in 624 men and women (age range 50 to 87 years), participating in a population-based cohort study.	0
1596	After adjustment for age, sex, @COMPOUND$ tolerance status, and Framingham risk score, the oxLDL/@PROTEIN$ ratio was negatively related to FMD (P = 0.017).	0
1597	The @PROTEIN$ isolated from the youngest group had the highest capacity to form @COMPOUND$ and AGEs under glycation in vitro.	1
1598	The patterns of nerves immunoreactive (IR) to antibodies towards serotonin (@COMPOUND$) and the invertebrate @PROTEIN$ FMRFamide are described in relation to the musculature.	0
1599	The patterns of nerves immunoreactive (IR) to antibodies towards @COMPOUND$ (5-HT) and the invertebrate neuropeptide @PROTEIN$ are described in relation to the musculature.	0
1600	The patterns of nerves immunoreactive (IR) to antibodies towards @COMPOUND$ (5-HT) and the invertebrate @PROTEIN$ FMRFamide are described in relation to the musculature.	0
1601	The patterns of nerves immunoreactive (IR) to antibodies towards serotonin (@COMPOUND$) and the invertebrate neuropeptide @PROTEIN$ are described in relation to the musculature.	0
1602	Immunotoxicity of perfluorooctanoic acid and perfluorooctane @COMPOUND$ and the role of @PROTEIN$.	0
1603	The results obtained from the Fluo-3 image experiments showed that @PROTEIN$ pretreatment of cultured neurons at a final concentration of 50, 100, or 200 ng/ml acutely and dose dependently attenuated the @COMPOUND$+) influx induced by application of KCl (60 mM) or glutamate (50 microM).	1
1604	The results obtained from the @COMPOUND$ image experiments showed that @PROTEIN$ pretreatment of cultured neurons at a final concentration of 50, 100, or 200 ng/ml acutely and dose dependently attenuated the Ca(2+) influx induced by application of KCl (60 mM) or glutamate (50 microM).	0
1605	A vitreous fraction showing @PROTEIN$ 1000 Da, consistent with @COMPOUND$.	0
1606	The secretion of endorphins, @COMPOUND$ (P(4)), human chorionic gonadotropin, 17beta-estradiol, and @PROTEIN$ by trophoblasts that lie adjacent to the embryoblast in the blastocyst suggests that these pregnancy-associated factors may directly signal the growth and development of the embryoblast.	0
1607	The secretion of endorphins, progesterone (P(4)), human chorionic gonadotropin, @COMPOUND$, and @PROTEIN$ by trophoblasts that lie adjacent to the embryoblast in the blastocyst suggests that these pregnancy-associated factors may directly signal the growth and development of the embryoblast.	0
1608	A specific @COMPOUND$-labelled probe, obtained by PCR amplification of a 270-bp fragment of the gene coding the LCDV @PROTEIN$, was used for ISH.	1
1609	No differences in estradiol, @COMPOUND$, or @PROTEIN$ plasma concentrations were observed in exposed males or females compared to controls.	0
1610	No differences in @COMPOUND$, testosterone, or @PROTEIN$ plasma concentrations were observed in exposed males or females compared to controls.	0
1611	Having compared four kinds of antibody immobilizations on Au surface, an optimized mAb 8G3 was immobilized onto the Au electrode with @PROTEIN$ on a mixed self-assembled monolayer (SAM) of @COMPOUND$ (11-MUA) and 6-mercaptohexan-1-ol (6-MHO) as adhesive layer.	0
1612	Having compared four kinds of antibody immobilizations on Au surface, an optimized mAb 8G3 was immobilized onto the Au electrode with @PROTEIN$ on a mixed self-assembled monolayer (SAM) of 11-mercaptoundecanoic acid (11-@COMPOUND$) and 6-mercaptohexan-1-ol (6-MHO) as adhesive layer.	0
1613	Having compared four kinds of antibody immobilizations on Au surface, an optimized mAb 8G3 was immobilized onto the Au electrode with @PROTEIN$ on a mixed self-assembled monolayer (SAM) of 11-mercaptoundecanoic acid (11-MUA) and 6-mercaptohexan-1-ol (6-@COMPOUND$) as adhesive layer.	0
1614	Having compared four kinds of antibody immobilizations on Au surface, an optimized mAb 8G3 was immobilized onto the Au electrode with @PROTEIN$ on a mixed self-assembled monolayer (SAM) of 11-mercaptoundecanoic acid (11-MUA) and @COMPOUND$ (6-MHO) as adhesive layer.	0
1615	@COMPOUND$ is a potent glucocorticoid with high affinity for the @PROTEIN$, which is now used for the treatment of inflammatory bowel diseases.	1
1616	Studies on the antioxidant effect and interaction of @COMPOUND$ and dicholesteroyl diselenide with hepatic @PROTEIN$ and isoforms of lactate dehydrogenase.	0
1617	Studies on the interaction of dicholesteroyl diselenide (DCDS) and @COMPOUND$ (DPDS) with hepatic @PROTEIN$ (ALA-D) and different isoforms of lactate dehydrogenase (LDH) from different tissues were investigated.	0
1618	Studies on the interaction of dicholesteroyl diselenide (DCDS) and @COMPOUND$ (DPDS) with hepatic delta-aminolevulinic acid dehydratase (ALA-D) and different isoforms of lactate dehydrogenase (@PROTEIN$) from different tissues were investigated.	0
1619	@COMPOUND$ is an effective chemo-sensitizer via @PROTEIN$ inhibition.	1
1620	@COMPOUND$ also recovered the depletion of I-kappaBalpha via @PROTEIN$ 2 inhibition, which resulted in a decrease of NF-kappaB activity in EcR293/TG cells.	1
1621	@COMPOUND$ also recovered the depletion of @PROTEIN$ via TGase 2 inhibition, which resulted in a decrease of NF-kappaB activity in EcR293/TG cells.	1
1622	This diagnosis was confirmed by genetic testing, which revealed a novel point mutation in the @PROTEIN$ gene, c.2545G--&gt;C, leading to a codon encoding for @COMPOUND$ instead of glycine (p.Gly849Arg).	1
1623	This diagnosis was confirmed by genetic testing, which revealed a novel point mutation in the @PROTEIN$ gene, c.2545G--&gt;C, leading to a codon encoding for arginine instead of @COMPOUND$ (p.Gly849Arg).	1
1624	Signaling involving @COMPOUND$ is organized in subcellular compartments and a distinct cAMP compartment might be required for proper @PROTEIN$ mobility and function.	1
1625	Engineered @COMPOUND$-containing glutaredoxin displays strong @PROTEIN$ activity rivaling natural enzyme.	0
1626	Engineered @COMPOUND$-containing @PROTEIN$ displays strong glutathione peroxidase activity rivaling natural enzyme.	1
1627	The use of a common thioredoxin fold with a high affinity for @COMPOUND$ in glutaredoxin (Grx) and @PROTEIN$ (GPx) suggests a possibility of engineering Grx into GPx and vice versa.	1
1628	The use of a common thioredoxin fold with a high affinity for @COMPOUND$ in @PROTEIN$ (Grx) and glutathione peroxidase (GPx) suggests a possibility of engineering Grx into GPx and vice versa.	1
1629	The potassium channels blockade by either @COMPOUND$ or @PROTEIN$ also resulted in a potent inhibition of HEDS-induced aortic relaxation, whereas apamine only slightly reduced it.	0
1630	The potassium channels blockade by either tetraethylammonium or @PROTEIN$ also resulted in a potent inhibition of HEDS-induced aortic relaxation, whereas @COMPOUND$ only slightly reduced it.	0
1631	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, @COMPOUND$, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1632	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of @COMPOUND$, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1633	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, @COMPOUND$ and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1634	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, @COMPOUND$, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1635	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, @COMPOUND$, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1636	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, @COMPOUND$, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1637	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, @COMPOUND$, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1638	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, @COMPOUND$, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1639	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and @COMPOUND$ ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1640	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of @COMPOUND$, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1641	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, @COMPOUND$, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1642	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, @COMPOUND$ and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1643	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, @COMPOUND$, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1644	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, @COMPOUND$, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1645	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and @COMPOUND$ ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1646	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, @COMPOUND$, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1647	The beneficial effect of DHA on the treatment groups was accompanied by decreases in blood-brain barrier disruption, brain edema, @COMPOUND$ (MDA) production, inflammatory cell infiltration, interleukin-6 (@PROTEIN$) expression and caspase-3 activity.	0
1648	The beneficial effect of DHA on the treatment groups was accompanied by decreases in blood-brain barrier disruption, brain edema, @COMPOUND$ (MDA) production, inflammatory cell infiltration, @PROTEIN$ (IL-6) expression and caspase-3 activity.	0
1649	Elevation of antioxidative capacity, as evidenced by decreased MDA level and increased @PROTEIN$ activity and @COMPOUND$ level, was detected only in the chronic daily-administration group.	0
1650	Magnesium (Mg), @PROTEIN$ (IL-8), and @COMPOUND$ levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	0
1651	Magnesium (Mg), interleukin 8 (@PROTEIN$), and @COMPOUND$ levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	0
1652	@COMPOUND$ (Mg), @PROTEIN$ (IL-8), and malondialdehyde levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	0
1653	@COMPOUND$ (Mg), interleukin 8 (@PROTEIN$), and malondialdehyde levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	0
1654	The estrogen-induced increase in @PROTEIN$ protein in MCF-7-HER2 cells was abrogated by the antiestrogen ICI 182780 and by gefitinib (@COMPOUND$ ; a phospho-tyrosine kinase inhibitor), indicating an ER-mediated effect and confirming involvement of receptor tyrosine kinases, respectively.	1
1655	The estrogen-induced increase in @PROTEIN$ protein in MCF-7-HER2 cells was abrogated by the antiestrogen ICI 182780 and by @COMPOUND$ (Iressa ; a phospho-tyrosine kinase inhibitor), indicating an ER-mediated effect and confirming involvement of receptor tyrosine kinases, respectively.	1
1656	The estrogen-induced increase in @PROTEIN$ protein in MCF-7-HER2 cells was abrogated by the antiestrogen @COMPOUND$ and by gefitinib (Iressa ; a phospho-tyrosine kinase inhibitor), indicating an ER-mediated effect and confirming involvement of receptor tyrosine kinases, respectively.	1
1657	Enzymatic activities of an H(2)O(2) independent oxidase along with @PROTEIN$ and an azoreductase suggest their prominent role during the decolorization of reactive yellow @COMPOUND$.	1
1658	Enzymatic activities of an H(2)O(2) independent oxidase along with laccase and an @PROTEIN$ suggest their prominent role during the decolorization of reactive yellow @COMPOUND$.	1
1659	@PROTEIN$ activity was prominent in presence of cofactors @COMPOUND$ and NADP in mineral salt medium.	1
1660	@PROTEIN$ activity was prominent in presence of cofactors NADH and @COMPOUND$ in mineral salt medium.	1
1661	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish peroxidase (@PROTEIN$), hydrogen peroxide, and a phenolic cosubstrate (@COMPOUND$).	1
1662	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish @PROTEIN$ (HRP), hydrogen peroxide, and a phenolic cosubstrate (@COMPOUND$).	1
1663	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish @PROTEIN$ (HRP), @COMPOUND$, and a phenolic cosubstrate (4-methoxyphenol).	1
1664	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish peroxidase (@PROTEIN$), @COMPOUND$, and a phenolic cosubstrate (4-methoxyphenol).	1
1665	Approximately 68% depletion of the parent compound and 98% depletion of its related acute aquatic toxicity are achieved in 6 h. Because no PFOA removal is observed in the absence of cosubstrate and/or following consumption thereof, we conclude that radical intermediate species generated during reaction between @PROTEIN$ and @COMPOUND$ mediate nonspecific depletion of PFOA and that these intermediates may be sufficiently reactive to sever the extremely stable C-F bonds of PFOA.	1
1666	The mechanisms may include the recently revealed anti-inflammatory effects of @PROTEIN$ as well as its conventional @COMPOUND$ and free fatty acids lowering effects, and possibly may also include changes in body fat distribution and plasma adiponectin level.	1
1667	Expression levels of the functional activities (albumin secretion and @COMPOUND$ removal) and the cell-cell adhesion molecules (cadherin and @PROTEIN$) were higher in the hepatocytes that formed spheroids compared to those which assumed a monolayer configuration, and these levels were maintained for at least 10 days.	0
1668	After 2 and 6 weeks of treatment, parotid gland was removed and total protein and @COMPOUND$ (free and total) concentration and amylase and @PROTEIN$ activities were determined.	0
1669	At week 2 of the study, parotid gland of diabetic rats presented a reduction of total protein concentration (55%) and an increase of amylase (120%) and @PROTEIN$ (160%) activities, free (150%) and total (170%) @COMPOUND$ concentration.	0
1670	A @PROTEIN$ (F2) and lipase-like materials (F1) were purified from the culture supernatant of P. monteilii TKU009 with soybean powder as the sole carbon/@COMPOUND$ source.	0
1671	Angiotensin II (@PROTEIN$) is the key peptide hormone in the renin-angiotensin-@COMPOUND$ system (RAAS).	1
1672	Angiotensin II (Ang II) is the key @PROTEIN$ in the renin-angiotensin-@COMPOUND$ system (RAAS).	1
1673	Angiotensin II (Ang II) is the key peptide hormone in the renin-@PROTEIN$-@COMPOUND$ system (RAAS).	1
1674	@PROTEIN$ (Ang II) is the key peptide hormone in the renin-angiotensin-@COMPOUND$ system (RAAS).	1
1675	@PROTEIN$ single nucleotide polymorphism G2677T/A and haplotype are correlated with response to @COMPOUND$-cisplatin chemotherapy in patients with non-small-cell lung cancer.	1
1676	Two principal signaling pathways that regulate proliferation are PI3K/@COMPOUND$/Akt and @PROTEIN$/Ras/ERK1/2.	0
1677	Two principal signaling pathways that regulate proliferation are PI3K/@COMPOUND$/Akt and Shc/@PROTEIN$/ERK1/2.	0
1678	Two principal signaling pathways that regulate proliferation are @PROTEIN$/@COMPOUND$/Akt and Shc/Ras/ERK1/2.	1
1679	Two principal signaling pathways that regulate proliferation are PI3K/@COMPOUND$/@PROTEIN$ and Shc/Ras/ERK1/2.	1
1680	Two principal signaling pathways that regulate proliferation are PI3K/@COMPOUND$/Akt and Shc/Ras/@PROTEIN$/2.	0
1681	However, @COMPOUND$ treatment resulted in intracellular accumulation of @PROTEIN$ and prevented its translocation to the cell surface.	1
1682	We report the interaction of a potent synthetic derivative of @COMPOUND$, isoxazolcurcumin (IOC) with human serum albumin (@PROTEIN$) using various biophysical methods.	1
1683	We report the interaction of a potent synthetic derivative of curcumin, isoxazolcurcumin (@COMPOUND$) with human @PROTEIN$ (HSA) using various biophysical methods.	1
1684	We report the interaction of a potent synthetic derivative of @COMPOUND$, isoxazolcurcumin (IOC) with human @PROTEIN$ (HSA) using various biophysical methods.	1
1685	We report the interaction of a potent synthetic derivative of curcumin, isoxazolcurcumin (@COMPOUND$) with human serum albumin (@PROTEIN$) using various biophysical methods.	1
1686	The observed fluorescence quenching of @PROTEIN$ by @COMPOUND$ is due to a complex formation by a static quenching process with a quenching constant of the order of 10(5) M(-1).	1
1687	From the observed Förster-type fluorescence resonance energy transfer (FRET), the donor (Trp 214 in @PROTEIN$) to acceptor (@COMPOUND$) distance is calculated to be 3.2 nm.	1
1688	The preferred binding site of IOC was analyzed by ligand displacement experiments with 1-anilino-8-naphthalenesulfonate (ANS) and @COMPOUND$-bound @PROTEIN$.	1
1689	The preferred binding site of IOC was analyzed by ligand displacement experiments with @COMPOUND$ (ANS) and warfarin-bound @PROTEIN$.	1
1690	The preferred binding site of @COMPOUND$ was analyzed by ligand displacement experiments with 1-anilino-8-naphthalenesulfonate (ANS) and warfarin-bound @PROTEIN$.	1
1691	A number of site-specific modifications of the nucleosome core histones-including the trimethylated forms of @PROTEIN$ lysines K4, K9, and @COMPOUND$-are of particular interest for postmortem research, because these marks differentiate between active and inactive chromatin and seem to remain relatively stable during tissue autolysis.	1
1692	We here demonstrate that @PROTEIN$ confers a sensitivity towards near ultraviolet (UVA) light, which rapidly causes @COMPOUND$+) entry.	1
1693	In the presence of the photosensitising agents @COMPOUND$ (100 nM) or hypericin (10 nM), the sensitivity of light-induced @PROTEIN$ activation was increased and extended towards the visible spectrum.	1
1694	In the presence of the photosensitising agents acridine orange (100 nM) or @COMPOUND$ (10 nM), the sensitivity of light-induced @PROTEIN$ activation was increased and extended towards the visible spectrum.	1
1695	Quantitative proteomics analysis of macrophage rafts reveals compartmentalized activation of the proteasome and of proteasome-mediated @PROTEIN$ activation in response to @COMPOUND$.	1
1696	@COMPOUND$ toxicity and @PROTEIN$-dependent detoxification in astrocytes.	1
1697	Lower expression of IGFBP1 and @PROTEIN$ mRNA and protein was observed in hESF from women with vs. those without endometriosis in response to @COMPOUND$, but not P4, suggesting a blunted response of these decidual biomarkers to activation of the PKA pathway in eutopic endometrium in women with disease.	1
1698	Lower expression of @PROTEIN$ and prolactin mRNA and protein was observed in hESF from women with vs. those without endometriosis in response to @COMPOUND$, but not P4, suggesting a blunted response of these decidual biomarkers to activation of the PKA pathway in eutopic endometrium in women with disease.	1
1699	Furthermore, constitutive expression of an @COMPOUND$-insensitive, active form of @PROTEIN$ protein mimicked the effects of low oxygen, inhibiting the differentiation of trophoblast giant cells.	0
1700	Effect of the inoculum size on carbapenem susceptibilities of @PROTEIN$-negative, @COMPOUND$-resistant Haemophilus influenzae.	0
1701	However, the effect of inoculum size of @PROTEIN$-negative, @COMPOUND$-resistant H. influenzae (BLNAR) on MICs for carbapenems has not been investigated.	0
1702	@COMPOUND$ has been the mainstay of endocrine therapy for @PROTEIN$-positive breast cancer.	1
1703	A subthreshold stimulation by acute pathological threatening conditions (e.g., global ischemia subthreshold for cell death) enhances neuronal @PROTEIN$ and glial Cx43 hemichannel activity, favoring @COMPOUND$ release and generation of preconditioning.	1
1704	A subthreshold stimulation by acute pathological threatening conditions (e.g., global ischemia subthreshold for cell death) enhances neuronal Cx36 and glial @PROTEIN$ hemichannel activity, favoring @COMPOUND$ release and generation of preconditioning.	1
1705	A study of rituximab and ifosfamide, carboplatin, and @COMPOUND$ chemotherapy in children with recurrent/refractory B-cell (@PROTEIN$+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.	1
1706	A study of rituximab and ifosfamide, @COMPOUND$, and etoposide chemotherapy in children with recurrent/refractory B-cell (@PROTEIN$+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.	1
1707	A study of rituximab and @COMPOUND$, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (@PROTEIN$+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.	1
1708	The inhibition of female rabbit sexual behavior by @COMPOUND$ : @PROTEIN$-dependent and-independent effects.	1
1709	The influence of @COMPOUND$, atorvastatin and high-cholesterol diet on @PROTEIN$ activity, amyloid beta and cholesterol synthesis in rat brain.	0
1710	The influence of simvastatin, @COMPOUND$ and high-cholesterol diet on @PROTEIN$ activity, amyloid beta and cholesterol synthesis in rat brain.	0
1711	The aim of this study was to investigate the effects of acute and chronic exercise on @COMPOUND$ reactive substances, as an indicator of lipid peroxidation, in the hippocampus, which has a high concentration of @PROTEIN$, and prefrontal cortex and striatum, which have high dopamine content.	0
1712	The aim of this study was to investigate the effects of acute and chronic exercise on thiobarbituric acid reactive substances, as an indicator of lipid peroxidation, in the hippocampus, which has a high concentration of @PROTEIN$, and prefrontal cortex and striatum, which have high @COMPOUND$ content.	0
1713	Additionally we examined antioxidant enzyme activities, @PROTEIN$ and glutathione peroxidase and nitrite-@COMPOUND$ levels to assess the effects of reactive oxygen and nitrogen species.	0
1714	Additionally we examined antioxidant enzyme activities, superoxide dismutase and @PROTEIN$ and nitrite-@COMPOUND$ levels to assess the effects of reactive oxygen and nitrogen species.	0
1715	Oral administration of (PhSe)(2) in rats did not change plasma alanine and @PROTEIN$ activities (AST and ALT) as well as @COMPOUND$ and creatinine levels.	0
1716	Oral administration of (PhSe)(2) in rats did not change plasma alanine and aspartate aminotransferase activities (@PROTEIN$ and ALT) as well as @COMPOUND$ and creatinine levels.	0
1717	Oral administration of (PhSe)(2) in rats did not change plasma alanine and @PROTEIN$ activities (AST and ALT) as well as urea and @COMPOUND$ levels.	0
1718	Oral administration of (PhSe)(2) in rats did not change plasma alanine and aspartate aminotransferase activities (@PROTEIN$ and ALT) as well as urea and @COMPOUND$ levels.	0
1719	Total plasma @COMPOUND$ level, @PROTEIN$ C677T polymorphism, inherited abnormalities of the natural anticoagulant system as well as plasma folate and cobalamin levels were determined.	0
1720	Total plasma homocysteine level, @PROTEIN$ C677T polymorphism, inherited abnormalities of the natural anticoagulant system as well as plasma folate and @COMPOUND$ levels were determined.	0
1721	Total plasma homocysteine level, @PROTEIN$ C677T polymorphism, inherited abnormalities of the natural anticoagulant system as well as plasma @COMPOUND$ and cobalamin levels were determined.	0
1722	The @PROTEIN$ proto-oncogene and microRNA-@COMPOUND$ comprise an active autoregulatory feedback loop in human hematopoietic cells.	1
1723	Herein we show that @PROTEIN$ expression is subject to posttranscriptional regulation by microRNA (miRNA)-@COMPOUND$.	1
1724	Exogenous expression of @PROTEIN$ mRNA lacking the 3'-UTR partially rescued the miR-@COMPOUND$ induced cell-cycle block.	1
1725	Occupancy of one canonical @PROTEIN$ binding site was demonstrated by chromatin immunoprecipitation analysis and shown to be required for miR-@COMPOUND$ expression in K562 cells.	1
1726	In aggregate, these findings suggest the presence of a @PROTEIN$-miR-@COMPOUND$ autoregulatory feedback loop of potential importance in human hematopoiesis.	1
1727	The central homeostasis is characterized by increased cerebrocortical synaptosomal T(3) content, deiodinase type II (@PROTEIN$) activity, and @COMPOUND$ content.	0
1728	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/@COMPOUND$ (GCV) therapy directed by the @PROTEIN$ (CEA) promoter.	1
1729	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/ganciclovir (@COMPOUND$) therapy directed by the carcinoembryonic antigen (@PROTEIN$) promoter.	1
1730	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/@COMPOUND$ (GCV) therapy directed by the carcinoembryonic antigen (@PROTEIN$) promoter.	1
1731	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/ganciclovir (@COMPOUND$) therapy directed by the @PROTEIN$ (CEA) promoter.	1
1732	Cytopathic effects of AxdAdB-3 plus AxCEAprTK (an adenovirus expressing HSVtk directed by CEA promoter) or AxCAHSVtk (an adenovirus expressing HSVtk directed by a nonspecific @PROTEIN$ promoter) with @COMPOUND$ administration were examined in several GBC lines and normal cells.	0
1733	Cyclophilin A (CypA), a receptor for the immunosuppressive agent @COMPOUND$ (CsA), is a cis-trans peptidyl-prolyl isomerase (@PROTEIN$) which accelerates the cis-trans isomerization of prolyl-peptide bonds, interacts with a variety of proteins and therefore regulates their activities.	0
1734	Cyclophilin A (@PROTEIN$), a receptor for the immunosuppressive agent @COMPOUND$ (CsA), is a cis-trans peptidyl-prolyl isomerase (PPIase) which accelerates the cis-trans isomerization of prolyl-peptide bonds, interacts with a variety of proteins and therefore regulates their activities.	1
1735	@PROTEIN$ (CypA), a receptor for the immunosuppressive agent @COMPOUND$ (CsA), is a cis-trans peptidyl-prolyl isomerase (PPIase) which accelerates the cis-trans isomerization of prolyl-peptide bonds, interacts with a variety of proteins and therefore regulates their activities.	1
1736	While studies have shown that @COMPOUND$ does not exhibit nonspecific actions on @PROTEIN$, its effects on steroid hormone production have not been reported.	0
1737	Augmentation of antibody responses by @COMPOUND$ and @PROTEIN$.	0
1738	@PROTEIN$ alpha is a proximal mediator of synergistic hepatotoxicity from @COMPOUND$/lipopolysaccharide coexposure.	1
1739	A small cytoplasmic protein, @PROTEIN$, has been identified in human hepatic tissue, but its role in @COMPOUND$ metabolism is unknown.	0
1740	As with @PROTEIN$, they are involved in making @COMPOUND$ available to apo-enzymes inside the cell.	1
1741	BrdU proliferation assays showed that in vivo proliferation of CD8+ T cells was reduced in @COMPOUND$-fed mice, and @PROTEIN$-dependent in vitro proliferation of naive CD8+ T cells was also reduced.	0
1742	The supernatant of the majority of the strains did not release the aglycone from @COMPOUND$, suggesting that cell-associated beta-glucosidases (beta-@PROTEIN$) are mainly responsible for the metabolism of soybean glyco-conjugates.	0
1743	The supernatant of the majority of the strains did not release the aglycone from @COMPOUND$, suggesting that cell-associated @PROTEIN$ (beta-Glu) are mainly responsible for the metabolism of soybean glyco-conjugates.	0
1744	Optimization of chitosan succinate and chitosan @COMPOUND$ microspheres for oral delivery of @PROTEIN$ using response surface methodology.	0
1745	The relative pharmacological efficacy for chitosan @COMPOUND$ and chitosan succinate microspheres (18.66+/-3.84%, 16.24+/-4%) was almost three-fold higher than the efficacy of the oral @PROTEIN$ administration (4.68+/-1.52%).	0
1746	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), @PROTEIN$ and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of @COMPOUND$, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
1747	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (@PROTEIN$), leptin and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of @COMPOUND$, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
1748	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), leptin and @PROTEIN$ receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, @COMPOUND$ and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
1749	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), @PROTEIN$ and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, @COMPOUND$ and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
1750	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (@PROTEIN$), leptin and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, @COMPOUND$ and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
1751	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), leptin and @PROTEIN$ receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of @COMPOUND$, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
1752	Pretransplant conditioning consisted of @COMPOUND$, l-@PROTEIN$ and TBI (2 Gy).	0
1753	Effects of CYP2C19 and @PROTEIN$ genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and @COMPOUND$.	0
1754	Effects of @PROTEIN$ and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and @COMPOUND$.	0
1755	Among the R-Nx strains, a substitution of @COMPOUND$ to Cys at position 81 (Gly81à Cys) of the @PROTEIN$ gene in 10 strains isolated from wild birds and ovine foetuses, and of Asp to Tyr at position 87 (Asp87à Tyr) in one strain isolated from ewe faeces, were revealed by sequencing the gene.	1
1756	We determined the plasma concentrations of tryptophan (TRP), @COMPOUND$, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn @PROTEIN$ (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1757	We determined the plasma concentrations of @COMPOUND$ (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1758	We determined the plasma concentrations of @COMPOUND$ (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn @PROTEIN$ (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1759	We determined the plasma concentrations of tryptophan (TRP), @COMPOUND$, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1760	We determined the plasma concentrations of tryptophan (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn su@COMPOUND$ dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1761	We determined the plasma concentrations of tryptophan (TRP), KYN, @COMPOUND$ (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1762	We determined the plasma concentrations of tryptophan (TRP), @COMPOUND$, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1763	We determined the plasma concentrations of tryptophan (TRP), KYN, @COMPOUND$ (3-HKYN); two distinct SOX markers: Cu/Zn @PROTEIN$ (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1764	We determined the plasma concentrations of @COMPOUND$ (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1765	We determined the plasma concentrations of tryptophan (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn su@COMPOUND$ dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1766	We determined the plasma concentrations of tryptophan (TRP), KYN, @COMPOUND$ (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1767	ESRD patients showed a significant increase in Cu/Zn @PROTEIN$, total @COMPOUND$ and hs CRP levels between controls and all patients group.	0
1768	ESRD patients showed a significant increase in Cu/Zn SOD, total @COMPOUND$ and hs @PROTEIN$ levels between controls and all patients group.	0
1769	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and @COMPOUND$ (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
1770	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (@COMPOUND$), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
1771	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (@COMPOUND$) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
1772	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (@COMPOUND$), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
1773	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and @COMPOUND$ (beta-NAD) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
1774	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of @COMPOUND$ (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
1775	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of @COMPOUND$ (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
1776	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (@COMPOUND$) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
1777	An extensive kinetic profile towards a plethora of purines and mutational analyses have established models on how @PROTEIN$ recognizes the @COMPOUND$ and revealed specific amino acid residues involved in proper folding, topogenesis, function and specificity.	1
1778	The present work describes for the first time the purification of the @PROTEIN$ transporter of A. nidulans through overexpression via the strong, @COMPOUND$-inducible, glucose-repressible, alcA promoter.	1
1779	The present work describes for the first time the purification of the @PROTEIN$ transporter of A. nidulans through overexpression via the strong, ethanol-inducible, @COMPOUND$-repressible, alcA promoter.	1
1780	The present work describes for the first time the purification of the UapA transporter of A. nidulans through overexpression via the strong, @COMPOUND$-inducible, glucose-repressible, @PROTEIN$ promoter.	1
1781	The present work describes for the first time the purification of the UapA transporter of A. nidulans through overexpression via the strong, ethanol-inducible, @COMPOUND$-repressible, @PROTEIN$ promoter.	1
1782	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), phosphomannomutase (PMM) and @PROTEIN$ (GMPP).	1
1783	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), @PROTEIN$ (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
1784	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : @PROTEIN$ (PMI), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
1785	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : @PROTEIN$ (PMI), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
1786	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), phosphomannomutase (@PROTEIN$) and GDP-mannose pyrophosphorylase (GMPP).	1
1787	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), phosphomannomutase (PMM) and @PROTEIN$ (GMPP).	1
1788	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (@PROTEIN$), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
1789	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), phosphomannomutase (@PROTEIN$) and GDP-mannose pyrophosphorylase (GMPP).	1
1790	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (@PROTEIN$), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
1791	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), @PROTEIN$ (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
1792	Synthesis of GDP-@COMPOUND$ from exogenous mannose requires @PROTEIN$ or phosphotransferase enzymes together with PMM and GMPP.	1
1793	Synthesis of GDP-@COMPOUND$ from exogenous mannose requires hexokinase or phosphotransferase enzymes together with @PROTEIN$ and GMPP.	1
1794	Clarified glycomic and protemic information combined with publicly available microarray data sets allowed us to identify @PROTEIN$ as a receptor of @COMPOUND$ epitope.	1
1795	The 2-(acylamino)-3-thiophenecarboxylates suppressed @PROTEIN$-mediated @COMPOUND$ (-) current in T84 colonic cells in response to cholera and Escherichia coli (STa) toxins, and prevented intestinal fluid accumulation in a closed-loop mouse model of secretory diarrhea.	1
1796	@PROTEIN$ and free @COMPOUND$ are independent risk factors for benign prostatic hyperplasia.	0
1797	The objective of the present study was to test the @PROTEIN$, @COMPOUND$ and metabolic syndrome hypotheses as promoters of BPH.	0
1798	Using a multivariate analysis, BPH as measured by the total prostate gland volume correlated statistically significantly with fasting serum @PROTEIN$ (beta=0.200, P=0.028), free @COMPOUND$ (beta=0.233, P=0.008) and lean body mass (beta=0.257, P=0.034).	0
1799	@PROTEIN$ and free @COMPOUND$ appear to be independent risk factors for BPH, confirming both the insulin and the oestradiol hypotheses.	0
1800	Insulin and free @COMPOUND$ appear to be independent risk factors for BPH, confirming both the @PROTEIN$ and the oestradiol hypotheses.	0
1801	@COMPOUND$ plus single-dose @PROTEIN$ glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.	0
1802	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) NHP (O) Cl2 with R = pCl-C6H4 1a, pBr-C6H4 2a, C6H5 3a, and pMe-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of @COMPOUND$, 2b and 3a, were studied.	0
1803	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) @COMPOUND$ (O) Cl2 with R = pCl-C6H4 1a, pBr-C6H4 2a, C6H5 3a, and pMe-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of compound 2a, 2b and 3a, were studied.	0
1804	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) NHP (O) Cl2 with R = pCl-C6H4 1a, @COMPOUND$-C6H4 2a, C6H5 3a, and pMe-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of compound 2a, 2b and 3a, were studied.	0
1805	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) NHP (O) Cl2 with R = pCl-C6H4 1a, pBr-C6H4 2a, C6H5 3a, and @COMPOUND$-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of compound 2a, 2b and 3a, were studied.	0
1806	The protein glycation inhibitory activity of ethanolic extract of Lawsonia inermis (henna) plant tissues was evaluated in vitro using the model system of bovine @PROTEIN$ and @COMPOUND$.	0
1807	@COMPOUND$-regulated activity of @PROTEIN$.	1
1808	The biological roles of the @COMPOUND$-regulated conformational equilibrium of @PROTEIN$ are discussed in terms of the self and non-self discrimination mechanism.	1
1809	These results underscore the differential regulation of GPX expression in response to cadmium, aluminium and @COMPOUND$, and strongly support a role for @PROTEIN$ and possibly other GPX genes in stress and/or metabolic signalling.	1
1810	These results underscore the differential regulation of @PROTEIN$ expression in response to cadmium, @COMPOUND$ and nitric oxide, and strongly support a role for GPX6 and possibly other GPX genes in stress and/or metabolic signalling.	1
1811	These results underscore the differential regulation of GPX expression in response to cadmium, @COMPOUND$ and nitric oxide, and strongly support a role for @PROTEIN$ and possibly other GPX genes in stress and/or metabolic signalling.	1
1812	These results underscore the differential regulation of @PROTEIN$ expression in response to cadmium, aluminium and @COMPOUND$, and strongly support a role for GPX6 and possibly other GPX genes in stress and/or metabolic signalling.	1
1813	@COMPOUND$ treatment significantly attenuated TNF-alpha, IL-6, and @PROTEIN$ 6 h after CLP.	1
1814	@COMPOUND$ treatment significantly attenuated TNF-alpha, @PROTEIN$, and IL-1beta 6 h after CLP.	1
1815	@COMPOUND$ treatment significantly attenuated @PROTEIN$, IL-6, and IL-1beta 6 h after CLP.	1
1816	The previous amphotericin B, @PROTEIN$, hyperbaric @COMPOUND$ and nasal and left maxillary sinus surgical debridement therapy was ineffective in stopping the progression of the infection to the brain.	0
1817	The previous @COMPOUND$, @PROTEIN$, hyperbaric oxygen and nasal and left maxillary sinus surgical debridement therapy was ineffective in stopping the progression of the infection to the brain.	0
1818	Bacterial strains differed in their ability to synthesize @COMPOUND$ and hydrogen cyanide compounds, as well as in their @PROTEIN$ activity.	0
1819	Bacterial strains differed in their ability to synthesize auxin and @COMPOUND$ compounds, as well as in their @PROTEIN$ activity.	0
1820	Model analysis of local @COMPOUND$ delivery with liposome-encapsulated @PROTEIN$.	1
1821	Liposome-encapsulated @PROTEIN$ (LHs) are comparable to red blood cells (RBCs) in terms of @COMPOUND$ (O(2))-carrying capacity.	1
1822	Moreover, both lung and plasma concentrations of the pro-inflammatory cytokines tumour necrosis factor-alpha and @PROTEIN$ were higher in @COMPOUND$-treated animals at this time-point.	1
1823	Increased intrahepatic vascular tone in cirrhosis has been attributed to a decrease of hepatic @COMPOUND$ (NO) secondary to disturbances in the post-translational regulation of the enzyme @PROTEIN$.	0
1824	Zebularine suppresses the apoptotic potential of @COMPOUND$ via cAMP/PKA/@PROTEIN$ pathway against human oral squamous cell carcinoma cells.	1
1825	Zebularine suppresses the apoptotic potential of 5-fluorouracil via @COMPOUND$/PKA/@PROTEIN$ pathway against human oral squamous cell carcinoma cells.	0
1826	Donor testicular cells were prepared from heterozygous chicken beta actin (CAG)/enhanced @PROTEIN$ (EGFP)-transgenic rats (EGFP Tg rats) during the second week after birth and injected into the seminiferous tubules of the MT-myc Tg rats (line-A and-B; both subfertile) or rats pretreated with @COMPOUND$ to remove endogenous spermatogonia.	0
1827	Donor testicular cells were prepared from heterozygous chicken beta actin (@PROTEIN$)/enhanced green fluorescent protein (EGFP)-transgenic rats (EGFP Tg rats) during the second week after birth and injected into the seminiferous tubules of the MT-myc Tg rats (line-A and-B; both subfertile) or rats pretreated with @COMPOUND$ to remove endogenous spermatogonia.	0
1828	Donor testicular cells were prepared from heterozygous chicken @PROTEIN$ (CAG)/enhanced green fluorescent protein (EGFP)-transgenic rats (EGFP Tg rats) during the second week after birth and injected into the seminiferous tubules of the MT-myc Tg rats (line-A and-B; both subfertile) or rats pretreated with @COMPOUND$ to remove endogenous spermatogonia.	0
1829	In the present work, the activity of the enzymes xylose reductase (XR); @COMPOUND$ dehydrogenase (XD); and glucose-6-phosphate dehydrogenase (@PROTEIN$) during cultivation of Candida guilliermondii on rice straw hemicellulosic hydrolysate was measured and correlated with xylitol production under different pH values (around 4.5 and 7.5) and initial xylose concentration (around 30 and 70 g l(-1)).	1
1830	In the present work, the activity of the enzymes @PROTEIN$ (XR); @COMPOUND$ dehydrogenase (XD); and glucose-6-phosphate dehydrogenase (G6PD) during cultivation of Candida guilliermondii on rice straw hemicellulosic hydrolysate was measured and correlated with xylitol production under different pH values (around 4.5 and 7.5) and initial xylose concentration (around 30 and 70 g l(-1)).	1
1831	The order of the cytotoxicity of the compounds was; IV &gt; III &gt; II &gt; I &gt; V. @COMPOUND$, had the highest Hammett and log P values (0.23 and 4.21, respectively) and exerted both highest cytotoxicity and strongest @PROTEIN$ inhibition.	1
1832	Tests were carried out on cell cultures of human keratinocytes and mouse 3T3 fibroblasts incubated with radiolabeled acetate, and on homogenates prepared from yeast cells expressing human @PROTEIN$, incubated with radiolabeled @COMPOUND$.	0
1833	Inhibition of rat liver @PROTEIN$ and L by the peptide aldehyde @COMPOUND$ and its analogues.	1
1834	The concentration required for 50% inhibition (IC(50)) by @COMPOUND$ was 88 nM for cathepsin B and 163 nM for @PROTEIN$.	1
1835	The concentration required for 50% inhibition (IC(50)) by @COMPOUND$ was 88 nM for @PROTEIN$ and 163 nM for cathepsin L.	1
1836	@COMPOUND$, a newer anticonvulsant, does not undergo @PROTEIN$ metabolism and does not alter the pharmacokinetics of chemotherapy, antiemetics, and corticosteroids, which are metabolized by the liver.	0
1837	@PROTEIN$ is responsible for the sulfation and inactivation of @COMPOUND$ (E2) at physiological concentrations.	1
1838	In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by staurosporine (STS) abolished ((3)H) @COMPOUND$ (3) binding and @PROTEIN$ protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis.	0
1839	In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by @COMPOUND$ (STS) abolished ((3)H) 1,25-dihydroxy vitamin D (3) binding and @PROTEIN$ protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis.	0
1840	The @COMPOUND$-enhanced degradation of @PROTEIN$ involves both proteasomal and lysosomal activities.	1
1841	As this effect might be related to deregulation of @PROTEIN$ (Cx43) synthesis, trafficking, or degradation, we investigated the impact of @COMPOUND$ on these events.	1
1842	As this effect might be related to deregulation of connexin 43 (@PROTEIN$) synthesis, trafficking, or degradation, we investigated the impact of @COMPOUND$ on these events.	1
1843	Inhibition of either proteasomes or lysosomes with their specific inhibitors largely restored total @PROTEIN$ protein levels, thus suggesting that both proteasomes and lysosomes may participate in the @COMPOUND$-enhanced Cx43 internalization and degradation.	1
1844	Finally, @COMPOUND$ also interfered with restoration of gap junction plaques following the inhibition of @PROTEIN$ transport to plasma membrane.	1
1845	Taken together, multiple modes of action seem to contribute to downregulation of @PROTEIN$ in @COMPOUND$-treated rat liver epithelial cells.	1
1846	@COMPOUND$ demonstrates potent inhibition of @PROTEIN$-4 activity with excellent tolerability at doses of up to and including 200 mg qd.	1
1847	The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with @COMPOUND$ or @PROTEIN$ receptor with 2-methyl-6-(phenylethynyl)-pyridine (MPEP).	0
1848	The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with MK-801 or @PROTEIN$ receptor with 2-methyl-6-(phenylethynyl)-pyridine (@COMPOUND$).	1
1849	The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with MK-801 or @PROTEIN$ receptor with @COMPOUND$ (MPEP).	1
1850	The CL(int) was obtained using either individual or combined cofactors for cytochrome P450 (P450) and UGT enzymes with @COMPOUND$ activation and in the presence and absence of 2% bovine serum albumin (@PROTEIN$).	0
1851	The CL(int) was obtained using either individual or combined cofactors for cytochrome P450 (P450) and UGT enzymes with @COMPOUND$ activation and in the presence and absence of 2% bovine @PROTEIN$ (BSA).	0
1852	@PROTEIN$ has been identified as an endoplasmic reticulum (ER)-resident @COMPOUND$+) sensor that regulates store-operated calcium entry (SOCE) in immune cells and platelets, but the identity of the platelet SOC channel has remained elusive.	1
1853	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between @COMPOUND$-clavulanate and cefotaxime, ceftriaxone, ceftazidime and aztreonam.	1
1854	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, ceftriaxone, @COMPOUND$ and aztreonam.	1
1855	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and @COMPOUND$, ceftriaxone, ceftazidime and aztreonam.	1
1856	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, @COMPOUND$, ceftazidime and aztreonam.	1
1857	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, ceftriaxone, ceftazidime and @COMPOUND$.	1
1858	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-@COMPOUND$ and cefotaxime, ceftriaxone, ceftazidime and aztreonam.	1
1859	Mitochondrial @PROTEIN$ (ALDH-2)--maker of and marker for nitrate tolerance in response to @COMPOUND$ treatment.	1
1860	Mitochondrial aldehyde dehydrogenase (@PROTEIN$-2)--maker of and marker for nitrate tolerance in response to @COMPOUND$ treatment.	1
1861	Mitochondrial aldehyde dehydrogenase (@PROTEIN$-2)--maker of and marker for @COMPOUND$ tolerance in response to nitroglycerin treatment.	1
1862	Mitochondrial @PROTEIN$ (ALDH-2)--maker of and marker for @COMPOUND$ tolerance in response to nitroglycerin treatment.	1
1863	According to the oxidative stress concept, increased vascular @COMPOUND$ and peroxynitrite production as well as an increased sensitivity to vasoconstrictors secondary to activation of @PROTEIN$ as well as vascular NADPH oxidases contribute to the development of tolerance.	0
1864	According to the oxidative stress concept, increased vascular superoxide and @COMPOUND$ production as well as an increased sensitivity to vasoconstrictors secondary to activation of @PROTEIN$ as well as vascular NADPH oxidases contribute to the development of tolerance.	0
1865	mitochondrial aldehyde dehydrogenase (@PROTEIN$-2)) and mitochondria as potential sources of reactive @COMPOUND$ species (ROS).	0
1866	mitochondrial @PROTEIN$ (ALDH-2)) and mitochondria as potential sources of reactive @COMPOUND$ species (ROS).	0
1867	Finally, we will address the question whether @PROTEIN$-2 inactivation by nitroglycerin could be a useful marker for clinical nitrate tolerance and discuss the redox-regulation of this enzyme by oxidative stress and @COMPOUND$.	0
1868	Finally, we will address the question whether @PROTEIN$-2 inactivation by @COMPOUND$ could be a useful marker for clinical nitrate tolerance and discuss the redox-regulation of this enzyme by oxidative stress and dihydrolipoic acid.	0
1869	Finally, we will address the question whether @PROTEIN$-2 inactivation by nitroglycerin could be a useful marker for clinical @COMPOUND$ tolerance and discuss the redox-regulation of this enzyme by oxidative stress and dihydrolipoic acid.	0
1870	Examination of @COMPOUND$-induced expression of the small heat shock protein gene, @PROTEIN$, in Xenopus laevis A6 kidney epithelial cells.	1
1871	In the present study, we have characterized the effect of @COMPOUND$ on the accumulation of the small heat shock protein (@PROTEIN$), HSP30, in Xenopus laevis A6 kidney epithelial cells.	1
1872	In the present study, we have characterized the effect of @COMPOUND$ on the accumulation of the small heat shock protein (HSP), @PROTEIN$, in Xenopus laevis A6 kidney epithelial cells.	1
1873	Immunocytochemical analysis of @COMPOUND$-treated A6 cells revealed @PROTEIN$ accumulation primarily in the cytoplasm in a punctate pattern supplemented with larger HSP30 staining structures.	1
1874	Also, @PROTEIN$ co-localized with the F-actin cytoskeleton at higher @COMPOUND$ concentrations.	1
1875	Also, HSP30 co-localized with the F-@PROTEIN$ cytoskeleton at higher @COMPOUND$ concentrations.	0
1876	Cloning, expression, and characterization of @COMPOUND$-induced @PROTEIN$ from the earthworms Metaphire posthuma and Polypheretima elongata.	1
1877	In this study we report the sequences of @PROTEIN$ cDNA from two species of Megascoleidae earthworms, Metaphire posthuma and Polypheretima elongata, by mRNA differential display after exposure of the organisms to @COMPOUND$.	1
1878	Complementary (c)DNA was verified as the @PROTEIN$ gene by the characteristics of its predicted translation product, namely a high @COMPOUND$ content, conserved CXC motifs, and a molecular weight of around 8 kDa.	1
1879	These earthworms could be used to evaluate heavy-metal pollution in soil due to the inducible @PROTEIN$ by @COMPOUND$ exposure.	1
1880	Despite the reciprocal relationship that exists between inflammation and thrombosis, we asked whether thrombosis can develop without inflammation, and whether stress-related hormones (@PROTEIN$ and @COMPOUND$) influence platelet-mediated thrombosis.	0
1881	Surprisingly, no role of @PROTEIN$/2 or STAT-3 was found in the protein-mediated protection of hepatocytes during @COMPOUND$ exposure.	0
1882	Surprisingly, no role of ERK1/2 or @PROTEIN$-3 was found in the protein-mediated protection of hepatocytes during @COMPOUND$ exposure.	0
1883	Furthermore, increased production of high inducible nitric oxide synthase (iNOS) and @PROTEIN$ (COX-2) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1
1884	Furthermore, increased production of high inducible @PROTEIN$ (iNOS) and cyclooxygenase 2 (COX-2) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1
1885	Furthermore, increased production of high inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (@PROTEIN$) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1
1886	Furthermore, increased production of high inducible nitric oxide synthase (@PROTEIN$) and cyclooxygenase 2 (COX-2) expressions were detected in the hippocampus and cerebral cortex of @COMPOUND$ and cholesterol co-treated mice by immunohistochemical analysis.	1
1887	After intravenous administration of either DOTAP/@COMPOUND$ or DOTMA/cholesterol liposomes, serum @PROTEIN$ and ALT levels were normal, suggesting that liver injury as well as cytokine production was caused by lipoplexes, but not by cationic liposomes.	0
1888	After intravenous administration of either DOTAP/cholesterol or @COMPOUND$/cholesterol liposomes, serum @PROTEIN$ and ALT levels were normal, suggesting that liver injury as well as cytokine production was caused by lipoplexes, but not by cationic liposomes.	0
1889	After intravenous administration of either @COMPOUND$/cholesterol or DOTMA/cholesterol liposomes, serum @PROTEIN$ and ALT levels were normal, suggesting that liver injury as well as cytokine production was caused by lipoplexes, but not by cationic liposomes.	0
1890	@COMPOUND$ was the most potent regulator of @PROTEIN$ affinity, with concentrations of 5 mmol L(-1) causing an increase in p(50) from 5 to 19 mm Hg at pH 7.5, while the order of potency of the other phosphates was IHP&gt;ATP&gt;BPG.	1
1891	The objective of this study was to determine: (i) the prevalence of resistance in current clinical isolates of Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Moraxella catarrhalis and Klebsiella pneumoniae; (ii) the prevalence of production of extended-spectrum @PROTEIN$ (ESBLs) and @COMPOUND$ resistance in S. aureus; and (iii) regional differences in the prevalence of ESBL production and clonality of K. pneumoniae isolates.	1
1892	Together, these results provide compelling evidence that @PROTEIN$ does not have a klotho-independent role in the regulation of systemic phosphate and @COMPOUND$ homeostasis.	0
1893	By conducting this initial screen on EMT6 cells and applying protein function and genomic structure criteria to genes identified as upregulated in response to @COMPOUND$/TSA, we were able to identify two characterized breast cancer TSGs (Timp3 and Rprm) and four putative TSGs (Atp1B2, @PROTEIN$, FoxJ1 and Smpd3) silenced in this line.	1
1894	By conducting this initial screen on EMT6 cells and applying protein function and genomic structure criteria to genes identified as upregulated in response to @COMPOUND$/TSA, we were able to identify two characterized breast cancer TSGs (@PROTEIN$ and Rprm) and four putative TSGs (Atp1B2, Dusp2, FoxJ1 and Smpd3) silenced in this line.	1
1895	By conducting this initial screen on EMT6 cells and applying protein function and genomic structure criteria to genes identified as upregulated in response to @COMPOUND$/TSA, we were able to identify two characterized breast cancer TSGs (Timp3 and Rprm) and four putative TSGs (Atp1B2, Dusp2, @PROTEIN$ and Smpd3) silenced in this line.	1
1896	By conducting this initial screen on EMT6 cells and applying protein function and genomic structure criteria to genes identified as upregulated in response to @COMPOUND$/TSA, we were able to identify two characterized breast cancer TSGs (Timp3 and Rprm) and four putative TSGs (Atp1B2, Dusp2, FoxJ1 and @PROTEIN$) silenced in this line.	1
1897	Urinary concentrations of @COMPOUND$, dihydrogenistein, O-desmethylangolensin, and equol exceeded @PROTEIN$ aglycone equivalents.	0
1898	Urinary concentrations of dihydrodaidzein, dihydrogenistein, O-desmethylangolensin, and @COMPOUND$ exceeded @PROTEIN$ aglycone equivalents.	0
1899	Urinary concentrations of dihydrodaidzein, dihydrogenistein, @COMPOUND$, and equol exceeded @PROTEIN$ aglycone equivalents.	0
1900	Urinary concentrations of dihydrodaidzein, @COMPOUND$, O-desmethylangolensin, and equol exceeded @PROTEIN$ aglycone equivalents.	0
1901	Concentrations of @COMPOUND$, @PROTEIN$, C-peptide, nonesterified fatty acids, triacylglycerol, total and exogenous glucose kinetics were assessed for 6 h postprandially.	0
1902	After 120 min, @COMPOUND$ and @PROTEIN$ responses declined, but remained higher after the Pol 0.05) in parallel to the inhibition of lipolysis.	0
1903	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1904	Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1905	Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1906	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1907	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1908	Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1909	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1910	Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1911	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1912	Furthermore, NaHS enhanced inhibitory effects of @COMPOUND$, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1913	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1914	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1915	Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1916	Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1917	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), @COMPOUND$ (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1918	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (@PROTEIN$), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1919	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (@COMPOUND$), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1920	Furthermore, NaHS enhanced inhibitory effects of apocynin, @COMPOUND$ (NAC), reduced glutathione (GSH), catalase (@PROTEIN$), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1921	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), @PROTEIN$ (CAT), superoxide dismutase (SOD), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1922	Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), @PROTEIN$ (SOD), Nomega-nitro-@COMPOUND$ (L-NAME) on ROS production and redox enzymes levels induced by Met.	0
1923	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via gonadotropin-releasing hormone (@PROTEIN$), luteinizing hormone (LH) and testosterone/@COMPOUND$ (Te/E(2)).	0
1924	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via @PROTEIN$ (GnRH), luteinizing hormone (LH) and testosterone/@COMPOUND$ (Te/E(2)).	0
1925	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via @PROTEIN$ (GnRH), luteinizing hormone (LH) and @COMPOUND$/estradiol (Te/E(2)).	0
1926	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via gonadotropin-releasing hormone (@PROTEIN$), luteinizing hormone (LH) and @COMPOUND$/estradiol (Te/E(2)).	0
1927	The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the @PROTEIN$ (CD39) and the ecto-5'-nucleotidase (CD73).	1
1928	The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the ecto-apyrase (@PROTEIN$) and the ecto-5'-nucleotidase (CD73).	1
1929	The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the ecto-apyrase (CD39) and the @PROTEIN$ (CD73).	1
1930	Critical role of @PROTEIN$ in prostacyclin production by human endothelial cells under modification of @COMPOUND$ tone.	0
1931	Critical role of @PROTEIN$ in @COMPOUND$ production by human endothelial cells under modification of hydroperoxide tone.	1
1932	We aimed at evaluating the relative contribution of cyclooxygenase (@PROTEIN$)-1 and COX-2 to the synthesis of prostacyclin in endothelial cells under static conditions in the presence or absence of exogenous @COMPOUND$ and/or altered intracellular redox balance.	0
1933	We aimed at evaluating the relative contribution of cyclooxygenase (COX)-1 and @PROTEIN$ to the synthesis of prostacyclin in endothelial cells under static conditions in the presence or absence of exogenous @COMPOUND$ and/or altered intracellular redox balance.	0
1934	We aimed at evaluating the relative contribution of cyclooxygenase (COX)-1 and @PROTEIN$ to the synthesis of @COMPOUND$ in endothelial cells under static conditions in the presence or absence of exogenous arachidonic acid and/or altered intracellular redox balance.	1
1935	We aimed at evaluating the relative contribution of cyclooxygenase (@PROTEIN$)-1 and COX-2 to the synthesis of @COMPOUND$ in endothelial cells under static conditions in the presence or absence of exogenous arachidonic acid and/or altered intracellular redox balance.	1
1936	Mechanism-based inactivation of @PROTEIN$ by tienilic acid and (+/-)-@COMPOUND$ : a comparison of kinetics and probe substrate selection.	1
1937	Mechanism-based inactivation of @PROTEIN$ by @COMPOUND$ and (+/-)-suprofen : a comparison of kinetics and probe substrate selection.	1
1938	In vitro experiments were conducted to compare k(inact), K(I) and inactivation efficiency (k(inact)/K(I)) of @PROTEIN$ (P450) 2C9 by @COMPOUND$ and (+/-)-suprofen using (S)-flurbiprofen, diclofenac, and (S)-warfarin as reporter substrates.	1
1939	In vitro experiments were conducted to compare k(inact), K(I) and inactivation efficiency (k(inact)/K(I)) of @PROTEIN$ (P450) 2C9 by tienilic acid and (+/-)-@COMPOUND$ using (S)-flurbiprofen, diclofenac, and (S)-warfarin as reporter substrates.	1
1940	At the end of treatment, BMI, WHR, HbA1c, fasting @COMPOUND$, @PROTEIN$, HOMA-IR, alanine aminotransferase values decreased in both groups.	0
1941	The anterior pituitary gland contains five types of cells secreting specific hormones (growth hormone, @PROTEIN$ (ACTH), gonadotropic hormone, prolactin, and thyroid-stimulating hormone), and the double staining results indicated that @COMPOUND$ is localized to the ACTH-secreting cells.	0
1942	The anterior pituitary gland contains five types of cells secreting specific hormones (growth hormone, adrenocorticotropic hormone (ACTH), gonadotropic hormone, @PROTEIN$, and thyroid-stimulating hormone), and the double staining results indicated that @COMPOUND$ is localized to the ACTH-secreting cells.	0
1943	The anterior pituitary gland contains five types of cells secreting specific hormones (@PROTEIN$, adrenocorticotropic hormone (ACTH), gonadotropic hormone, prolactin, and thyroid-stimulating hormone), and the double staining results indicated that @COMPOUND$ is localized to the ACTH-secreting cells.	0
1944	By combining endosperm @PROTEIN$/SDH suppression with embryo LKR/SDH suppression through crosses, the @COMPOUND$ level in embryo was reduced and resulted in higher lysine accumulation in mature kernels.	1
1945	By combining endosperm LKR/@PROTEIN$ suppression with embryo LKR/SDH suppression through crosses, the @COMPOUND$ level in embryo was reduced and resulted in higher lysine accumulation in mature kernels.	1
1946	Resistin, an adipokine-linked obesity with type 2 diabetes, impairs @COMPOUND$-stimulated @PROTEIN$ secretion (GSIS) in beta-cells.	1
1947	Light stimulates @COMPOUND$ hydrolysis via the G-protein @PROTEIN$, which directly binds to and activates phosphodiesterase.	1
1948	In addition, @PROTEIN$ facilitates bi-directional flux of @COMPOUND$ by modifying the phospholipid content of the plasma membrane.	1
1949	Overall, @PROTEIN$ is the cell surface receptor responsible for selective uptake of lipoprotein @COMPOUND$ and its ultimate delivery to sites of hormone synthesis in steroidogenic tissues.	1
1950	This effect is independent of any change in neutrophil adhesion or adhesion molecule expression but is related to the ability of statins to reduce @COMPOUND$-induced @PROTEIN$ activity in neutrophils.	1
1951	This was confirmed by the ability of the @PROTEIN$ precursor @COMPOUND$ to rescue the statin-mediated reduction in neutrophil transendothelial migration.	1
1952	@PROTEIN$ as an alternative to @COMPOUND$ in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.	0
1953	@PROTEIN$ cytokine profile may be related to the risk of the vaginal erosions following placement of @COMPOUND$ meshes.	1
1954	These results suggest that @COMPOUND$ by activation of ERK1/2 and @PROTEIN$/Akt signal pathways protects SH-SY5Y cells from H(2)O(2)-induced apoptosis.	1
1955	These results suggest that @COMPOUND$ by activation of @PROTEIN$/2 and PI3K/Akt signal pathways protects SH-SY5Y cells from H(2)O(2)-induced apoptosis.	1
1956	These results suggest that @COMPOUND$ by activation of ERK1/2 and PI3K/@PROTEIN$ signal pathways protects SH-SY5Y cells from H(2)O(2)-induced apoptosis.	1
1957	This decrease was not modified by @PROTEIN$ or @COMPOUND$, demonstrating that ONOO (-) was responsible for the effect.	0
1958	This decrease was not modified by @PROTEIN$ or Trolox, demonstrating that @COMPOUND$ (-) was responsible for the effect.	0
1959	Profile of serum @PROTEIN$ and IL-10 shortly after ovariectomy and @COMPOUND$ replacement in rats.	0
1960	Profile of serum IL-1beta and @PROTEIN$ shortly after ovariectomy and @COMPOUND$ replacement in rats.	0
1961	A low plasma @PROTEIN$ @COMPOUND$ (HDL-c) concentration is an important risk factor for the development of atherosclerotic cardiovascular disease.	1
1962	The different mechanisms might be explained by the different sensitivity of @PROTEIN$ isoforms to Ca2+, @COMPOUND$+, and Ba2+.	1
1963	The transcription factors @PROTEIN$ and retinoid X receptors participate in @COMPOUND$-induced locomotor activities.	1
1964	We now show that treatment of cells with phosphomimic @PROTEIN$ (uPA138E/303E, @COMPOUND$ 138 and 303 substituted with glutamic acid) strongly inhibits matrix-induced cell migration.	1
1965	The nuclear NF-kappaB @PROTEIN$ expression after treatment with the SFN-@COMPOUND$ combination was also evaluated by western blot analysis.	0
1966	Treatment ACCs cells with SFN and @COMPOUND$ in combination, led to synergistic inhibition on cell growth and a decreased expression in nuclear NF-kappaB @PROTEIN$ protein.	1
1967	Our results demonstrate synergism between SFN and @COMPOUND$ at higher doses against the ACC-M and ACC-2 cells, which was associated with the decreased expression of nuclear NF-kappaB @PROTEIN$ protein.	1
1968	Human genetic diseases that affect N-glycosylation result from the defective synthesis of the N-linked sugar moiety (@COMPOUND$) of @PROTEIN$.	1
1969	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (@PROTEIN$, catalase, glutathione peroxidase, glutathione-S-transferase and @COMPOUND$).	0
1970	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, catalase, glutathione peroxidase, @PROTEIN$ and @COMPOUND$).	0
1971	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, @PROTEIN$, glutathione peroxidase, glutathione-S-transferase and @COMPOUND$).	0
1972	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, catalase, @PROTEIN$, glutathione-S-transferase and @COMPOUND$).	0
1973	Antiobesity effect of @COMPOUND$ involves the @PROTEIN$ and PPAR-gamma signal pathways.	1
1974	Antiobesity effect of @COMPOUND$ involves the AMPK and @PROTEIN$ signal pathways.	1
1975	This inhibitory effect of @COMPOUND$ on adipocyte differentiation was accompanied by @PROTEIN$ inhibition in rosiglitazone-treated cells.	1
1976	Taken together, these results suggest that the antiobesity effect of red ginseng rich constituent, @COMPOUND$, involves the @PROTEIN$ signaling pathway and PPAR-gamma inhibition.	1
1977	Taken together, these results suggest that the antiobesity effect of red ginseng rich constituent, @COMPOUND$, involves the AMPK signaling pathway and @PROTEIN$ inhibition.	1
1978	Experiments using a classical inhibitor of phosphotyrosine @PROTEIN$, @COMPOUND$, also showed that the ecto-phosphatase activity was inhibited in a dose-dependent manner.	1
1979	Circulating @COMPOUND$, adiponectin, leptin, @PROTEIN$, hsCRP and insulin levels were determined both at baseline and after TLC intervention and statin treatment.	0
1980	Circulating @COMPOUND$, adiponectin, leptin, TNF-alpha, hsCRP and @PROTEIN$ levels were determined both at baseline and after TLC intervention and statin treatment.	0
1981	Circulating @COMPOUND$, adiponectin, @PROTEIN$, TNF-alpha, hsCRP and insulin levels were determined both at baseline and after TLC intervention and statin treatment.	0
1982	VEGF, @PROTEIN$ and @COMPOUND$ levels in exhaled breath condensate and serum of patients with lung cancer.	0
1983	@PROTEIN$, TNF-alpha and @COMPOUND$ levels in exhaled breath condensate and serum of patients with lung cancer.	0
1984	The aim of the present study was to evaluate the levels of VEGF, @COMPOUND$ and @PROTEIN$ in EBC and serum of patients with primary lung cancer prior to the initiation of any treatment, in order to evaluate their possible diagnostic role.	0
1985	The aim of the present study was to evaluate the levels of @PROTEIN$, @COMPOUND$ and TNF-alpha in EBC and serum of patients with primary lung cancer prior to the initiation of any treatment, in order to evaluate their possible diagnostic role.	0
1986	Furthermore, associations between VEGF, @COMPOUND$ and @PROTEIN$ levels in EBC and serum with clinicopathologic factors were investigated.	0
1987	Furthermore, associations between @PROTEIN$, @COMPOUND$ and TNF-alpha levels in EBC and serum with clinicopathologic factors were investigated.	0
1988	@PROTEIN$, VEGF and @COMPOUND$ levels in EBC and serum were analyzed by an immunoenzymatic method (ELISA).	0
1989	TNF-alpha, @PROTEIN$ and @COMPOUND$ levels in EBC and serum were analyzed by an immunoenzymatic method (ELISA).	0
1990	Currently, adreno-corticotrophic hormone (@PROTEIN$), steroids and @COMPOUND$ (VGB) form the mainstay of its treatment.	0
1991	The addition of a protein kinase C (PKC) activator, @COMPOUND$, rescued PhIP-inhibited @PROTEIN$ expression in LTA-stimulated cells.	1
1992	This action was mimicked solely by 100 nm CH-275, a selective agonist at the somatostatin type 1 receptor (@PROTEIN$), but not by 100 nm BIM-23027, L-362855, or @COMPOUND$ ; agonists selective for the other four SSTRs known to exist in MIN6.	0
1993	The aim of this study was to assess in rats the effect of protein feeding on the: 1) distribution of endogenous @COMPOUND$ production (EGP) among gluconeogenic organs, and 2) repercussion on the @PROTEIN$ sensitivity of glucose metabolism.	1
1994	Transcription of @PROTEIN$ in the rodent ovary and placenta: alternative modes of @COMPOUND$ dependent and independent regulation.	1
1995	The substrate for the synthesis of all steroid hormones is cholesterol, and its conversion to the first steroid, @COMPOUND$, by the cholesterol side-chain cleavage cytochrome P450 (@PROTEIN$) enzyme complex takes place in the inner mitochondrial membranes.	1
1996	The substrate for the synthesis of all steroid hormones is cholesterol, and its conversion to the first steroid, @COMPOUND$, by the cholesterol side-chain cleavage @PROTEIN$ (CYP11A1) enzyme complex takes place in the inner mitochondrial membranes.	1
1997	Collectively, these studies identify a novel role for @COMPOUND$ (3) and the @PROTEIN$ in the control of adipocyte metabolism and lipid storage in vivo.	0
1998	Most cells contain @COMPOUND$ sulfoxide reductases, which catalyze a @PROTEIN$-dependent reduction of methionine sulfoxide back to methionine.	1
1999	The intracellular free methionine and @COMPOUND$ pools were not altered, nor was the specific activity of the key enzyme, @PROTEIN$.	0
2000	The intracellular free @COMPOUND$ and S-adenosylmethionine pools were not altered, nor was the specific activity of the key enzyme, @PROTEIN$.	0
2001	MIN6 cells excreted insulin, @PROTEIN$, @COMPOUND$ and ghrelin.	0
2002	MIN6 cells excreted insulin, glucagon, @COMPOUND$ and @PROTEIN$.	0
2003	They expressed mRNAs of insulin I and II, proglucagon, @COMPOUND$, @PROTEIN$ (PP) and ghrelin which were shown in the mouse pancreatic islet core and periphery obtained by LCM.	0
2004	They expressed mRNAs of insulin I and II, proglucagon, @COMPOUND$, pancreatic polypeptide (PP) and @PROTEIN$ which were shown in the mouse pancreatic islet core and periphery obtained by LCM.	0
2005	They expressed mRNAs of @PROTEIN$ I and II, proglucagon, @COMPOUND$, pancreatic polypeptide (PP) and ghrelin which were shown in the mouse pancreatic islet core and periphery obtained by LCM.	0
2006	@PROTEIN$, @COMPOUND$ and ghrelin were detectable in the culture medium.	0
2007	Glucagon, @COMPOUND$ and @PROTEIN$ were detectable in the culture medium.	0
2008	We measured pain using a visual analog pain scale at five time points in 0-48 h, oxycodone use for pain, @COMPOUND$ for fever, C-reactive protein (@PROTEIN$), and total and percent gammadeltaT-cells.	0
2009	Association between @PROTEIN$ resistance, @COMPOUND$ intolerance, and hypertension in pregnancy.	0
2010	These results suggest that @PROTEIN$ resistance and relative @COMPOUND$ intolerance are associated with an increased risk of new-onset hypertension in pregnancy, particularly preeclampsia, and support the hypothesis that insulin resistance may play a role in the pathogenesis of this disorder.	0
2011	Quantum chemical studies for oxidation of @COMPOUND$ by @PROTEIN$.	1
2012	Since @COMPOUND$ oxidation has recently been shown to involve @PROTEIN$, the study on its mechanism at molecular level using quantum chemical calculations for the model of cytochrome active site is reported here.	1
2013	Pretreatment with oligonol diminished the levels of proliferating cell nuclear antigen and expression of @PROTEIN$ in papillomas and carcinomas, respectively, as compared to @COMPOUND$ plus TPA treatment alone.	1
2014	Pretreatment with oligonol diminished the levels of @PROTEIN$ and expression of COX-2 in papillomas and carcinomas, respectively, as compared to @COMPOUND$ plus TPA treatment alone.	1
2015	Euthyroid animals with a palpation score &gt;or=3 were significantly older, had higher body weights, lower alkaline phosphatase, alanine aminotransferase, phosphate, and urine specific gravity, but higher @PROTEIN$ and @COMPOUND$ concentrations than hyperthyroid cats.	0
2016	Euthyroid animals with a palpation score &gt;or=3 were significantly older, had higher body weights, lower alkaline phosphatase, alanine aminotransferase, @COMPOUND$, and urine specific gravity, but higher @PROTEIN$ and creatinine concentrations than hyperthyroid cats.	0
2017	Euthyroid animals with a palpation score &gt;or=3 were significantly older, had higher body weights, lower @PROTEIN$, alanine aminotransferase, @COMPOUND$, and urine specific gravity, but higher lipase and creatinine concentrations than hyperthyroid cats.	0
2018	Euthyroid animals with a palpation score &gt;or=3 were significantly older, had higher body weights, lower @PROTEIN$, alanine aminotransferase, phosphate, and urine specific gravity, but higher lipase and @COMPOUND$ concentrations than hyperthyroid cats.	0
2019	Cocaine stimulated @PROTEIN$, @COMPOUND$, and LH, whereas cocaine+nalbuphine in combination produced a smaller increase in ACTH, and decreased cortisol and LH.	0
2020	Thus it appears that nalbuphine attenuated cocaine's effects on @PROTEIN$, @COMPOUND$, and LH.	0
2021	In this work we show that in FaO rat hepatoma cells inhibition of the @PROTEIN$ (EGFR) with the tyrphostin @COMPOUND$ enhances TGF-beta-induced cell death, coincident with an elevated increase in ROS production and GSH depletion.	1
2022	In this work we show that in FaO rat hepatoma cells inhibition of the epidermal growth factor receptor (@PROTEIN$) with the tyrphostin @COMPOUND$ enhances TGF-beta-induced cell death, coincident with an elevated increase in ROS production and GSH depletion.	1
2023	A substrate regeneration cycle coupling @PROTEIN$ with l-@COMPOUND$ (AsA: 0, 1.0, 3.0, 10.0 and 50.0 mmol/l; as reducing reagent system) was applied to the chemo-mechanical reaction unit in order to amplify the output signal of the tonometric biosensor.	0
2024	In the present work we studied the effect of @PROTEIN$ and-3 on neuronal @COMPOUND$ release and the short-term regulation of tyrosine hydroxylase in the olfactory bulb.	0
2025	Results showed that both endothelins increased tyrosine hydroxylase activity through the activation of a non-conventional endothelin G-protein coupled receptor, coupled to the stimulation of @PROTEIN$ and C, as well as @COMPOUND$+)/calmodulin-dependent protein kinase II.	0
2026	Results showed that both endothelins increased tyrosine hydroxylase activity through the activation of a non-conventional endothelin G-protein coupled receptor, coupled to the stimulation of @PROTEIN$ A and C, as well as @COMPOUND$+)/calmodulin-dependent protein kinase II.	0
2027	Results showed that both endothelins increased tyrosine hydroxylase activity through the activation of a non-conventional endothelin G-protein coupled receptor, coupled to the stimulation of protein kinase A and C, as well as @COMPOUND$+)/@PROTEIN$-dependent protein kinase II.	1
2028	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0
2029	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione S-transferase (GST) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0
2030	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes @PROTEIN$ (SOD), catalase (CAT), glutathione S-transferase (GST) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0
2031	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione S-transferase (GST) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0
2032	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione S-transferase (GST) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0
2033	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST) and @PROTEIN$ (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0
2034	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (@PROTEIN$) and glutathione reductase (GR), as well as the non-enzymatic antioxidants glutathione (@COMPOUND$) and serum urate.	0
2035	@PROTEIN$ receptors are membrane cation channels gated by extracellular @COMPOUND$.	1
2036	End-point measures were HOMA (homoeostasis model assessment)-IR, androgens, lipids, inflammatory markers (hsCRP (high-sensitivity C-reactive protein)) and endothelial function (FMD (flow-mediated dilation), ADMA (@COMPOUND$), PAI-1 (plasminogen activator inhibitor-1) and vWF (@PROTEIN$)).	0
2037	End-point measures were HOMA (homoeostasis model assessment)-IR, androgens, lipids, inflammatory markers (hsCRP (high-sensitivity C-reactive protein)) and endothelial function (FMD (flow-mediated dilation), @COMPOUND$ (asymmetric dimethylarginine), PAI-1 (plasminogen activator inhibitor-1) and vWF (@PROTEIN$)).	0
2038	While the three @PROTEIN$ isotypes showed comparable Km and k(cat) for L-serine and acetyl-CoA, they showed remarkable differences in their sensitivity to inhibition by @COMPOUND$.	1
2039	While the three @PROTEIN$ isotypes showed comparable Km and k(cat) for @COMPOUND$ and acetyl-CoA, they showed remarkable differences in their sensitivity to inhibition by L-cysteine.	1
2040	We propose that multiple @PROTEIN$ isotypes with different properties may play complementary roles in the regulation of the @COMPOUND$ biosynthetic pathway in E. histolytica under different conditions, e.g.	1
2041	Spermine oxidase (@PROTEIN$) is a FAD-containing enzyme involved in animal cell polyamines (PA) homeostasis, selectively active on @COMPOUND$ and producing H(2)O(2), spermidine, and the 3-aminopropanal.	1
2042	@PROTEIN$ (SMO) is a FAD-containing enzyme involved in animal cell polyamines (PA) homeostasis, selectively active on @COMPOUND$ and producing H(2)O(2), spermidine, and the 3-aminopropanal.	1
2043	Pretreatment with DEX abrogated @PROTEIN$ inhibition by sst (2)-preferring analogue @COMPOUND$ in TT.	1
2044	@COMPOUND$ and DHEA-sulfate response to rapid adrenocorticotropic hormone (@PROTEIN$) stimulation was inadequate.	0
2045	Cortisol and @COMPOUND$ response to rapid @PROTEIN$ (ACTH) stimulation was inadequate.	0
2046	Cortisol and @COMPOUND$ response to rapid adrenocorticotropic hormone (@PROTEIN$) stimulation was inadequate.	0
2047	@COMPOUND$ and DHEA-sulfate response to rapid @PROTEIN$ (ACTH) stimulation was inadequate.	0
2048	Treatment of RPE cells with high @COMPOUND$-induced a significant increased of @PROTEIN$, accompanied by an increase in cell damage, NO and nitrotyrosine levels.	1
2049	High @COMPOUND$ causes increased cell damage and NO generation in RPE cells by a process of @PROTEIN$ expression that requires the activation of p38MAPK and ERK.	1
2050	High @COMPOUND$ causes increased cell damage and NO generation in RPE cells by a process of iNOS expression that requires the activation of p38MAPK and @PROTEIN$.	0
2051	High @COMPOUND$ causes increased cell damage and NO generation in RPE cells by a process of iNOS expression that requires the activation of @PROTEIN$ and ERK.	0
2052	A crude peel extract and purified fraction of Flemingia vestita, as well as a crude rhizome extract of Stephania glabra and fractions were tested with respect to the activity of @PROTEIN$, NO efflux and @COMPOUND$ concentration in the cestode Raillietina echinobothrida in order to find out the possible mode of anthelmintic action of these plant-derived components.	0
2053	In this study, we describe the crystal structure of yeast @PROTEIN$ in complex with @COMPOUND$ (chitobiose).	1
2054	Mutagenesis studies confirm the critical role of the @COMPOUND$-interacting residues in substrate binding and suggest that efficient oligosaccharide binding is required for @PROTEIN$ activity.	1
2055	Prediction of the effect of erythromycin, @COMPOUND$, and their metabolites, alone and in combination, on @PROTEIN$ inhibition.	0
2056	Prediction of the effect of @COMPOUND$, diltiazem, and their metabolites, alone and in combination, on @PROTEIN$ inhibition.	0
2057	@PROTEIN$ is involved in @COMPOUND$-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines.	1
2058	Both @PROTEIN$ and PKA are effectors of the second messenger @COMPOUND$.	1
2059	Since a polypeptide lacking the @COMPOUND$-rich region (P-region) of @PROTEIN$ (103Q) cannot form aggresomes, this domain serves as an aggresome-targeting signal.	1
2060	The COMT enzyme breaks down extracellular @COMPOUND$ (DA) and has a particularly important role in the prefrontal cortex (PFC) where @PROTEIN$ are sparse.	1
2061	The @PROTEIN$ enzyme breaks down extracellular @COMPOUND$ (DA) and has a particularly important role in the prefrontal cortex (PFC) where DA transporters are sparse.	1
2062	Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and @PROTEIN$-mediated @COMPOUND$ uptake in healthy obese subjects.	1
2063	The purpose of this study was to propose a new preparation method to fabricate @PROTEIN$-loaded poly(lactic-coglycolic acid) (@COMPOUND$) microparticles satisfying protein loading, release profiles, burst release, and particularly stability of the encapsulated protein.	1
2064	This injury induces central sensitization leading to tactile allodynia and is mediated by activation of @COMPOUND$+) permeable AMPA/kainate receptors through @PROTEIN$ and PKA.	1
2065	Stimulation of choline @PROTEIN$ by @COMPOUND$, a neural cell adhesion molecule ligand.	1
2066	This is the first @PROTEIN$ with a known primary structure and a glutamine instead of @COMPOUND$ residue at position 179 in the highly conserved-6 subsite, shown to be involved in substrate binding.	1
2067	This is the first @PROTEIN$ with a known primary structure and a @COMPOUND$ instead of glycine residue at position 179 in the highly conserved-6 subsite, shown to be involved in substrate binding.	1
2068	Functional @PROTEIN$ is not required for macrophage @COMPOUND$ efflux to human serum.	0
2069	Treatment with acidified saline reduced fetal basal pH from 7.35+/-0.01 to 7.29+/-0.01 but did not alter basal cardiovascular variables, blood @COMPOUND$, or plasma concentrations of catecholamines, @PROTEIN$, and cortisol.	0
2070	Treatment with acidified saline reduced fetal basal pH from 7.35+/-0.01 to 7.29+/-0.01 but did not alter basal cardiovascular variables, blood glucose, or plasma concentrations of catecholamines, @PROTEIN$, and @COMPOUND$.	0
2071	During hypoxemia, treatment with acidified saline increased the magnitude of the fetal bradycardia and femoral vasoconstriction and concomitantly increased chemoreflex function and enhanced the increments in plasma concentrations of catecholamines, @PROTEIN$, and @COMPOUND$.	0
2072	The induction of @PROTEIN$ by YC-1 was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo(4,3-alpha)quinozalin-1-one (ODQ) or by the protein kinase pyrimidin-4-ylamine (@COMPOUND$).	0
2073	The induction of @PROTEIN$ by @COMPOUND$ was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo(4,3-alpha)quinozalin-1-one (ODQ) or by the protein kinase pyrimidin-4-ylamine (BAY 41-2272).	1
2074	The induction of @PROTEIN$ by YC-1 was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo(4,3-alpha)quinozalin-1-one (ODQ) or by the protein kinase @COMPOUND$ (BAY 41-2272).	0
2075	The induction of @PROTEIN$ by YC-1 was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo(4,3-alpha)quinozalin-1-one (@COMPOUND$) or by the protein kinase pyrimidin-4-ylamine (BAY 41-2272).	0
2076	Although no significant change in the apparent K(m) was revealed in animals that exhibited an escalation in the rate of cocaine intake, an increased @COMPOUND$ uptake rate was found suggesting an upregulation of @PROTEIN$ number in response to a history of high cocaine intake.	1
2077	Gas exchange was monitored and blood samples were collected during exercise for GH, @PROTEIN$, insulin, and blood glucose and @COMPOUND$ determination.	0
2078	Gas exchange was monitored and blood samples were collected during exercise for GH, ACTH, @PROTEIN$, and blood @COMPOUND$ and lactate determination.	0
2079	Gas exchange was monitored and blood samples were collected during exercise for GH, ACTH, @PROTEIN$, and blood glucose and @COMPOUND$ determination.	0
2080	Gas exchange was monitored and blood samples were collected during exercise for GH, @PROTEIN$, insulin, and blood @COMPOUND$ and lactate determination.	0
2081	Plasma levels of @COMPOUND$, cortisol, and @PROTEIN$ were measured.	0
2082	Plasma levels of citalopram, @COMPOUND$, and @PROTEIN$ were measured.	0
2083	An increase in @COMPOUND$ and @PROTEIN$ concentrations was observed from the EOI until 60 min after the EOI.	0
2084	Different lag-time of pulse-released nerve growth factor (@PROTEIN$) from genipin-crosslinked gelatin within @COMPOUND$ (PCL) conduits was evaluated in large-gap peripheral nerve repair.	0
2085	Different lag-time of pulse-released nerve growth factor (@PROTEIN$) from @COMPOUND$-crosslinked gelatin within polycaprolactone (PCL) conduits was evaluated in large-gap peripheral nerve repair.	0
2086	In this study, 10% (w/v) gelatin was mixed with @PROTEIN$, crosslinked with 0%, 0.1%, 0.5%, and 1% (w/v) @COMPOUND$, and then sucked into the wall of PCL conduits.	0
2087	It was found from this group that @COMPOUND$ was the best alternative to warfarin for examining the interactions of drugs at Sudlow site I on @PROTEIN$.	1
2088	However, the ethyl ester of commipheric acid (150 mg/kg, twice daily) lowered fasting blood @COMPOUND$ and plasma @PROTEIN$, and plasma triglycerides without affecting food intake or body weight.	0
2089	Identification of Aldh1a, @PROTEIN$ and RAR orthologs in protostomes pushes back the @COMPOUND$ genetic machinery in evolutionary time to the bilaterian ancestor.	1
2090	As release of @COMPOUND$ can be a rate-limiting step for @PROTEIN$ activity, NADH binding was evaluated for R166wt and R166H enzymes.	1
2091	@COMPOUND$ is the most powerful intracellular antioxidant and plays a role in the detoxification of a variety of electrophilic compounds and peroxides via catalysis by glutathione-S-transferases (@PROTEIN$) and glutathione peroxidases (GPx).	1
2092	@COMPOUND$ is the most powerful intracellular antioxidant and plays a role in the detoxification of a variety of electrophilic compounds and peroxides via catalysis by glutathione-S-transferases (GST) and @PROTEIN$ (GPx).	1
2093	@COMPOUND$ is the most powerful intracellular antioxidant and plays a role in the detoxification of a variety of electrophilic compounds and peroxides via catalysis by @PROTEIN$ (GST) and glutathione peroxidases (GPx).	1
2094	Peripheral @PROTEIN$ gastroprotection against @COMPOUND$ : the role of exendin, NO, CGRP, prostaglandins and blood flow.	0
2095	Peripheral GLP-1 gastroprotection against @COMPOUND$ : the role of exendin, NO, @PROTEIN$, prostaglandins and blood flow.	0
2096	@COMPOUND$ was administered through an orogastric cannula right after the injection of @PROTEIN$ (1, 10, 100, 1000 or 10,000 ng/kg; i.p.).	0
2097	It inhibited Trypanosoma brucei @PROTEIN$ with an IC(50) value of 240 microM and has been shown to be a competitive reversible inhibitor (Ki=200+/-10 microM) of this enzyme with respect to its cofactor @COMPOUND$ (+).	1
2098	We have also described LD between @PROTEIN$ alleles and HLA class II DRB1 allelic groups and found significant LD between DRB104-G01B, DRB113-G010401, DRB114-G010108, DRB115-@COMPOUND$, DRB103-G0101A and DRB103-G01B.	0
2099	We have also described LD between HLA-G alleles and HLA class II @PROTEIN$ allelic groups and found significant LD between DRB104-G01B, DRB113-G010401, DRB114-G010108, DRB115-@COMPOUND$, DRB103-G0101A and DRB103-G01B.	0
2100	It is suggested that in this animal model, characterized by TSH elevation and low-grade inflammation, an increased expression and function of @PROTEIN$, resulting in @COMPOUND$ generation, accounts for an impaired NO availability.	1
2101	Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates @PROTEIN$ resistance and @COMPOUND$ intolerance in obese mice.	0
2102	These changes were associated with an alleviation of hyperglycemia, @COMPOUND$ intolerance, and @PROTEIN$ resistance.	0
2103	Vernakalant was metabolized rapidly via 4-O-demethylation by @PROTEIN$ (CYP)2D6 to its major metabolite RSD1385, which then circulated predominantly as an inactive @COMPOUND$ conjugate.	0
2104	Vernakalant was metabolized rapidly via 4-O-demethylation by cytochrome P450 (@PROTEIN$)2D6 to its major metabolite RSD1385, which then circulated predominantly as an inactive @COMPOUND$ conjugate.	0
2105	Thus, CS-mediated down-regulation of @PROTEIN$ in human macrophages and lung epithelial cells in vitro and in mouse lung in vivo involves the induction of @COMPOUND$/threonine phosphorylation and proteasomal degradation, which may have implications for steroid resistance and abnormal inflammation caused by cigarette smoke.	0
2106	Thus, CS-mediated down-regulation of @PROTEIN$ in human macrophages and lung epithelial cells in vitro and in mouse lung in vivo involves the induction of serine/@COMPOUND$ phosphorylation and proteasomal degradation, which may have implications for steroid resistance and abnormal inflammation caused by cigarette smoke.	0
2107	Immunofluorescence microscopy of live human umbilical vein endothelial cells showed that @PROTEIN$ multimers rapidly formed strings several hundred micrometers long on the cell surface after stimulation with @COMPOUND$.	1
2108	Soluble P-selectin reduced the number of platelet-decorated @PROTEIN$ strings in the absence of @COMPOUND$+) and Mg(2+) but had no effect in the presence of these cations.	1
2109	The capacity for osmotic adjustment, superoxide dismutase (@PROTEIN$) and ascorbate peroxidase (APX) activities and @COMPOUND$ content were also elevated in the transgenic Arabidopsis plants.	0
2110	The capacity for osmotic adjustment, superoxide dismutase (SOD) and ascorbate peroxidase (@PROTEIN$) activities and @COMPOUND$ content were also elevated in the transgenic Arabidopsis plants.	0
2111	The capacity for osmotic adjustment, @PROTEIN$ (SOD) and ascorbate peroxidase (APX) activities and @COMPOUND$ content were also elevated in the transgenic Arabidopsis plants.	0
2112	To prevent the effects of interfering anionic species, such as uric acid and ascorbic acid, on the sensor response, the Pt-Ir electrode was coated with @COMPOUND$, and then @PROTEIN$ was immobilized on the coated electrode.	0
2113	To prevent the effects of interfering anionic species, such as @COMPOUND$ and ascorbic acid, on the sensor response, the Pt-Ir electrode was coated with Nafion, and then @PROTEIN$ was immobilized on the coated electrode.	0
2114	To prevent the effects of interfering anionic species, such as uric acid and @COMPOUND$, on the sensor response, the Pt-Ir electrode was coated with Nafion, and then @PROTEIN$ was immobilized on the coated electrode.	0
2115	Serum free @COMPOUND$ in association with @PROTEIN$ as a diagnostic marker of acute myocardial infarction.	1
2116	The aim of this study was to monitor the level of serum free @COMPOUND$ in combination with @PROTEIN$ (Myo) and creatine kinase (total activity and CK-MB level) for usefulness as a predictor of AMI in ICU patients.	0
2117	L-@COMPOUND$ was the most effective promoter of @PROTEIN$ absorption compared with others CPPs.	1
2118	A dose-dependent relationship of L-@COMPOUND$ and @PROTEIN$ bioavailability was statically significant.	1
2119	There was no significant difference in the release of @PROTEIN$ in nasal lavage fluid and the integrity of nasal respiratory epithelium when L-@COMPOUND$ was present.	0
2120	Pharmacological stimulation of @PROTEIN$ channels with @COMPOUND$ (10 nM) selectively enhanced the frequency of glutamate-mediated spontaneous (sEPSCs) and miniature excitatory postsynaptic currents (mEPSCs) recorded from putative striatal medium spiny neurons.	1
2121	Consistently, the totality of striatal neurons responded to capsaicin (10 nM or 10 microM) after prevention of desensitization of @PROTEIN$ channels with the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (@COMPOUND$).	1
2122	Consistently, the totality of striatal neurons responded to @COMPOUND$ (10 nM or 10 microM) after prevention of desensitization of @PROTEIN$ channels with the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA).	1
2123	Consistently, the totality of striatal neurons responded to capsaicin (10 nM or 10 microM) after prevention of desensitization of @PROTEIN$ channels with the protein kinase C (PKC) activator @COMPOUND$ (PMA).	1
2124	The effects of capsaicin and of @COMPOUND$ were absent after pharmacological or genetic inactivation of @PROTEIN$ channels.	1
2125	The effects of @COMPOUND$ and of PMA were absent after pharmacological or genetic inactivation of @PROTEIN$ channels.	1
2126	Finally, we provided evidence for @COMPOUND$ as an endovanilloid substance in the striatum, since genetic inhibition of anandamide degradation resulted in a tonic activation of @PROTEIN$ channels modulating glutamate but not GABA release.	1
2127	The cellular response to dsRNA or its synthetic analog @COMPOUND$ (poly I:C) results in IRF-3-, @PROTEIN$- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	1
2128	The cellular response to dsRNA or its synthetic analog polyinosinic-polycytidylic acid (@COMPOUND$) results in @PROTEIN$-, IRF-7- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	1
2129	The cellular response to dsRNA or its synthetic analog @COMPOUND$ (poly I:C) results in @PROTEIN$-, IRF-7- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	1
2130	The cellular response to dsRNA or its synthetic analog polyinosinic-polycytidylic acid (@COMPOUND$) results in IRF-3-, @PROTEIN$- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	1
2131	Fluoroimmunoassay based on the fluorescent property of quantum dot was used along with immunoassay to detect 2,4-D. CdTe capped with mercaptopropionic acid, was conjugated using N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) and a coupling reagent like @COMPOUND$ (NHS) to alkaline phosphatase (@PROTEIN$) which was in turn conjugated to 2,4-D molecule.	1
2132	Fluoroimmunoassay based on the fluorescent property of quantum dot was used along with immunoassay to detect 2,4-D. CdTe capped with mercaptopropionic acid, was conjugated using N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) and a coupling reagent like @COMPOUND$ (NHS) to @PROTEIN$ (ALP) which was in turn conjugated to 2,4-D molecule.	1
2133	@PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0
2134	Superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0
2135	@PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0
2136	Superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0
2137	Superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0
2138	Superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0
2139	Superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0
2140	Superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0
2141	Superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GSH-Px) activities as well as @COMPOUND$ reactive substances (TBARSs) and nitric oxide (NO) levels were analysed in erythrocyte and plasma of rats.	0
2142	Superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GSH-Px) activities as well as thiobarbituric acid reactive substances (TBARSs) and @COMPOUND$ (NO) levels were analysed in erythrocyte and plasma of rats.	0
2143	The erythrocyte @PROTEIN$ activity was higher in @COMPOUND$ group and there was a statistically significant increase, when compared with the erdosteine plus ischemia/reperfusion group.	1
2144	A search of publicly available microarray data reveals that expression of mitochondrial manganese superoxide dismutase (@PROTEIN$), responsible for the conversion of superoxide (O(2)(-)) to @COMPOUND$ (H(2)O(2)), is consistently increased in high-grade and advanced-stage bladder tumors.	1
2145	A search of publicly available microarray data reveals that expression of mitochondrial manganese @PROTEIN$ (Sod2), responsible for the conversion of superoxide (O(2)(-)) to @COMPOUND$ (H(2)O(2)), is consistently increased in high-grade and advanced-stage bladder tumors.	1
2146	In vivo @PROTEIN$ blockade by @COMPOUND$ significantly increased infarct volumes at 24 h in mice undergoing 30 min of transient middle cerebral artery occlusion (tMCAO).	1
2147	Glutathione S-transferases (@PROTEIN$) are multifunctional phase II detoxification enzymes that catalyze the attachment of electrophilic substrates to @COMPOUND$.	1
2148	@PROTEIN$ (GSTs) are multifunctional phase II detoxification enzymes that catalyze the attachment of electrophilic substrates to @COMPOUND$.	1
2149	The mechanism of lysoPAF-mediated inhibition of neutrophils involves an elevation in the intracellular @COMPOUND$ level, and pharmacological blockade of @PROTEIN$ completely reverses the inhibitory effect of lysoPAF.	1
2150	Sympathetic neurogenic Ca2+ signalling in rat arteries: ATP, @COMPOUND$ and @PROTEIN$.	0
2151	Sympathetic neurogenic Ca2+ signalling in rat arteries: @COMPOUND$, noradrenaline and @PROTEIN$.	0
2152	The effect of tropomyosin on @PROTEIN$ filaments was independent of ionic strength, but became stronger as the @COMPOUND$ concentration increased.	1
2153	The effect of @PROTEIN$ on actin filaments was independent of ionic strength, but became stronger as the @COMPOUND$ concentration increased.	1
2154	Activation of Bax and @PROTEIN$ was demonstrated in peripheral blood mononuclear cells, and induction of apoptosis was related to overall @COMPOUND$ exposure, as monitored by the plasma concentration of oligonucleosomal DNA/histone complexes.	0
2155	Activation of @PROTEIN$ and Bak was demonstrated in peripheral blood mononuclear cells, and induction of apoptosis was related to overall @COMPOUND$ exposure, as monitored by the plasma concentration of oligonucleosomal DNA/histone complexes.	0
2156	The acyl @PROTEIN$ peptide features a unique post-translational modification of O-n-octanoylation at @COMPOUND$ 3, and is the only gastrointestinal signal that increases meal size.	1
2157	Tests of the blood samples obtained at the ED revealed leucocytosis (11 070.6+/-4302.5/microl), increased blood @COMPOUND$, @PROTEIN$, CK and CK-MB levels.	0
2158	Age-associated impairment of @PROTEIN$ phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through PI3 kinase, PTEN, and PP2A.	1
2159	Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through PI3 kinase, @PROTEIN$, and PP2A.	1
2160	Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through @PROTEIN$, PTEN, and PP2A.	1
2161	Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through PI3 kinase, PTEN, and @PROTEIN$.	1
2162	Unfolding and inactivation of abalone (Haliotis diversicolor) @PROTEIN$ during denaturation by @COMPOUND$.	1
2163	Unfolding and inactivation of @PROTEIN$ from abalone (Haliotis diversicolor) during denaturation by @COMPOUND$ (GuHCl) of different concentrations has first been studied.	1
2164	An efficient electrocatalytic biosensor for sulfite detection was developed by co-immobilizing sulfite oxidase and @PROTEIN$ with polyaniline @COMPOUND$ in a layer-by-layer assembly.	0
2165	An efficient electrocatalytic biosensor for sulfite detection was developed by co-immobilizing @PROTEIN$ and cytochrome c with polyaniline @COMPOUND$ in a layer-by-layer assembly.	0
2166	Eukaryotes plus their archaebacterial sisters form the clade neomura, which evolved from a radically modified derivative of an actinobacterial posibacterium that had replaced the ancestral eubacterial murein peptidoglycan by N-linked @PROTEIN$, radically modified its DNA-handling enzymes, and evolved cotranslational protein secretion, but not the isoprenoid-@COMPOUND$ lipids of archaebacteria.	0
2167	Eukaryotes plus their archaebacterial sisters form the clade neomura, which evolved from a radically modified derivative of an actinobacterial posibacterium that had replaced the ancestral eubacterial murein @COMPOUND$ by N-linked @PROTEIN$, radically modified its DNA-handling enzymes, and evolved cotranslational protein secretion, but not the isoprenoid-ether lipids of archaebacteria.	1
2168	@COMPOUND$, a new inhibitor of non-apoptotic death, rescued cells from death by @PROTEIN$, although the effect was also partial and temporary.	1
2169	In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of CYP11A1, HSD3B1, @PROTEIN$ and oxytocin transcripts was reduced.	1
2170	In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of @PROTEIN$, HSD3B1, CYP19A1 and oxytocin transcripts was reduced.	1
2171	In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of CYP11A1, @PROTEIN$, CYP19A1 and oxytocin transcripts was reduced.	1
2172	In granulosa-lutein cells, STAR transcript abundance was not affected by @PROTEIN$, whereas @COMPOUND$-induced expression of CYP11A1, HSD3B1, CYP19A1 and oxytocin transcripts was reduced.	1
2173	In granulosa-lutein cells, STAR transcript abundance was not affected by BMP6, whereas @COMPOUND$-induced expression of CYP11A1, HSD3B1, CYP19A1 and @PROTEIN$ transcripts was reduced.	1
2174	In both cell types, follistatin attenuated the suppressive effect of activin A and @PROTEIN$ on @COMPOUND$-induced P4 secretion but had no effect alone.	1
2175	ETEC infection also caused a drastic inhibition of host @PROTEIN$ activity, as measured by @COMPOUND$ fluorescence.	0
2176	The purified enzymes were a monomer with an apparent molecular mass of 32 kDa (Chi32) and 46 kDa (Chi46), respectively, and showed @PROTEIN$ activity bands with 0.01% @COMPOUND$ chitin as a substrate after SDS-PAGE.	0
2177	Possible relation of @COMPOUND$-induced @PROTEIN$ expression to the upregulation of VEGF and BDNF mRNA levels in rat C6 glioma cells.	1
2178	Possible relation of @COMPOUND$-induced HO-1 expression to the upregulation of @PROTEIN$ and BDNF mRNA levels in rat C6 glioma cells.	1
2179	Possible relation of @COMPOUND$-induced HO-1 expression to the upregulation of VEGF and @PROTEIN$ mRNA levels in rat C6 glioma cells.	1
2180	Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding @PROTEIN$ (HO-1), vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1
2181	Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding heme oxygenase-1 (@PROTEIN$), vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1
2182	Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding heme oxygenase-1 (HO-1), vascular endothelial growth factor (VEGF), and @PROTEIN$ (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1
2183	Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding heme oxygenase-1 (HO-1), vascular endothelial growth factor (@PROTEIN$), and brain-derived neurotrophic factor (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1
2184	Based on this hypothetical idea, the direct effect of @COMPOUND$ on the expression of genes encoding heme oxygenase-1 (HO-1), vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (@PROTEIN$) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	1
2185	@COMPOUND$ is a pesticide whose acute toxicity is due to inhibition of @PROTEIN$.	1
2186	The inducible form of @PROTEIN$ (NOS2) plays an important role in sepsis incurred as a result of infection with Gram-negative bacteria that elaborate @COMPOUND$.	1
2187	The inducible form of nitric oxide synthase (@PROTEIN$) plays an important role in sepsis incurred as a result of infection with Gram-negative bacteria that elaborate @COMPOUND$.	1
2188	TP53, BCL-2 and @PROTEIN$ analysis in 199 ovarian cancer patients treated with @COMPOUND$-platinum regimens.	0
2189	TP53, @PROTEIN$ and BAX analysis in 199 ovarian cancer patients treated with taxane-@COMPOUND$ regimens.	0
2190	TP53, BCL-2 and @PROTEIN$ analysis in 199 ovarian cancer patients treated with taxane-@COMPOUND$ regimens.	0
2191	TP53, @PROTEIN$ and BAX analysis in 199 ovarian cancer patients treated with @COMPOUND$-platinum regimens.	0
2192	@PROTEIN$, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with taxane-@COMPOUND$ regimens.	0
2193	@PROTEIN$, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with @COMPOUND$-platinum regimens.	0
2194	@PROTEIN$, an intracellular sensor of bacteria-derived @COMPOUND$ (MDP) has been implicated as a key player in intestinal immune health and disease.	1
2195	Exposure of HEK293 cells to BK produced a concentration-dependent rise in intracellular Ca(2+) (EC(50)=36.5+/-8.0 x 10(-9)M), a rapid increase in @COMPOUND$ phosphorylation of @PROTEIN$ (EC(50)=9.8+/-0.4 x 10(-9)M), and elevation in ECAR by approximately 20%.	1
2196	@PROTEIN$ expression coupled with infusion of the IGF binding protein inhibitor @COMPOUND$ significantly prevented corticospinal motor neuron death 0.05), but did not promote corticospinal axon regeneration.	1
2197	A significant decrease was observed in GABA (A) alpha(1), @PROTEIN$ (67), and CRF, but not NR2A, mRNAs in adult rats that consumed @COMPOUND$ in comparison to controls.	1
2198	A significant decrease was observed in GABA (A) alpha(1), GAD (67), and CRF, but not @PROTEIN$, mRNAs in adult rats that consumed @COMPOUND$ in comparison to controls.	0
2199	A significant decrease was observed in @COMPOUND$ (A) alpha(1), GAD (67), and CRF, but not @PROTEIN$, mRNAs in adult rats that consumed ethanol in comparison to controls.	0
2200	A significant decrease was observed in GABA (A) alpha(1), GAD (67), and @PROTEIN$, but not NR2A, mRNAs in adult rats that consumed @COMPOUND$ in comparison to controls.	1
2201	A significant decrease was observed in @COMPOUND$ (A) alpha(1), GAD (67), and @PROTEIN$, but not NR2A, mRNAs in adult rats that consumed ethanol in comparison to controls.	0
2202	A significant decrease was observed in @COMPOUND$ (A) alpha(1), @PROTEIN$ (67), and CRF, but not NR2A, mRNAs in adult rats that consumed ethanol in comparison to controls.	0
2203	We showed previously that activation of the angiotensin type 1 receptor (AT1R), which belongs to the G protein-coupled receptor (GPCR) family, leads to c-Src-dependent @COMPOUND$ phosphorylation of beta2-adaptin, a subunit of the clathrin adaptor @PROTEIN$.	1
2204	We showed previously that activation of the angiotensin type 1 receptor (AT1R), which belongs to the G protein-coupled receptor (GPCR) family, leads to @PROTEIN$-dependent @COMPOUND$ phosphorylation of beta2-adaptin, a subunit of the clathrin adaptor AP-2.	1
2205	Genotoxic effect of 2,4,6-@COMPOUND$ on @PROTEIN$ gene in zebrafish liver.	1
2206	Extensive neutrophil infiltration and chemoattractant factor interleukin 8 (@PROTEIN$) expression in IL-10 KO mice were observed after @COMPOUND$ administration.	1
2207	Extensive neutrophil infiltration and chemoattractant factor @PROTEIN$ (IL-8) expression in IL-10 KO mice were observed after @COMPOUND$ administration.	1
2208	In addition, increased signal transducer and activator of transcription factors (@PROTEIN$) 1 and STAT3 were observed in @COMPOUND$ treated IL-10 KO mice.	1
2209	In addition, increased signal transducer and activator of transcription factors (STAT) 1 and @PROTEIN$ were observed in @COMPOUND$ treated IL-10 KO mice.	1
2210	@PROTEIN$-mediated @COMPOUND$ efflux generates microparticles in addition to HDL through processes governed by membrane rigidity.	1
2211	@COMPOUND$ treatment, in vivo or ex vivo, increased nuclear NFkappaB activation in cerebral arteries and increased levels of the proinflammatory products of NFkappaB activation, @PROTEIN$ (COX-2) and inducible nitric oxide synthase (iNOS).	1
2212	@COMPOUND$ treatment, in vivo or ex vivo, increased nuclear NFkappaB activation in cerebral arteries and increased levels of the proinflammatory products of NFkappaB activation, cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (@PROTEIN$).	1
2213	@COMPOUND$ treatment, in vivo or ex vivo, increased nuclear NFkappaB activation in cerebral arteries and increased levels of the proinflammatory products of NFkappaB activation, cyclooxygenase-2 (COX-2) and inducible @PROTEIN$ (iNOS).	1
2214	@COMPOUND$ treatment, in vivo or ex vivo, increased nuclear NFkappaB activation in cerebral arteries and increased levels of the proinflammatory products of NFkappaB activation, cyclooxygenase-2 (@PROTEIN$) and inducible nitric oxide synthase (iNOS).	1
2215	Effects of DHT on COX-2 and @PROTEIN$ were attenuated by @COMPOUND$.	0
2216	Effects of @COMPOUND$ on COX-2 and @PROTEIN$ were attenuated by flutamide.	1
2217	Effects of DHT on @PROTEIN$ and iNOS were attenuated by @COMPOUND$.	0
2218	Effects of @COMPOUND$ on @PROTEIN$ and iNOS were attenuated by flutamide.	1
2219	In conclusion, activation of the NFkappaB-mediated COX-2/@PROTEIN$ pathway by the selective androgen receptor agonist, @COMPOUND$, results in a state of vascular inflammation.	1
2220	In conclusion, activation of the NFkappaB-mediated @PROTEIN$/iNOS pathway by the selective androgen receptor agonist, @COMPOUND$, results in a state of vascular inflammation.	1
2221	The electrons released from @COMPOUND$ by @PROTEIN$ were transferred to CTC in the reaction medium, and CTC reduction activity could be assessed spectrophotometrically and spectrofluorometrically.	1
2222	Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by @PROTEIN$ inhibition or @COMPOUND$ chemotherapy.	0
2223	@COMPOUND$ attenuates the HFS-induced, @PROTEIN$-mediated LTP in a dose-dependent manner in rat striatum.	1
2224	These results suggest that @PROTEIN$ delivers @COMPOUND$ to mitochondria where regulatory oxysterols are generated.	1
2225	17beta-Hydroxysteroid dehydrogenase type 1 (@PROTEIN$) is a key enzyme of @COMPOUND$ biosynthesis, which might play an important role in follicular development of the ovary.	1
2226	@PROTEIN$ (HSD17B1) is a key enzyme of @COMPOUND$ biosynthesis, which might play an important role in follicular development of the ovary.	1
2227	@PROTEIN$ promoter hypermethylation correlates with a survival benefit from @COMPOUND$ in patients with recurrent anaplastic astrocytoma but not glioblastoma.	1
2228	To investigate the correlation between O(6)-methylguanine-DNA-methyltransferase (@PROTEIN$) promoter methylation and benefit from @COMPOUND$ in patients with recurrent high-grade glioma.	1
2229	@COMPOUND$ binding to human @PROTEIN$ : a study of protein conformation and binding affinity.	1
2230	This review will focus on recent evidence that @COMPOUND$, @PROTEIN$ and neuropeptide Y act by converging on neuronal cyclic nucleotide-dependent pathways to alter the autonomic phenotype in both health and disease.	1
2231	This review will focus on recent evidence that @COMPOUND$, natriuretic peptides and @PROTEIN$ act by converging on neuronal cyclic nucleotide-dependent pathways to alter the autonomic phenotype in both health and disease.	1
2232	Deletion of the first @COMPOUND$-rich region of the varicella-zoster virus @PROTEIN$ ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry.	1
2233	Glucocorticoid-activated GR repressed @PROTEIN$ gene induction by @COMPOUND$ (LPS).	1
2234	The endothelial (Ca(2+))(@COMPOUND$) response to @PROTEIN$ (100 nM) was significantly attenuated.	1
2235	The endothelial (@COMPOUND$+))(CYT) response to @PROTEIN$ (100 nM) was significantly attenuated.	1
2236	The purpose of this research was to enhance intranasal drug targeting to the CNS by incorporating a vasoconstrictor (phenylephrine (PHE)) into nasal formulations containing therapeutic @PROTEIN$ (hypocretin-1 (HC) or the dipeptide L-Tyr-D-Arg (D-@COMPOUND$)).	0
